var title_f1_28_1472="8mmx8cm angioplasty balloon";
var content_f1_28_1472=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F54796&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F54796&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    The appearance of an 8mm x 8cm-angioplasty balloon during the treatment of a stenotic lesion at the venous anastomosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 269px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The indentation of the balloon caused by the lesion is clearly apparent. The balloon has been passed over a guidewire.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Gerald Beathard, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_28_1472=[""].join("\n");
var outline_f1_28_1472=null;
var title_f1_28_1473="Healthy gingiva";
var content_f1_28_1473=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F54818&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F54818&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Healthy gingiva",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 328px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFIAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDBid8t8zcMe9SbnDZLt+dMC7HbPdj/ADpwG5889K8259ckI8sn99sUyIMXBeR8emaeynIHSnRozHOMCobNFsN3DdhS/wD30amjVwPvt+dOigwcbeO1WHQqOetK4pW2Kjl8cu3p1qpO8gJwzZPvVyc4qlMDtJ7mrjIhxKryOP439Bg1ZtLeaUAksM+pqWzszNMMg4rpLa0CqMLTvcznaJkxWZXqzE/WnLAzngkfjW1NBtjOByeBTre1CgZPHrSuQnpcxPsrDpuz9anitCR1Y/jWylpukyelWFt1UdKNQczGjtWB6sAPQ1OImX+JsfWtBoxkZxSmAgZ/XFFyW7mVLGeTub86pSlxxlsfWtO8JXPWs2dvlPcmmpFxhcou7DklwPrUPmkkgs3PuanG5iQRz9aetrvIwOafMaciRBCjtzvYn61ejDBQWY+/JqxDa7ByPpU0cYBKntWdx6MZGGH8RGfemOrBsBzjpyaupHkj09aa0eGG7mlzFRSKmCo5cnHvTGLkj5jj61dmh43Y4qqp2sTj601ItRvsRBZE3fM3B556U61kcAEu2Tx19adkM2WwR3GaeqjDKvDL3qr3KSsWV3NkF2LIcAsecVXcSMDjIUnJPv6D1qQDbK4J3A4AJ7GpbhkIHGOPyoTBqzM18hsAsAO2aYrPk/M351JL87nHSrEVvlcmochuNlqZ0quOAxxj1qvh+cs3r1rVaAs2MVA8RVtpHNCYWTMqRZM/ebHsajKPjO58n3NaNzCVUDGBUAjYnA6D9afMJU0VTGxA2s5/E0wq/GXb86144DgDGTjmo7m324IWnzC5VcqQI8n8Tce9WYYX5DM31z+lLaoFmBxxWrDbZPHepbBqxTWBiRksO3WnfZHU/eOB71vw2gdCCuMd/WntZZAPbsaDBzVzAW0Yt1P50+W2aEqQzenWtV4Ci5A6Us0e5FOB060XHfUzmtWZc7jg+9UprVlJyzVu26AqQetRXcXOMdutFyOtjlrqzdkYZOfrWVEZIpdjO3Hua7J4Qy5x7Vz+q2+2XcopqQ0rshQtx8zH8akVXDkbmx/vU62UMyjHWr/2bcv3elNsbjbczZFcr99vzqi5cNyzYHvW7JAApULis+W3JBahMVkVY3kH8be3NTiR1Vcux59ag2lXwfWpJByv1FXciUTUu0EUzKsiygHO9Rwc/X8qZF1yKlt0imu/KuLn7NESxMpjLheOBgc8nj8adEnJx3qGzoWmgqQlzyO9aFvbDadw4HSi2hP1rSt1GzA5z/nFK5nKT6FERAPnHvUM6qSfT2rTdRg7QMAVmXeVY+vepHHUzJ+ZMY4pqw+Y3TjoKmCbnJNWbaLkACg1ehZ0+32KGIFbcKARggD8qqQxhUHvWlCn7vHYVSZyT1ZUnGZEXPfpVmKPGBjJNRQLmYHBx61pbdgBpLuKWmhFHGM9O2alMIL5IpVxxQ8igMMZFUmRYjMSrjdUc2NhAHanSsSOecd6pO5IYZ7d6LlqFzI1GTlgOCDWbJllwBWlMA5PrUcFqWYg9Kk60kkVYrfJQYxW1a2wCcrnNEdsBjOOvFasEXy8YOaLmU5GfNCFQ8cY71T6yKB071s3SbIW3ZyOBVCxtwzHuB0FIqG1x6x4TP60yVADk59q2GgVIlLkIGIwW7/T1rLkIbAxnHQ0mrBF3CRRs78qaznhypJrYwTHuA6YGCOKqNGAjZHA/nQy4OxkqCrY6VPEhwzbTjPJHP602RPmq5ZOjIIZF2qST5mTkcdD7U0zd7XIdoLbsH1602TGw+mKkSMhhnIpGRnlSLIXewXLdBk4yaLiI7WJWY7hgY64zWnBbxbWWYNHIfuqQcfU8dKVbaSxvZV3mGeJiuIyeVI7E84Poeeeg6VaeLhwg3BRnceMkd8HkfhzSRnOVyg1hL5pZQDGAGDudgKnocHnFVZoMXirL+nQitO2tTOcQoJDvBEpHzbiPunPY0T2lysvlmNlRVOVbJEYzj64B/WmiebW1zNvrQNA/wAuCOc1SitskgkniugvLVwpi2MoTjD5VufUHvVaGDacYpPQcZe6Vre2yvTOKZdWuUbjpmtWKMK59hRdINh5U5GRgEf/AK/rTI5nzHKNHtIYdRWxpxBwwHP8qZcW26HIxkU7S2RJAZj+6HLAdSB1A9/Sg2l7yNtVwoIp4OUx2xmptRtZbG9ntQshij/eJvwW8s/dZsccjHtVaF9oywzjkA02caV1cjkAOahwpwCOBxkdqsOCUJB96g+4PX+lQy0iCP5V4zjPWoZyWbOTn0qwyDaRzUZjOM55oKsV5FxGBWLqkYPOK3rjJXIFZN8u5e3XmmKC1M22jIKmteJVKjnrVSOPIGBWhGnT0plyRBcRjPtVOePAyBWjc5K+9U5z8gouZpGPMmH96hf7yj/aFW5h82T1qq2PMXjncKtMco6GjIhDufc1bteSv61HKvL49TUlkfmGRioua20Nm3i49qlGFbHUg/lUSy7QCuORTCxyW70MxUWydT87YJrNvzlyParauQvXr3qrMB5bHPOaC4qzKix5PHSr8EeGXHaooR0JA9atLgMBQOWpeC5TkY5qwT8nFQoRjHoKeX6dwOmKVzGw6FguD6GrpffGM9qz0BLA81bQjaOKEwlEkLAYqJnYNhSQTxUckuXGPrT3Taqnep3gsADkjkjn06VSDlsRu2E747iqkgwufvE+9TTOpbbk1Xm+VBgnk0NmkUQCMk46mrUUWyPdjmmwqpOAN2R09atpnyxkjA4pDkRsq4BJ568VesJEWSMyHbHkbiB0FU8bwPagnAOOaVxOF1YsalcxXBPkRsrEtkH7oGflx7461VsGEMimQqEyN2egHuBz+VKikFWYjaevtRty28rwenP60X6lKNlY7u9vbWztnilSMraRsDG0eW5K+X8rcgls5zg7RnuCeImka5unkY7mJydkYXcfUgVVdXk8yWSQtKzbuTktz1J71etpG2yiMpGrgI0hQkqM57c8459auU+YiFH2a7iyx+TIFLxycBiEbO32Pofb6U2SEmNnZQI2Bwx4Bwece9ToUnllc7t2wEK3zM7YAPTvkk/hVi1ikkvF8uZPNUAgiPdz6Yxyef09qncL2Of1G1e3nCyIVLKHUdflPI5rS8G6SmsaulvcGRLbpLJHjKZyE69i2B+NaPiTRUtdJjuluWnmikEcgb0LEccnGD+ec03wMzrqV5HGcEwxz5/65TRvj2yA1XCNppMudRyotx3MyaK18uMwLNuJzuYjBXA4x65zVYWpuZG/eLEsWPmbozE8D24BOfQVq66Bb3DwR7fLillC7Tkhd5wDWbp5+ad5OAxEe45OzPVsD0Ax+PFRIuF+XmNzTleS3WM+T9nlmVZLiUBn3A8ne2PmII9velvY5RfNHKc3MTBXlujuLdAMDHpj1471n7WjZ1injkLYO6MYCjkYBIyPXA9eeatRXcCqim3Rtin5pSzbye2OwHP880KWljJxd7okFs1xcFZIwJjuw6j92w4OGBA2gHjHH59a+pwyGESB4j5JAZogOFPQn1Ht+dQyPukYxp5UbHJR28zH5jNRTeb5pkZmaVON5OcD0z6UrjUNTTh8qQRQswiuIVy8c0Y3Z9ueQRgjjp15NRXltGC6QxiZgBKXEwYxr3DKOh74ycVXtbi6itlWSSd7YMdhABKN6ByMgewOKuWPlzuEjleAohZdy72Vjw3IHAwTj6+tDdyXFxdyrdW3lkPbNNJbtwsrRFA3Gcc/Q/hUU8kMqxDLoVDDyzGMLzxznnP0rZ1aCJ7eNo2v23FvluJFwBnkog4HPUDpxWXPclhIZ03mQKDx3Axuz1z7dKQou6KCrDtuUulbay5R16xsORkY5B6dvXtVCCFhJHH8jHcNuOcZrVnkdoBBu/dKxcD3I55/AVUt7eWV9kSM7BSSFHYDJP4CmbRdk7mlPuS2tj9sa4Aj2KmWPlL/AHOen4VXRSCTjj60jqF3KpJXAIzx+FPgy5RR1bPtQZ2sh0nAx1IFNSPf09OaWUZAOelORwsQTYAeOR+P+NILaEDpye4qBwVyOtWj61CwGOOvY0gK8hAj9TisyWPeScdOtaExHI7VWbG8imhpWK8KfID3FWhgA460zaNobnAp4A9aY2rkU4BBzWfc1ozkbcY5rMnJzxSuEUZsoJJ5qsP9chPqKvTKdhPSqUg2SR/WqW4TehtP/rGHuadGQrZxRIP3jD3NOCdM96k0Wxdiwep6dKeh55PFQwqTwfSpNhJyDyD2oJsWHR4trSRsqtnbkcH6VTljMiZ6KD+dTyHEYwT61DGT5eCemTVCSHRdCDUsZH3hz71EWCNheSV61GjHOCOKTZXLc0FkCkAnPGetWAVIGDkEdaz0BzyatREDn06CpE4l2PGOetSRE5wuST2xVVJBg57Uodsb1zgeh6UXJcSTaWkLAn5QTjHQUKVUgk7vz4FQtIW4yQM1ZuXhjsYRbSEzSBkuEZfuAEEbT6H+lNMGuhBI0sNi+UjMU8qhWYfNleTt9uRn6iqErlj83bPQ1cv7s3htQUCJBCIUUdMAkk/iTmqyRhmPHBobNIKy1LEBBIYABsdu1SLuLZycdaIY8dBgVMFIPyg5NK4tBdw2bR0FCglQNvH5U/ZnAUDPtS+W2cc7u1AJIgKk+4FBG05PIHJDZwfb1q8LeWNUdgPn5Ge/4VG8W9tw65pgmigOZckHaeCVFXwgitFlWe1crwIm5fPoVx+vT3oS2Uvtcqoz94g4NR3NusM+N8coxncpyKL2G7S0LtiLXyQSbxpCv7wRxqVA+vJx78Vu2LW4s1NvJczRxo214oyjiQ4yzN04GR17nHasK0eRT5TXj28RHO0biwHQYHWrElxdMd7eZHN/rpWmUCOTHCttx7n/ACKpSsYzhzMua5G0lq6+W899dxeWyhfmduoY9DuAjPGODmsnwXO8Wv2ixgYl3RP3Owg7v0FWTemS3nW5RUlDeczsSuCNpXHfB2kE9ct7mqvggquvQStngSsAox/A35d+lUpe8hqNqUkyrqcim7faiiNWZjj60+1tc7JWEkc2QxVYySAcnLenb3701YhFcE3IBkRdyqyhlZuwOeCvUmrzTwRzMkNzN5Jct5qx4JXHQL3POAT+lZ3u7mr0VkK5tEbaIJpgxBjZGKIzHqAMZI5AHPbPeq6xuWaIoxuM4+bqMdv0q0zic+ZcPHM8qbVj3F29vu8IegC9MComSIDyyUMucMyEkJg9CMDn9KTZKQyON2BYYIXghsHJ+lKHZJHFvGYkYYaNzuB/OnLF0OAcjuKesOVIwrZHORSEyrA8tjciRAY5EyMHIyCMEH6ikVGa4L+d5O5id+4tt46ErzyDjOKsERq674QFGcgHk/jTEQbcBQcDO48EdvxFK5XmWrO5jL7rh2cplDcNuIwy8ZJ3YOe+Oc+1ZtwxuXBYgMTycYq0AYdjRbQynduxyT79j+VQTB2kZ5OWIySRjNO5CSvdFO5ABYJgAdM96fbMQ4kgMhCnaHAxlsdBSS9QcbdjZXHUd6kttkk0zuGXC+YqJ0LDrkfnTTLa0GO2QWHQnFPhlMUbKVIYjBBHQUiMEZC6kMvcfxA9/qKWeGUgtLuzgE7vvAH7uc+oouKy2ZKkbGMuykR4IDE4BPtnr9BVdvl684/nWrDcxJFHPDbIJUiMXLkKrkY3Io74GSTnJJ4HFZsgJ6HIHek2St9SLOSQaY5G1s9cUuMfWkmU7CcUkNooS/eb0qsSWc4zVlwTwTTV+VG4yTxTRZIANoHf2pvlhO/GOTVq3X5VZsEjtTZxknI6ntTM762M+bJBHbtVJ0PJxWlKgLYA6GojDxwKVyr2RkSpwaoXIzLGp4wRW5cQYBNYk6n7QM9dwq4szk7m0pxKwbpk81ONrNx2qYQfvG+XPJpzWxHYilew1NMBgYz1p0RXvj2pu0gc81ETtPNFy0rlrKhHBGW2/L7HPX8qpTqBL8jHGAR7e1TJJ82RST9AR2pjSsyuwPBPXvS5+Y5PNOI4AzT4YC/J6VLNLpbj4A0jAA8ipx8px6dalgtwDx1q39lBwSP8aTRm5q5ngtnGCO9TL79asSW/FRMm1fekVdMJHAjUKqqyghmBOW5zz246cVEXyctjA7VdEsNtZ7kj33Ts2HcZVFwMEDP3wc9QQRiqIIRccdSMGmEdRzoGCdFLZzj0qVAScDOBxmoo1ZmBHb1q9aw8ZPc0A3YljXA4GT2qRYXPSrMEOR0q2kY7DJpmDnYqw2x/H1qeOxLSYGM4zzV6OBmXBHGanWykbBRXIPTCk5ouZuoVVgOWIcr8pLYP3jjjJPP4U+azkscFtgkkhVkwu4hW7g9AffqKmMEgJJYnPqKSSORxGrYITO3270cyFzFdIoxExYF5mBVGUZ2++Mc/XOapXdmxR5kycdWJzu9znv7V0qapIkDJLEJCc4OMD8R3AqKS0t7m2FwjuSow6yZYs3c4+v8AniqsnsONRp6nLFhAqvayuso+bcmQwHIPQ/LgetWiJruMStHPeIpYIjMMR9TliDknoeR7VNN9rs7oP59xbnIcngZx39CfrxUS2wjdp7lCJlbokix5B5BGBgcA9MjjnrSN731KBMbgLfrcGSRt6yK27AOOQp+8T65qbw6Ws9RbdC+RmJkIw65OD1HB/CrbpceZNLHeoQW2NcCQksTznGOvOMDv0qOztiRe3C3GyMyFBNcE7ySrZJHJ55HrQim1ytEVxci5uXnmXLMxCKyBiFHC4zx1HPXvxSQxTJHJkEBSQwaNcAjnHP16D/CpYoI5Mi1jm2HlYvLLByOpDenXHWnh3k8sBoHVUwAqA7SevUdfft2qdgbtogE7SwhESGFEGdyrtdicAnI6n/69KitlFkIKqu0dgF/CtGx07fGskzYhOQCrAtnHcdRn1NXEis45VMcMpbCndJyobPPA6inZ7sydRLRFO2g3NiOMZxhWEe5GH16g/wCeKmhthsP+k/vmJXYADgd+tXWnVCzRqf8AdGFVfy+lQC6lDjDsOADt7gfzobMeZszbqyCsTvyvHLLjkjpiqbWhT5gufSt1rhyjcZY4GWAwAPaqxDDIboKktTaMWRTgADBz1pJW5BwAemBWlcRoyrwd3c+tUZoiFOKRalcy5V+Yk+uMUxeJ1JGeeB/SrLA/MMd6rOh3Y7E4P9aDdaliyCTTrHOszxYZtkI+bJHAHoM4q9KswtDZXzOjRt5sYf5WG7qMEZJJwcZ454NQ6akyGQxSxxmRDAwlIAdGGSMnjoB3BrTTSVZYwlzaJuI2q9wv7z/ZVuhNUjKbSepituJ+djkdmNOMY5x+tW7yFUuZI0bcgc4OD/XmmiPgcVOwOWhRaIDHr2pkoxGR61qras5zj8TTLi0KD5gR+FFzN1Ec48ZD45wabj5l9M1fuo+fl7d6rFMEZHNUjWMrkiYBBHIpkh3ZAoAIFT20JdwqjJNJsT01IUti5AC5Y1fTSX25fIFdDpemiIAsoLVeuLcbMY/Smo3VzhqV7uyPNtUhEOQBxXL3q4uE/wB4V23imPymz61x1yN88Y/2hTia03dXO8t7Xrhavpp4mBGOnQ1JZJ8mSB14rZgiCqMEc1oopnG6jRy97ozRpuHI+lYN1blDhgQa9MMQZNpPJ6isPV9KVo2KY3fSplC2x0UcQ07SOExtIp5GV+lWLmAxsQw5zUK8cVKZ6PNdXIx8zgEVowx52gVRxtfnnHpWzokZuLgA8oOaG7EVXZXNHT7DKhmHXvWsLBcDg81ct4gABjmrQQcDBxT5e55zqNswLzTdoJQe/tWRLCckYwa7aSPIwRxWNqVlgl1Bz3qGrG1Kr0Zy08S7syZC9AQM4P0qsMkhcdTmte8gBRj3XnpWYhywBwMcbqZ3QldE0QAHHf8AxrTt028du1ULYDzR7VtK0Ztwvlr5u7O8E5x6EdDTSMqkiSFASF5J9q17W16FxUGl2/yB2HXpxW5DHwCAKNziqTtoMigAFWYoiMYLYHTnp9Kmjjx0/nVmKFm+6OncnA/WmkYOZnmAEngYpj2ynqorTMRDEHGfY0wxe1TYamZL2eQcde2apPG8L7lyCODXQmPHPUVBcW6yK2OGHOBzzQtNjSNTuZcrQX0GZflYYDHHIGeTntWW1ulqwARSHVotzIPnXuAR0/nW3bxxwzeTNFmTJByueMZzj2qO/MCxzRzMpVxldhwOvUgcemK03VzohOzstjC1iGFIvMwkMyKv3V+8wA4DcnPIH9etTpbwrpaqiRLK4xIG+YsyjJBPYNkDHXmmPykogkbY3yLhdxIPoOvpz65q9pds95odwsgDywXLBd5IySwznH3j14pR1NpStFXZFEN6DbPdRyB/LZWUIcYxhc/d6/Wp9N0uIuZ7rOwv8sbHlh6kjoP50W8hgeWJSZDguclF2+/Tr6D1q09wTORbkSHbgOR09cU9N2ZTb2Q278ppGwyEKxCIi4UL/U/Wowks5AAIHTAq5b2Zf5piM9cetX4ogo+UDHtWbdzF1FHRGUlh03frVlbFMDJH4CtIR8cCniPjpSsZOqzNNjHnhm/Ko5NPUr8p5+nFa/l59aGjwDiqUSPas5e6snRSduR6ismeLgnIrtJY+D+tczrduYR5kYwp+8Klqx0UqnM7MwZUGc4zg5x61BIpLZIyD681aJBJzjp3qJxtGB06/U0HdFlu3lCadGh+YmVpW2sDtwAPmGOM8c55zQtwV88Ksa+djzFCjkDtUXmSPHFFkkKCq7eAR1I9+fWrkduYI0d2BmdQ0WwggL1yT6+1FyXZbkOzgYTDfeB56elXLKzaU5x8tSWloZWGcketdVa2KJaEAfN34pKPMzmrVlFGItpx0FQXVv8ALnFa8kRU1XnjyvSqt0Obm6nDX0flTunTPTjtWfMhLAjoTW94ii8sxyY6HFYzLux9aSeh3UndXGxRl2wOprq9C00qA7Lkms3QbFppgzDqfSu9htRbgKvUD5j704R5mYYmtb3UQeXgYAxUEyYznpWiwB9sVVuVHNas4LnnXjlAkG7HeuDf/WIT6ivSfHMavp7k9ua81c7pY1HqKiJ30H7h6pYZZQAO9bCDGBkcVh6fIcED1rXhyec01I45LUvRpu7806WBfLI6k9vWmRAg9eamQHOc4PUHPSrUiTiPEGnFX8xV4rnJlIPHWvUdWtEmiYA7vfFefatbNBMwwPrWTXKz0cNWurMySe5rs/C9rstlZh8zcmuSsoxNdxRvnDN2r0WwiEcKjH4Ut2PFTsuUvxJx0FWVUdMio4QanxWh59xjINvTJqK7i82PJAPboBVnFKEBAxu35P5Yz+fWle+hSdjj9RtfLJxnBrn5oGWNmVXK7SQR0XBHOfTkfnXf6pbRvuCHIx3GK4+9hKSMm7aCCOc4P+cCo20PQoVLop2i8q3Oeo9q1rVTNMkYOcnk+3esm25XABz3GOlb3h1RLcSyAHao2jNHQqq7Js6O0iHAxwOBWrFGBjgc1WtUAH0rQiWrSPMlIdGnTpiptrMAACVB4GKRB+NWY0kADorc9Dii1zJysQbCcn0600rU4X5egppFS0NSK5TmmMhwf6GrRWmlKRSkZd7CXCyp/ro+QR1I/wDrVkTylB5u4NJkk5/hJ9B/X9K6WRCDnpWLqlmiuGOPJbPuQce3NPY6aM1ezM25llwJgwDxKXw2FGc5xxz2AzVPT5pIY9SeBoisgXIZsEFsnK+uDnI+lTyQW/nooCkbs4uWwSOOuMde3pmqbpJEtwsS4tJJFPAyO5Vc+2T+XNO/U7kk1YntnaQ7OSHbLZPJA9cV0NjaKsSu3OchR0/E1naDZeanmyAhGP3vYdcfpXQINxBOOgAGOg7CpRy1562QqIeM1Oic1JBEzAsAcDqakC4qrM4nMYE9qdinhTTlWixDkR4pu0+1TFfSnCIsoIPfAGaLMnmRRlTqMc1k6lbCeF4zxuGM1uyptJB6j1qnOmc5pNXNITs7nmeWV2RuGUkH60MMxgZOc9Kva/D5GsT8AB8P09f/ANVV415GM5HOcVCPZjK6TLNpFHCDvxLIy9MkbePUdee1aNnbNPJuYZLHsOtNsLV5WXIJPYYrqbSzSGLGFd8gs4PA/wBkev1oS5tjmrVlH1I7W0SDAyGIHJHQfSr2/K4HIpNvHAAFAGPStV7ux58nzPUrSpk5P61UlXr6VoSCqk65zUMaZzfiO3MumzMv3k5rnLGBpduRknpXaXkXm29xFjO5Dis3w5Y5Cuw6etR1OunU5YM2vD9oLdFZhyo+Ue9bDLweuaFVVK7VCgDGBTnAJAVsg4zx0roiuVHDOXM7srsMZ9Kp3J6itG6QxkAkEEZBFZswG7NTJhE5DxhHv0u4B9K8/wBH08zzpI44BFem+IIhJaSqe/FYX2AWXlqCDmpgdEanLGyNHT1AXFa8IAArKscbRWtFzjPWkjNlmOrUec5A9/pVZBx71YjZl6Ma0RDJ5jmIhh97nB7+9cr4n01TH5ifMrDKk/qPwNddOGZSGzsUD5s5x+NZWoYMLxFQVPP0NOauiqUuV3RwXh+zEmpF5OsOTjH5V29uvyjNY2l2ohe4Pd3x+A7VuwjoMVjHubVp80i5H0zipQCTxUaDAxU69c1ZiG2lwdrqCQp5I9cdKcO1KDggjOR0oC5HJhozHuVUbbksvTHcY/H8DXLa9ZFHbcu11OCOv/667C4ii2oUcdPmwKzryAXUAXaTKowAB95f8R/L6UpI0pVOV3POHBR2Bzgn8a6vwnF/oHm4++5OfUCsHVbYxO2a7DQ4fJ0+2jHUICfqRmoi7s6687w0NmAcYq2g4qtEOmatoK2PNkyVBV60jUqeW3Zxw2BiqadKv2cRJZZGKY52ngmrgrsym9CN1CAqvQ9Tjk1Ay81cnSME7XJquVPoceuKU46ihLQhIp2/ETIFXk5zjmnEU9Y22iQqfLB5I9O9TFPoW2upUccmq7xrIjxtwGGAfQ9vwrWaz3XRjR8IV3g9eKzSMqfXFEouO5pCaexweqwvHcDJyUOPoadE/wDo8cBO5VZpGBHJc9/0rR1q2DXTAYAxnJ6L78VX0qz3zJudB3yc1krnrKacE2dDYKYtMt48YLDJH4n/ABq9CmenYVCiDd0x2x6VoWsR2NJyVTAwP4s9q0irs82pLdmqdo07CKNu3GP6/Ws7FW7qX/RoFAA3DcQPSq38q3rO7S7I4qaaTYmOKmtseemcYzjmoqcueOce9ZxdncuWqHTKBIwHTJq1pxBRlzyDnFVpSSck5Jp9nII5DnoRVwajO5nNNwItRU/aGPris+Reta99tZcr1zWXJxzUVPiZdN+6jjPGluQbW4A7mM4HfqKoaXbeYwyOfpXV69bC50yaMsFwQ4YjO3B6/lmq2j2yRkhBkDgEjGR64rmafNY9KnWtTsXLG0VI4yAd2Dn0z7VoAdBxgUsSgDFL346CtVGxyyndgR7U05AxUhPy0tyqKU8stgqCcjoabMrlV6qyjrVmWqsp9qhmiKD/ACzD0PFWNMjVFxgYqrcH51+oq1aZDtj1qVuX0NSI549auQ2hLsm9NwwSPaotPjV5CZBlFGSTxj/GpUuhCJzwSygJmuhWtqc0m9kZs5BZtucZ4zVOXoast0qrMeKybNUYWrnERyOMise4w9wCvQHitTWz+7x3JrJQfOPY0oFssWB456ZrXgOQDWHp53DHvW3CcAURHIur2qxCA8iqxwpPWqyYIqRGKsCDgg8GtCDZtraS7sv3LlS38LDjj1NYl4gUSpLw4HBz3rXsrtvKO4kYzyp5P1rJ1Y4kcZyOSD6iqk1YUL3MiBcYHcmtGDiqC8MAD0rQg6CsomkmXUHyn0qVagRvl5qce9WZ3HilpoNITQFyYfOmBu4HY/0qndgDIIzg84PNXbGL7TcLEX8stn5vTjP9Kr3UZDt0we46U3FtXHGWtjm9XtRPbsQcSggBdv3s9ea3bZQMYHQVn3KYkQdAWFadsORWMF7xrOV0i7GKtJVZKtJ0raxztk6D8q1JH8q7ZjnBArLj54rRnVnjjk7lcNWtPZ2MZ6tXEjYl/kUdelWbxd0JOcY5qG2icMGOMVZuDiFuCe3Fbwj7juYyfvKxkd6uW/z2UynAxn+VU24erlm6hGRjgufSuel8VmbVNhiPgQyZKgMYmI9DyKoTIBcOqnKgnBFW7lTChhJz8wfIGMjGMfpVKU/vd3TmlU7Mun3Ri6m3lzqzZ8thhgPboaq6cu+5ZssVGcAnp6CrmuLiPd6Hio9JUeWWPGTXNfoejGX7s1FXGM+lbFlH5ljIBwQxIx9BWWOw9BWjY3IggcEbucgV0UWk/eOCtdrQY7b0iJ7LtpAajQ8AGpBUt3FawvFLx603NLmi4rDmO6kBwwNNzRmlcLCyHIJqswqcmoWx2oBFW6QMrqQMMpFZ2lghSp6jg1py+tULX5ZplH96ofxG0X7rNBfyp/X8aiViBzU0coVHG0FmGMmtEZsu2FmJU82RiBnAA7/jVCViXIPbgVpLciPTsIQGGAR0NZEjccVU+VJWIhdttkMp5qrMetTOetVZj1rBm6KVweR7GtSxjLOcDPNZFwcsPQmuhsVO7EedzdKIq7HJ2RpsUS1dcM2fly3BB+lZ9wzCMBl/HFat0CdOK5XepG/PUc1S1sFJ44924Kgx/n8K3qRaRzQld2MxzxVO4arMjVRnbIrBm6MDWW3SoO2c1SAwVPvVnUTuuwPQVVmfbtHvTgtCmGn9PxraiNYWjNuj59TW5EQRQkVLcuRnipN3HvUCNgdafuqyC/Z559eMD1qDVF3MxwQcYYEYOabbPjdzzWx4mjUxQyrj5hgkfxcAg1fLeJN7SOQVv35B7YrQgPSsxjtu2HYjNaNtyeayiaMur2qdTxVVGyamVqszZMDQTxzUYbpTs0AS2zbZ1IO0g9fSnSOz71P3t2T/ACqvuKHcvUdK0NUSOG6m8nvgkf3cgH8atbC6mLeRFbqHcMcbuuc9eau24PJqvdOJLiI8ErHzx3zVqEAIOetZxWrLb0LMdWUPFVU61YU0zNllD09a17JvNiIYAhemRWKhq1DM0a8EgfpWtOfK7synHmVjYJVByQo/Kql5MOAj59lNVnuieo6VC8wY9K0qV01ZEQpWd2I5BbnnmnRS7HDHPB9ahJyaAxB461yp2ZvbQsXkwlkDAY+XHNU36dalZtw5x0qOT1NVJuTuwSsrGXrgH2RySABySabpqlYEHcDvVrUE8y0kUddv60yxJMSs5JJGST69zXO1750qXuWLYzuqdT8uKgHWpA3FbGDJKeGHNRA0uaBEhb0pQ1R5pQaBWJCaaT1puaGoCwE1G2aUnmms3FAEb8j2rPPyXcnHXBrQ6jHrVe7hKyCYn5Wwo+uCaTXUqLtoPXnHPtVuGBniDL1Mgj/MVUjQlY8DLMSABWjd4ghESE/f5PrtHJ/M/pWkY3V2RN9EV7wqLhkVtyoNufp1qlK3WnuwANVJX96hlxQM1VJm61JI2BVOZ+tZs0SIWOZkHvXQ6XMI7iKR/uqcmucjGZc+lbNsxVBzVU9HcU9VY6i+JCXLPt2sgCjv9axLqR5GLSNubGKs3N81zBCjLgp1PrWdM5IPtXRVaexz0423K0rc1TnJwankbk81UmbANcrOhGDdnN1I3pxVC6k+ZfrU93MAXOerGse6nwASeM1S0Q0rsv6G331J6Ma6GLjFcvpbbLmQerZrpLdwcZIpxQ6m5azzycVIhzUWMg9cilQ4IqrakFmEjPOeK2NQuVk0uCBl/eKfvf7I6fz/AErDGQePSr01w8sEKPjEQIXn1raOxm90YN0NtyD0HSrkDYxmq14oaXpz1p8JBxzXPs7G+6L6NzU6mqsecZFToapGbJs4pc5FRsSBShvWmA5iSpA9K3NSKSaa1yQRIyxxj0Pyhs4+hI/CsIEE8VqySed4ejAU745NpbHHCkDn6Yq47NES3Rj7zIULA/KojGfQf/rq3EzZH6VXlOPJxjlV6f7oH9DVmBcYbtms0aMsrnNTIcd6iJwaeKGiSwh6U/NQq3SnZ4pCZIW980hNRbsHmgnigLEqmnGolOR1p+7I60rAONRv0zmlJwaazfLjPApgMYfu3JFMjVFKiIHZgYz9B/WlkP7uTHQDk0luwZU4+6APyqWtSlsSA9qcDTWwD1pQabAePc04HrTM0mcCkhEoNGajDc0u4UCH5oJppYe1ITxTsArNUbNxQajZqYAGO7Apl4zFo16Aktj+v60kf3s5xTJZVN0kZbMm0sB7AjNJ7DW5csBi5t89FbJ9qLqQtITuyBkKfUZ6/jUKOSe2cdqZM/5Vre0bEW1uQzP1AqozZanyvk/Wq5JBNYtmqQkze9U3bJ9qkuHwOTVG8mEUe49ew9ahstIZqWpQ6fNbLID+9bBI/hHr+db9q6sqlTkda871GOS6keWU5Y/kB6Ct/wAKaiZIDbSn95FwPcVEKnvFzp+7c7HOAaqSy56Gh5gYuDVdm610ydznSEYmqN/LsgdieAKtSHIJJrm/Et2UtxGh+Zj+lZs0SuzIuZC7f7Nc/r10VCInUmtCWdyuKy7qDzGBPXNUmaRRraRc733HgqxBrq7eQZGOhrhYn+yXJb+An5gBXTWl8qqAxyMcEd6ewSV9jpY2AQkmo/Mw3NZ6X8QXmVRx3OKa+p2w6zL+GTQ5Iz5WbAmC7fTParLSfLnNctJrMSA+TFJI3bPAqhdapqF0CiyeUhH3Yxzj69apVLB7Jsk8TeITbXsUVnhzG4Mp7Yzyo966KxZJ4llgYPE/zKwrzi5gZHwR15rT0Rp7Zi1vK8ZPUKeD+FYOdnqb+zTjoehIzLjjkVbQZwa5u31edVCzxJL7j5TWlDq6DgwS5+oq1URi4M1sU1hjmqJ1VDjEEv6Uh1aMf8u8xH+8BR7SIuRmjEMcn8qlFzLFBJGFCxykEg89PQ1zZuL/AFGRoYG8hWIH7vqc/wC12/CuevrKe2nZJ3cssjxnLE8qRn+Ype1fQpUr7nay3MYuREJF3v8AMFB5471p2Z3dTgd64OzVo3SSPh1OQa6nT9RR1AYiOT0PQ/Q04T11CcNNDfSMENg5IoXnIzyKgtbjazB+QeatSoCNw6+3etLmNmhFYDGacDUaDvUg4+tK4AT2oz8x+lKwqOTg5pXAmB49qARiog+BzQGOOM4obQWHM2D7VIOVHrVfOTmnb8c0rhYWZv3bD1FQwHbGMenNQ6rMYNOuJQcPtKp/vHgf59qLSUPbxsDlGUMDSb94tLQt7yaeG6VXU5qVW9aZNiXr0ppP50qcqT1pG560bCBWNPHXmkTkilwM9eaYAcZ4pG4HFPYZHSmNycGgSIyaTaTz2p2QrnP4VJJKixnHJ/lTQNlY/LGSeMniud1LdNfb0ZlMYwGBwRWreXRcFYmyT1bsPpVPyePr61lN30RrBW1YyLULuNeSjj/aXn9KSXVpujQLjHZjUph+XAFVpYuOlTd9yrIr3OteXGWFs5btlwBWqY3Ojy3TLsmhKiS3PVQ2MHPfrWFcwgyIo/vd66rR4ludQuLeYsRc243EnJyKSu3YJaK5z5kklOcBfQY5qGS33cnnPrWk1s0EzxSDDI200GPrWT8y0+xhXFoMHisJ/Os9RSS3+/np6+1dnNFwaw7+AC4jfHelYpM0YdWUxqJkaJjzhhUzX0RBIcUSKl3piQpEDKhzuxWYICOMdK2uzKyJrvUUWMhQzGubuJWuZS0nXsPSt2W3yvSseeExze1EZa6jSVik8I9Kja3yR9a0NtIEyw471qg1Kes6VLZgtIp+Ynp2rLtlboCcV2Xi28RojDGQxBOTXO2EGccUVN7I0pv3bsWK33AE5Jq9HbccLVuC2PAxV1YQowOalRIczMFsPT8q63T9JisPDFxeSoGuJhhSeSo9BWZa2xmnVF7mt3WL5P7OS2iyqxr36sa2jFJNszlJt2PO9XiQ3YMSnYVABPf1qzpsYx0qe7jaeLz5HUbT5aJjqMdadpicCuee50J+6aFvADz1q4IBngCnQJ0q4iZFSQVxEMc0x4gO1aAj9qb5JZsKMk9hSaBMm8OOkN+u6EGNFaWR8/dVRkn+Q/Gud1Ei78+RwBM87TbQMYBAPH0xXWwaeYtIu5ZCFkuF8pQRyqDls/XFc1cRBLSa4Kg7ZEQE9Rndn9KuTaSQo2bbRUtEyuCOaviDK1HAm1yO3rWjGnFLcbGwNNGuEc49DyKuw6jdRqFIjdR2IIpiR8VKseBTVyXZ7j01Jv4rfH+6/wD9aphqijnyJPwIqFYvalMQ7gU7tCsiY6xGP+XeX8xVK+8QLCpb7JIwA6bxUxgG3oKoahbgRfKOTUyckrlRjFsnttfE0QK2ZGR3kH+FKNSuXcFQiRj+Drn8aytOh27hjA9K1oIhkZojJyWpTgkdXp1pa3cCyKbgdiCeM+xxVR/IgmuLe6RzNHyjxn73fkEkCn280YS28uSTKnLhcjGOmPY96brAxqM20k5A4+orrly8t0jkSlzWb0OZvPMuHJd2ZedoJ4FRWtzLY/IF8yItnbnBX6H+lbBh+Q8ZqjPAM9K5mup1LsPXXLfDf6NcnaNzbVBwPXr71Yi1iycZBkGeeUNYN5bQSy2ttNPHaxyyEvNIOFwOP68epqe3iXzMI4dBna4GAw7HB6cVHNK9huEbG9HqVmQf3hGfVG/wqQXtqeky/iDWRHAKnWD2FXdkOCNH7bbA/wCuX8jTW1C2H/LX8lP+FUxB04prQDHSjmZPIi0+r2yDI3uR6Kaz73xGE2rHbSHcePmC/wCNNkh+Q1mXsRN5CB0wTipnOSWhpCnG5qR6hcTANsRAenU1MRJIq75C2e3SoreHaiqB0FXkTGKI36ikktiFYcdqkEfy1OEp23AqiCq64FVJlrRcYFU5lwDSuNGXnyp1lABKEEZrrLKFzPY6irLtJEbooxtB6fqa5ZwfMUeprstPD3lu7KD5MsOzGcYcelFNc0rCq6RKviW3VL9ZASWkXLDsMcCskpla6pYF1XS4nkGJwuA3oa50rjIIwRwRTrRs+ZbMijLTle6KEiVlajH8ufSt2ReKzb1MoeKwZug0w+RNGXU+U/Gam1Kz8uZpEH7pucjpVSBmdVVjlV6VvR3SNp5ilAJxxW0dSHoYDxAjgVkalb/LkDkV0TJgYxVC8jDRnim4gmc7EmTU6xDcD70sMfz4HrV0RdD71pFXFJnL6jI0s8mf7xq9YxYUYFZb3Ec95KE6Bq6LTItyjgdKle8zaXuxLUCk4GKtxW7MwAHWpIIgOav2rg4TGMnk1tGHc52+w7TYRCsrbR55GEJ/hHes7VcNnkMFHWtu8VDEfs6HCjkk/nXL+IdQhRVjtySqjG7pmibsrDhFyZkXFwrmKBM7EUkg+p61d05BgGudsZzJqhU9GUiur01R5fauOW51Shy6GjAOOnNXUHy1XhWrcSkHnpSuZtEgXvV3S7Rp5y3lO8UYy5QgEfnVeMYBbHAGemcVtrMljaG2uLMmOZCDNC+TIMdfbr0rSnFN3b0MptpWW5VvriN7RbZdwlTJKhSSx9BjqPrXM6tbmEJDJGEdY/myOSW55+nArf8AOaCfzbfc8zgfKfmwD/Cc9++R0zWR4im8/wD0gwrCuDGAOhI9vxpT1uyqas7GZZZ8mPJyQNpOeuO9acIyBWDosxfzY3Ylg24E+/augg5FKL0NZxs7FlFqZFpsX0qygqrmTGhKcsZYcZz+n41IBxTjjaBnjrj3oQiGRcZGc+9ZuqkR25bnIAxWo44rL1fKiIMAVcnqfT/CiWqNKSu0VLR1lyyReXjAKZz0HX8etacAB5FZVmwNwAoC7iFA6Z/Ote3+U4IIIOCPQ0loa1I2ZoWsbOSFZRgbjuOKfNukld3wWJyTTLd2jIZGKnpkVPPKZZS5YsT3YYrTocrTuVHXg+lVZlxnPbmrz9DVYjLDPQHJPsOtIuJh6nBC5aG4WRWXglCGwe/H/wBel04blTj7vykU7UpmudQwkZBbgKB1PpT9NjY3MicqxBIRv4iOoB9ahx1ujp5bQ1NKNARmp1jqK3GQcetW1FUc0hmz2FMaPirIHtTXHPHSgkz7hBsPvWdOzR3qsjYOwqRjOQeorXnxjHvWPeI3nysQQAB/KpaN6SuzSSIgIeCGAYEcgirSqR14qlpEhmt3h6t/rI+fT7w/KrsZ45pmc1Z2ZJikx+VOo9aGZ2IJetUphnIq7KeB6VQnbGT6c1Ny0ilGFkvWQZZlwoGK6i2xBp6AO0Zjyfl5+auJsLj/AEqSQNscNuU11dnKZo5PMclpDj73FFN2KrQehc0i++yysJMmN+TjsfWqt2yvcyuvCsxIp8kIhSIhw25c8dvao365ptytysxUVfmRWlXINZt2vymtZx1rOuhwfSsmao58ah9k1EI33CK34XScbo+9cRrx/wCJjx1ArW8PaoIisch5rem7Gs6V4qSOnkjOwnBxWdOp2tWy93HJD8o6isfUJAsTEHoK1mlucsbnNi4Vbt1z0NaCShlBB4zXF3V0RfSNnvV+DUsqFJ5zUwdtzedF2ujnNMmP26bceGP9a7rSZcqoFed2zbLkn3rtNJnVkTnGKa0ZrXjodShOM5qxbSeXOGLAY55rMecbcg8etZl9qR5CH8RWjlynNCm5aI2NY1gRxyRxn5m4JHpXFXlw00hyadNKZskk4qu+Mdazvd3Z30qKgMs2236OBjFdvpxBQelcXbrulBArs9NH7pa56nxCro2I6uJ0AFU4SMYq5F0yKk5TQ0ryvt8InwIjkNnvxWrPcrc3EYtWEawcGRm2ggA8ADtWFGQvzHt0qxJHEIhJmTcRx8vyk9xn1FbQm0rGMoJyuMkdXdDax+UeFZtxwSfrXP65MGYg7mUDav09f61tSN5aNIVAKDauO7ev4D+lcvqc3z4FS2dNGF2ULCXydQTcNqv8tdZbkEDGa4qVh1J56++a6nSrjzrdH9RzS2ZtWh1NmOrKHjAqqgz06VZjJz70HI0SIMdakOMetNAp361SJsMYDBz0rP1Uvugt14Xb5jZ7k8j+VaJKgkuMogLsM4yByR+PT8a5+8nElyJ55AjSHaqDso/ziqN6EbyuT2MmY3VkzkcF1BOev5VfkcSOLhV2iXJK/wB1v4h/nsayLYmR40aQNITyC2cf57fWtOWbbui+9uYNuPUY4H86HsaVY66FuI5qYEj6iqcLED6VOZM0kc7Q5zx0z7VFGyqryMeV6D1wMn+n5015OCB17Cq+ozm3YWytu34XKjBAzn+eefYU13KjC7sZFrMzXqMSMDO0jsf4j7mrJbyJmmSZsI+SBxn2/TFY0M3lFgVEy7j/AKtucjjnnP41LazS391GSm6EHcUzyR7/AONF9LHfKn9x1Ubbj5gG0SfOB0xmrI6cVTFwZynJI256cD6VZD84zmg86UWiYdKa/SkVuKa7DFImxVnyWCryTwKzNUctdbFAQd9/3j7mr0kv+kLjk84GcZOKyNYdoZFUMR6s2N2PpR0OqjHUmsJShB3chsdeR/n1rchYOAQevrXL2tygiCs4MhbLN6j2/wA81sWE4YBT+tSmOvT6mt9aG4BxUIYA/SlZhg802ctiKY4Xk+1ZGpS7Ynx6VozMCOOlYOrNlNuep5qWa043Zl2r7JgevrXSWEoZAD1rlSPmyMmtbS7na+xj9KT0OqrC6OsEhZVyegwKM5NJDGhtEk8z52P3MVII/lXnknGKe557sQy8Cs66xtNXpzjI61n3ZyprORcUcFrrf8TNmHQVSDsrBlJHPatLWI83bmsk/KxU/hWkPhPRpq8Ujp9K1UhVWU8Vc1S6RrVypByK5OJiBweaJriQIV3ZFVdpWOedDW6MW4z5zn1NELfOuD3p9zjrUMJ+dfqKuOps1oUox87djk1taZchDyTWDuxIwH941bifFNjlC500uolo9inA71QkcyZxmqUbs2DniplJ35zx1pb7hCmo7E7S4QqvQ1E4JII5FNdulToPlzTuabElguWGa7DTseWvauU05f3oGMA11tgPkX0rCavI5q25qRirkQx2qnFj8KuRHI/GkjmZOmCVBBIGeF61KzzMhxvkijwWwCQMd+eKrMwDY69vrSXF0UD5AeNugXKoGx1x6iqukLlbKmpXQxtX7iDCj19SfeualLTzZTlieFq3f3GcrniqUqASJyoDIGwhJIz2Pvxn8aI66ndSp8qFjiD278IFGNzucbcnt61f0V/KZoiNoz8uapxxqY5GZ2AVSRgZJP0qRS0ckRlyJGGTuByMVbWhUo3TR1lu/FXInHJxms2zcOvX5h1GavRY9P1oSPPkiyGHUUm89qj4ApjvgdaLCSIdTuNls6HG18A+uAelVLxCXQgJtKhlUrhiMcEH6VFeTBrlCyB4kIYq3Rsdj7VBd3Ut1PJNc7mL5IfGAFx2APb0+lKLvdnZTg1YjQmNdyg5YhmbZuUd+ec4B5Jq8bkSAs6gMCFLA8H1x6ioJLhLZPKRCSwxkN2IHQev09KtRKeJraVpQxwCBz07g8f/AK6bV9C5d2XRgAPGWZD3K4wfQ0vmeh49agE5W43fvLdSMEgHn/Gke4jLmQIxwQW3Nwfy560XOXkZK8zwosygj5iFbtkVkXMfnrNLOSI8dQeW9hU8kklyQiZIXgDPC96zvtzRgL8h2ZAJGcDPNCszopwa1W5JDYQJGRIAsqcsSQQD6U9YAkj/AHFwRwMYGapNezSMhZiD1DH8qsQTOjHzTt3AgM4JH5dzmnp0NWpdTVjkARSMbiTuGOavRyDuazLeSJpFG8Ae5xk+/t/jU8DbfnZN6cgjOB+YpNWOWcbmiJBxk0ySTPAPXjrVR5MHK5CHpuPNRSPleufYc4pXIVML473EHyqqvudw2d2OOD6dfr1rPlVLi4Hm8YB5c/54q/Kpt7Pe6xrJkEBj8xX1A9KxJpWZy+1iM9RweTTZ00l2JLlZBZqjSpJGjYXAGfwPXHvU9jcMoAcY4qgGYKCecnKgjkj/AA61bjnjkISOP5m6Be1S1c1lHSxuxTBsEnmpWJIrGEvlNtz0qZrogcmi5ySpa6E88oQHNYV23msxGTVu4mDCqAme3uo5U+8hDAHofY+1CNacLFfbtGVxx1FIrMkm4HpT7ifdcSTIAu4k7R0HtUDSB2XCgcYoZ0JM63SrvdGpz2rSMpYDPbpXK6XLsOwn3reikDLknmpT6HBVp2ZJK3Jqlc9D9KsyNgVTnYHArNkxRymrpiXd61h3vy7W710mtlRtHpXK6g/B9K1hsdtFXRJHINh55qKWXiq0cmcc0+UE5x3qjZxSKVzJ2HSiA7mT61HdLt5pLV8SL9RVxMpoz5D++f6mrMTVXugVnf6mpbc5+tUWtjRgbn2q05wo9KpRg7amLnaM0mIGJypNX4MMvPNZbtkVoWD5GD0FSVJaGjZDbMOo5rprI9smubiIVgc1v2Lq6g57c1E0ctRGzE1Wo2Hes+Ftox196n80BjngYxxULQw5S1uLF8Mo+U8scfh+lZ+pXhCbSx25JA96bc3QSM8j1rBurppZDg4X60tzelSu7jZCZ51RSFLsAM9ATU15cPJcidUVcHaqqcjC9/xp2kBvtZClB5iNH8/Q5HT8cUKBHInlnfj5thGMHPQ/hWqVkdel7Fizk8m4mhdwql9245XIIyDx29qQws4EuSd2TyfSonUSwW/lkO6RuGBPKgNx19iakt5wYyowc/p9KryZm11Ro2F0yoqEgDr071rQznqcGsFFXAIbDVLHIy8Fgo9ScUtUYyppm61wPT8KrTz9hk54AHOarwsj4Lzqi98DJrQg1aw0wySWsJll42u5GV6Z6/0otfdmfK4/CrsiaxkiiJm+6SXKdjxgk/T/AD0qrMIlQzSvGh6hSRk8YK49OPz+tRXHiGS63+e7ZLbtqDZnAwORWSLgyuD68sCxLMc+o6VT5Vsbwpzt7xdWWV8SPLIqE7wVTgEdR6496kjum85PKdmU8K+3aPc4/wAahEZI89GTanIdeiHOeAeSfr60jq5iWVyyocBw75eXvnHTA/r3qTRpG1BqUEqhZl89B/FjH6dqY89kZFaNZkAHY9/bPauflnbd5kYaOPp8pPPtRJKzYA5yPXIo5ifYLdG5eaqrWrQBF6EHHGfqBXPSuGc46e3SmNIcmlhfAznmhu5pCmoLQchARSXXkZwOo+tSpOjdirAcADOfc81RklAbj61CtyA2CBg85qbl8lzcjuMEYbgVcttTaIbRtZBzhhnFc6s3pTvNOMg4FVczlST3OoOqEgkxryODiq0uoybSEO1fQcZrFE7ZxTZGYN94MDRcUaKL7zGQjJyegqFyXYKMbRk4OT+JqKN26jqaccqnU49x371O5ajYVFXcqneB1bnBPsKJFLPmGPy1J+UF8nH1pryhkGQBg7iQOSfTNKcGN2cEc8BelFhiLOy8A5PSla8OCCRketV3BypU8A+nNV5mwxDClaw+RMuLdZJJPFNefeeO1UUXrt5z2FOZtnyqfnxk+1O4+RJ6EzNnApsAIIJyR0FQJJuVSWxkHk1LAS2OeBSKasjXibAU/lWlb3GEAasO3YnrnHr2qx5m0cnNJo5pwubL3Ax96qc8469qzZbknoagluTt6/nUONzNUiDV7gHryTXN3h3Ka0rxyzZNZk3Oa1Wx1QgoopKxB4rQhG5eaz5htq5byfuxTCexW1FRtJFZsT4kT/eFX9Qf92fWsYSYkT/erSJzskvXBnce5otWy3Wq1y5adz/tGi2kIeqaNeh0Fv2zTmwQR0IqrDIdg5pstxtyD0pWIim2DP8AMB61atZSpyDWdExkk3HgVejUjBHQ1DVjbyNq3nDAAmtS1nMY4xXMROUIrStrgjAz+dK9yJU+x0sd6Qme/wBaGv2bcoGDWSlyCMH86mR1bnmpcUQqaXQmaV5CSxJzT44ATuIFERDAYHSpdyhevSmlYu/YRnKlCgK7DkMvajK7PM378Ha428gHuD3qFpDk7mbioxcJHcAlBJET8y84Yd/cU7jSJJF+zTBT84GSrpkb1PQ/ShG2kqMgjrmoTMDtQ9FB2nvj0zUkbpubJCqw6kbgKQywLlgcDn/ClkuTjcQSP0qosgYJgAN3b+lSI+wkZxRcOVEwuWI4Yimb2IJzxUCkYB9TxxUrSqsZyFz2yMflSKtbYkjTzD8hHHJL/KP/AK9XLeONRj7SqK2A6QgliMdcnrzxVCN2n8x5UaWNQF3b8bSenHfpVtEZUZbeWMoBvJZPLPHYE9+elUTImZQVxbiRyAeW+XCfSoX2FCF4PTknc309KUlfLBDLgZOSP880x5E3p50ZZAc4DYJ/HrSJRMqK6cExg8HcPlHsO9JKpPKptA7Dv70WrHOQfzGcfSrTEleTn1OetBLlZmXt6k1CWCjGa0LgDJPc1j3Eio5wOgoNIvmHmNpEO44B9Kh+zMArKSfYihtQhRNoO5sflSJfr8ibSOSME1Ni05E0SkMM9O1WVA5yMn0p0LhlDYA7fSpDs28d+1Mzc7kBIB+U05OnXn3pUj/iIIB6Z7Ush2kAdhQVfoSJjI+WhzyR196IgduT0PIokB4HQ5waCb6kDNwAoIOc5z/SkDnIzj1xSyKAQR0qtckiMtnkc0XLWpbeUsRksQB1x0qCRUzuxnGfvd6arHAz6U7aCGyuSR1J4FFw2IQxVCwHAOCQOKglkIVyOcir4RRHtI+UcgZqnOvAQjA6YoGpJsrr1wowMZ5q1GSoUnHNVQrE7hxxjipY4nMqheckDngAmkW3c1BKTHhW+UdqVWBA9aovlJGRsEqcHByKUS4PtRcz5exYnIRvlqlPIRg9R/KnSShu9U53GOlIIoinY/XNRJEWHNP+8wAq3t8uOqFOXKjF1CPaDxVK3lIHsKuanJ8p54rDM21CR1q0iL6akmpXIxtzWYGzIn1H86SVi7EmkQfvF+orWKsZMklyZHyP4jUMLESc8Crc4w78dzVGU7TmqNLmrHLhcZyKjZzI4z2qraymRto61cZQuMdqlIFoSxuVrRt5Nw5NZGT1HWrVs7Dv71LRbV0bDR4QEc06Nhx2quswKBeQxPepYhlsbqzasOL01LqudoOeBU0UjA8c56CoEj+XCknFWok+UsR16D0qGVzIsRXBB54NOa5PPPPpVKU4OO9LHwvH3jRdj5VuW2nyByQ3vUbuxTzM5B4wBULjAG6ms2UIJxgdD3phbsPkmH/LIDpgn0p0EryEJ0XviqtqodiOcGtSKzyoKKCemCcUWCUlHRixEBSgwxxgDsamjgUYYncTxkDkUkUR3cKd1WlCoRvwMdqZk59hpjUDHHPXBx+dQSrlehyOnNPnnXgDk+vrUD3DGJl7A5zSGmyLTpcSSAEDa2B9a2Vk3ptOMY6HmuLEzw6qwwdr4P41sQ3ZRvYZOKZdaGt0W5pmhLLn5T0zTY5tzjLVUuJC0IZj82eRTo2CJycUyNLGpaXG12VucGrn2gYyDkY4rnRchSp69amN4NmPQdakiUTSnnBBycVzOp3SrKQD25NSXd6SOuaw7pmllxkkHrVJXN6NPqyxDcbmA7nkU+JyWL55z1qGCE5BxgYNLbqAcc9Kqx0aPY1Y9ReNRsAI71dt75WZFwCQSx9xWKqHnAyTRaPtdskswO0d8CoaMpU42Oujud/UjBxxnpUcjKXdiwwT0JrCa7b7q8DvimC728k5B/KgwUGjomulQhWcEdjTpLhMgqCCc9a5lb8b8tj29qmS9B5LGgTg0ak10N+08EVVmlMhEQbliPyrPuLuNMtu5NTaaPn81+p/QUWLS5VzGyQBGBjBJwKfFxjjNV2mUDcSOOKhW53ICDjnmixmm2jTbbkE447VQ1AqmG680k1yI1U9jWZfXe91TNFh002zUsYjMeuABVplbaY8/IDnHvVGyulhhz3NWoJRtZm6nn6UrBJu4qRKyZHWoJ4yoJqa2cbcnpk4ouGUj8aloFJpmTJJtcg9aiuCSAelRXzFZiR0HemyTfu/lOSRRY6LaJontz++G6pLqcKpLHpWaJhGNzHOKzb2+Mp2p0q4oxnFtiapdbyVB61kyE9BUsinfk00LxmtkZS0IdmAaE4kT6ipmX5B61En+sXPqKpGTZLcuPMkz6ms+QPLII4wWc9hWpDp1xeTtkFEyeTW7Y6ZDZpkAF+5PU02yk7GVpulm3i3yffNF5hela1xKq5BPA6YrHvD13cDtSLim9WU95ycVZt5B+NUCWyakjJB68Gk0amtDLluvHatC3Y5GCB6j1rHtmyQetaULAL71mwZrxOSvUcc1MkwCEntyBWK07K21SSzcYPapYnwMSMT6VNgUDSiIdiSMircMfIDD/61ZUNxtwuDxyc1oQ3C4BU5btSsEm0TXcYERI7elUbvKp8v6VZuJ1dGUMdwHTt+VZjXW+Iow+ZeKdghcmsJcNye/Ga6OxlVzg9OhriVmK5AODWhYagU+UNz65prQdWDkrnXyusSllIB+nas+5ly27OV6mqlxqCPFweowPWs+a7JjYHIzQzCEH1Lsso8skehqCOc7ByCetUHuQSQG69aiW4OzCj8c0rHQo6C6jKBOjA8g1YgmB+YflWNLL59wFLfKvOfU1P9oCnhvlPUU7Gsloka0sxMZLHtxmolui7AZJzWY9zuAAJz70qTbev3j6U7EchpykoF2nJzmpFYmM479TVKJyzDIPP5VZjU7gGP4CixNhsoDsqqcnvUccQ+0FQeMZJxV1owCSeCBkjFQW3zSueSMdD2qki1LQnRB5bALyq0yOEBFz3P51px226GRxyWp9tZcISOmOtDIU7GZKm18BcgDmoyiwygj+MdR2NdA1spZtqh0Pf0NZ19ZFd2M7hyPrWfUaqJ6GdcKqRkg5PeqEj4GCQeegq+xLAYGdw59qobPmIK8iqSKWi1K91KAp4wabFdny+vTqKfcwEn2qP7MoBLL7g+tVyhdWK11Mzyj5sADNaMGotEoJ+7WTKpySCBjotLHuktyqg8dKOUqVmjbfVwRkHr0qSDUUJYsfwrnVR+nT61Yj6gHFLkIailY1rvVy5IQZx2qrFK8jbnJyaijjVd27I9Klttu7B5p8o4tLRIu29wdwycAVblvyR8n51nFM8KaswWjY+7nioasO0d2alvdEKMsMAdferbhp4cr8o9TWdargqCoBA7960PNwuCOcVDMJ6PQzr4ADrlfWstZhtKkcjitS5IkUr6VjSJhjzzmkkbRempTu5cEoD1pltFvkANOmC+bWppsIeJ1ULu65NbRRjUnZGXeQ+WahSPdGTWxfWxkgJA+YdaykJRSrda0sczkVnPGDUWMyJj+8KJ8gn0pkMgEq59RVRRk3Y9CmtVjG5FJOTkY6VSvN6oSEOe2BRRUWNYO+5kPC7PyjA+uKq3UXbaxooqkjaTd7FAxMCSUb8qFRuflI/CiihoLsmt/MVuFP5VejkcgfIxJ9qKKhopE0cEpJkZX59qt28bb8lW2jviiis2VzNokZJDLkKc4yOKjXzIycq2fUA0UUrFRfQRWl3NuVjx0xUThgxYRsM+1FFWkVcqyJN1CMPwqMeahyEbd34NFFVYSkyT7RKo5V/yphllPO18emKKKaihczGgSklir/THWp4xIyjKtjoBjrRRT5UHM7EElrOpJVGOfQUkdnLu3MrZ7nFFFJIPaysSi1kkAwr+3FWrWwlJ3BHPOOnX3ooquVEOpJFpY2DgBGPbOK0bWynnmVIYZGPQKoyeOSaKKVhSm1G428ilhzFJHJG55IZSDWtpehXn9mNffZJDAWwXx938OtFFNR6GVWq4wi11ZfitCLcqATuJOcUCAx/NtPA9KKKhohSZHp5k2MrDcQfSlvoPNUOgIccYH8qKKmxcnZ3OemgZGfKHZndnHI9qqiItLuCMVI9KKKaRtzO1yz5SG3YeWc9jiix0mO7VhNL5EYUkblySewooq0c85NLQ0NF8C3uqJvto18sk5kkBVR+Pf8KztS8N3mk3bQXVs6M2dpxlW9waKKdjlhiqjquD2MaSxaMurRkMOnFUvs8gdtkb4HtRRRY7lNvUnSImNWKuMdeKnhiIPCMc+1FFDRcZOxctYg0nzKy/hWlEjp8ig4+lFFZyQpSYk8UoKMgbI5PHakMzDI2OPwoorJoE7rUpSF1B+U5b2qntZpCNp59qKKcUXfQpX1tIm1wjbe/FXtIlVJMyq/THAooreKOebvubl0kZiRoIWC4+bisC90ieYGW3idiOSAKKKpowi7IxZo5BkPGwI9QapGGQSqQrfeHb3oopxCR//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pink and firm gingival tissues with no recession.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_28_1473=[""].join("\n");
var outline_f1_28_1473=null;
var title_f1_28_1474="Post traumatic lung cyst CT";
var content_f1_28_1474=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F53339&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F53339&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Post-traumatic lung cyst",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 363px; height: 350px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Motor vehicle accident with paraspinal laceration (so-called Type II laceration) of the right lower lobe lung parenchyma. CT scan shows a thin-walled cavity with a gas liquid level resulting from bleeding into the posttraumatic cyst.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_28_1474=[""].join("\n");
var outline_f1_28_1474=null;
var title_f1_28_1475="Torsion of spermatic cord";
var content_f1_28_1475=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F77468&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F77468&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 519px\">",
"   <div class=\"ttl\">",
"    Torsion of spermatic cord",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 499px; height: 319px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Abnormality of testicular fixation permits torsion of spermatic vessels with subsequent infarction of the gonad.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_28_1475=[""].join("\n");
var outline_f1_28_1475=null;
var title_f1_28_1476="Lubiprostone: Patient drug information";
var content_f1_28_1476=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Lubiprostone: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/28/38339?source=see_link\">",
"     see \"Lubiprostone: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F2609746\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Amitiza&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10013733\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691793",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat hard stools (constipation).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10013732\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to lubiprostone or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a bowel block.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10013737\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10013738\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697889",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain or heartburn.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10013740\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10013735\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695904",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with food to stop an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695714",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10013736\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10013741\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10013742\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11557 Version 30.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-183.166.191.243-DB525E7F52-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_28_1476=[""].join("\n");
var outline_f1_28_1476=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2609746\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013733\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013732\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013737\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013738\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013740\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013735\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013736\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013741\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013742\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?37/28/38339?source=related_link\">",
"      Lubiprostone: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_28_1477="Carpal tunnel syndrome structures";
var content_f1_28_1477=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F59856&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F59856&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 523px\">",
"   <div class=\"ttl\">",
"    Structures involved with carpal tunnel syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 503px; height: 601px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This is a depiction of the volar surface of the right hand showing the relationship of the median nerve to the transverse carpal ligament (flexor retinaculum). The&nbsp;ligament attaches to the carpal bones, including the hamate, pisiform, trapezium, and scaphoid tuberosity (navicular).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_28_1477=[""].join("\n");
var outline_f1_28_1477=null;
var title_f1_28_1478="Erysipelothrix infection";
var content_f1_28_1478=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Erysipelothrix infection",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/28/1478/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/28/1478/contributors\">",
"     Annette C Reboli, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/28/1478/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/28/1478/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/28/1478/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/28/1478/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/28/1478/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 18, 2010.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Erysipelothrix rhusiopathiae is a pleomorphic, non-spore forming, gram-positive bacillus capable of causing self-limited soft tissue infection or serious systemic infection. E. rhusiopathiae is widespread in nature and also infects domestic and marine animals; it is found in sheep, horses, cattle, chickens, turkeys, crabs, fish, dogs, and cats [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/1\">",
"     1",
"    </a>",
"    ]. The risk may be highest from swine exposure because of the large number of exposed farmers.",
"   </p>",
"   <p>",
"    Infection in humans is usually due to occupational exposure. Thus, slaughterhouse workers, butchers, fishermen, aquarium workers, farmers, and veterinarians are at risk for infection with E. rhusiopathiae [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/2-5\">",
"     2-5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Little is known about the pathogenesis of human E. rhusiopathiae infection. The following observations have been made in vitro and in animal studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Erysipelothrix rhusiopathiae is a virulent organism with a capsule that resists phagocytosis and may contribute to intracellular survival (in the absence of opsonization with specific antibody) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/6,7\">",
"       6,7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Intracellular survival of virulent organisms in macrophages is associated with reduced stimulation of the oxidative respiratory burst [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The SpaA protein is a surface antigen of E. rhusiopathiae. The pathogenic significance of this protein was suggested in a mouse model in which exposure to SpaA antigen was protective in a vaccination system [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The enzymes neuraminidase and hyaluronidase may contribute to the pathogenicity of Erysipelothrix [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical spectrum of human infection includes three major forms of disease:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Localized cutaneous (erysipeloid) infection",
"     </li>",
"     <li>",
"      Diffuse cutaneous infection",
"     </li>",
"     <li>",
"      Systemic infection (bacteremia with or without endocarditis)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Localized cutaneous infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common form of human infection due to E. rhusiopathiae is the localized cutaneous form, known as erysipeloid of Rosenbach [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/10\">",
"     10",
"    </a>",
"    ]. When localized infection occurs, it is a usually subacute and involves the fingers",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hands (the sites of exposure). Abrasions or wounds of the skin serve as the portal of entry of the organism. As an example, erysipeloid has been described on the fingers or hands of fisherman or seafood packers who suffer minor trauma while handling contaminated shrimp, crab, or fish [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Infection can also occur following cat or dog bites. In a review from 18 emergency departments in the United States, E. rhusiopathiae was isolated from 2 of 57 patients with infected cat bites [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The incubation period following inoculation may last 2 to 7 days. Symptoms begin with pain at the site of inoculation (described as throbbing, itching, burning, or tingling). The skin lesion typically progresses slowly from a small red macule at the inoculation site to a well-developed violaceous lesion with central clearing and a raised border. Swelling is typically minimal; patients typically complain of stiffness and pain in the involved fingers. Local lymphangitis and adenitis occur in approximately 30 percent of cases. Systemic symptoms such as high fever or chills are uncommon (about 10 percent of patients) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Diffuse cutaneous infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diffuse cutaneous disease is characterized by proximal progression of involvement from the inoculation site",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    involvement of additional sites; such cases are rare [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/10\">",
"     10",
"    </a>",
"    ]. Lesions may be urticarial or bullous and these patients frequently have fever and arthralgias. Blood cultures are usually negative [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most patients with diffuse cutaneous infection have the same types of exposures as those with localized cutaneous infection. However eating contaminated seafood or undercooked pork has been associated with diffuse cutaneous disease. In such cases it is presumed that bacteremia precedes the appearance of diffuse cutaneous disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Systemic infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic infection with bacteremia (with or without endocarditis) is relatively uncommon. Most patients present with fever. Approximately 40 percent of patients with systemic infection have antecedent or concurrent skin lesions suggestive of erysipeloid [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/3\">",
"     3",
"    </a>",
"    ]. Cutaneous serpiginous lesions or multiple bullous lesions on the trunk and extremities may be seen. Patients with severe underlying liver or heart disease and systemic infection due to Erysipelothrix infection may have a clinical presentation resembling gram-negative sepsis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The epidemiologic exposures in patients with systemic infection are the same as those for localized cutaneous infection; persistent bacteremia has been reported after the ingestion of contaminated meat. Chronic liver disease is an important predisposing factor; more than one-third of patients with systemic infection are alcoholics [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/3,10,16\">",
"     3,10,16",
"    </a>",
"    ]. Bacteremia may also be seen in other immunocompromised patients, especially those receiving corticosteroid",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cytotoxic drug therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/15,17,18\">",
"     15,17,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Endocarditis",
"    </span>",
"    &nbsp;&mdash;&nbsp;E. rhusiopathiae bacteremia is often complicated by endocarditis; in one report, 90 percent of 49 cases of serious infection had proven or presumed endocarditis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/3\">",
"     3",
"    </a>",
"    ]. However, this figure may be falsely elevated rate due to reporting bias, since a number of cases with bacteremia in the absence of endocarditis have also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/15,17-19\">",
"     15,17-19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nearly all reported cases of endocarditis have involved native heart valves, with propensity for involvement of the aortic valve [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/3,20\">",
"     3,20",
"    </a>",
"    ]. Erysipelothrix endocarditis frequently causes extensive valve destruction. In one series one-third of patients died and an additional one-third required valve replacement [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Complications of Erysipelothrix endocarditis may include congestive heart failure, valve perforation, myocardial abscess, cerebral infarctions, and acute renal failure due to proliferative glomerulonephritis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Other manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uncommon forms of infection due to E. rhusiopathiae include brain abscess, meningitis, endophthalmitis, intra-abdominal abscess, osteomyelitis, septic arthritis (including infection of prosthetic joints), necrotizing fasciitis and peritoneal dialysis-related peritonitis with bacteremia [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/22-30\">",
"     22-30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A provisional diagnosis can often be made based on a history of appropriate epidemiologic exposure together with the characteristic physical findings. Erysipelothrix infection might be suspected in cutaneous or systemic gram positive infections that fail to respond to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    . Gram stain and culture of aspirated material are often negative because the organism is deep within the dermis.",
"   </p>",
"   <p>",
"    Organisms may be isolated from the blood with routine commercial blood culture media; growth is usually recognized in two to three days. However, errors in identification can occur; the organism has been misidentified as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"     Lactobacillus",
"    </a>",
"    or Enterococcus species [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Erysipeloid skin lesions may resolve in the absence of specific therapy; spontaneous resolution typically occurs within three weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/32\">",
"     32",
"    </a>",
"    ]. However, appropriate antibiotic therapy shortens the clinical illness and reduces the risk of relapse [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/20\">",
"     20",
"    </a>",
"    ]. Local heat may be helpful for patients with arthritis and painful, swollen lesions. Surgical incision or debridement of localized lesions is not indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Antibiotic susceptibility",
"    </span>",
"    &nbsp;&mdash;&nbsp;Penicillin is the drug of choice for all forms of Erysipelothrix infection based on in vitro data; there are no clinical trials (",
"    <a class=\"graphic graphic_table graphicRef73058 \" href=\"UTD.htm?5/0/5132\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/2-5,15,16,18-20,32-34\">",
"     2-5,15,16,18-20,32-34",
"    </a>",
"    ]. In vitro, penicillin and imipenem are the most active agents; other active agents include other beta-lactam antibiotics, fluoroquinolones,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/10/20646?source=see_link\">",
"     daptomycin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"     linezolid",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. Agents that are not consistently active against Erysipelothrix include macrolides, tetracyclines, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/54/1897?source=see_link\">",
"     chloramphenicol",
"    </a>",
"    ; these should not be used in the treatment of disseminated infection.",
"   </p>",
"   <p>",
"    E. rhusiopathiae is typically resistant to sulfonamides,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    , and aminoglycosides [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/3,33,34\">",
"     3,33,34",
"    </a>",
"    ]. Resistance to vancomycin is a clinically relevant characteristic, since this antibiotic is often used empirically in treatment of gram-positive infections. However, limited data suggest that Erysipelothrix is susceptible to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/10/20646?source=see_link\">",
"     daptomycin",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Clinical approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;The approach to antibiotic therapy depends on the clinical manifestations and results of blood cultures.",
"   </p>",
"   <p>",
"    For localized cutaneous infection, oral therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/46/23269?source=see_link\">",
"     penicillin V",
"    </a>",
"    (500 mg every six hours) should be administered. In the setting of penicillin allergy,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    (250 mg every 12 hours), or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    (300 mg every eight hours) may be administered. Seven days of therapy is usually curative.",
"   </p>",
"   <p>",
"    Parenteral therapy should be administered with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/42/22183?source=see_link\">",
"     penicillin G",
"    </a>",
"    (2 to 4 million units every four hours) for patients with diffuse cutaneous disease or systemic infection. Alternative therapies include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    (2 g once daily), imipenem (500 mg every six hours), or a fluoroquinolone (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    400 mg every 12 hours or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    500 mg once daily).",
"   </p>",
"   <p>",
"    The optimal duration of therapy has not been evaluated in clinical trials. Treatment duration should be based on the clinical response, the underlying health of the patient and whether endocarditis is known to be present or absent. Many patients with diffuse cutaneous disease can be switched to oral therapy after clinical response occurs. Short courses of therapy (eg, one week) are often curative in such patients. Duration of therapy in bacteremia patients without endocarditis is a clinical judgment; some experts favor a minimum of four weeks of therapy even when endocarditis or signs of metastatic infection are not present [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/3,20\">",
"     3,20",
"    </a>",
"    ]. Two weeks of intravenous therapy followed by 2 to 4 weeks of oral therapy has also been successful [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1478/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Erysipelothrix rhusiopathiae is a gram-positive bacillus capable of causing self-limited soft tissue infection or serious systemic infection in humans. It is widespread in nature and infects domestic animals. Infection in humans is usually due to occupational exposure. Slaughterhouse workers, butchers, fishermen, farmers, and veterinarians are at risk for infection with E. rhusiopathiae. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are three major forms of disease: localized cutaneous (erysipeloid) infection, diffuse cutaneous infection, and systemic infection (bacteremia with or without endocarditis). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Localized cutaneous infection is a subacute cellulitis that usually involves the fingers",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      hands; abrasions or wounds of the skin serve as the portal of entry of the organism. Following an incubation period of 2 to 7 days, symptoms begin with pain at the site of inoculation. The skin lesion typically progresses from a small red macule at the inoculation site to a well-developed violaceous lesion with central clearing and a raised border. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Localized cutaneous infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diffuse cutaneous disease is characterized by proximal progression of involvement from the inoculation site",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      involvement of additional sites; Lesions may be urticarial or bullous and these patients frequently have fever and arthralgias. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diffuse cutaneous infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Systemic infection with bacteremia (with or without endocarditis) presents with fever; approximately 40 percent of patients with systemic infection also have antecedent or concurrent skin lesions suggestive of erysipeloid. E. rhusiopathiae bacteremia is often complicated by endocarditis. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Systemic infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A provisional diagnosis can be made based on a history of appropriate epidemiologic exposure together with the characteristic physical findings. Organisms may be isolated from the blood with routine commercial blood culture media; growth is usually recognized in two to three days. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For treatment of localized cutaneous infection, we suggest oral therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?22/46/23269?source=see_link\">",
"       penicillin V",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). In the setting of penicillin allergy,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"       ciprofloxacin",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       clindamycin",
"      </a>",
"      are acceptable alternatives. Treatment duration is seven days; dosing is outlined in the Table (",
"      <a class=\"graphic graphic_table graphicRef73058 \" href=\"UTD.htm?5/0/5132\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Clinical approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For treatment of diffuse cutaneous disease, we suggest parenteral therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/42/22183?source=see_link\">",
"       penicillin G",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Alternative therapies include",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"       ceftriaxone",
"      </a>",
"      , imipenem, or a fluoroquinolone. Treatment duration is seven days; dosing is outlined in the Table (",
"      <a class=\"graphic graphic_table graphicRef73058 \" href=\"UTD.htm?5/0/5132\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Clinical approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For treatment of systemic infection with bacteremia (with or without endocarditis) we suggest parenteral therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/42/22183?source=see_link\">",
"       penicillin G",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Alternative therapies include",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"       ceftriaxone",
"      </a>",
"      , imipenem, or a fluoroquinolone. Treatment duration is at least 4 weeks; dosing is outlined in the Table (",
"      <a class=\"graphic graphic_table graphicRef73058 \" href=\"UTD.htm?5/0/5132\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Clinical approach'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/1\">",
"      Wang Q, Fidalgo S, Chang BJ, et al. The detection and recovery of Erysipelothrix spp. in meat and abattoir samples in Western Australia. J Appl Microbiol 2002; 92:844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/2\">",
"      Veraldi S, Girgenti V, Dassoni F, Gianotti R. Erysipeloid: a review. Clin Exp Dermatol 2009; 34:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/3\">",
"      Gorby GL, Peacock JE Jr. Erysipelothrix rhusiopathiae endocarditis: microbiologic, epidemiologic, and clinical features of an occupational disease. Rev Infect Dis 1988; 10:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/4\">",
"      Wang Q, Chang BJ, Riley TV. Erysipelothrix rhusiopathiae. Vet Microbiol 2010; 140:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/5\">",
"      McNamara DR, Zitterkopf NL, Baddour LM. A woman with a lesion on her finger and bacteremia. Clin Infect Dis 2005; 41:1005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/6\">",
"      Shimoji Y, Yokomizo Y, Sekizaki T, et al. Presence of a capsule in Erysipelothrix rhusiopathiae and its relationship to virulence for mice. Infect Immun 1994; 62:2806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/7\">",
"      Shimoji Y. Pathogenicity of Erysipelothrix rhusiopathiae: virulence factors and protective immunity. Microbes Infect 2000; 2:965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/8\">",
"      Cheun HI, Kawamoto K, Hiramatsu M, et al. Protective immunity of SpaA-antigen producing Lactococcus lactis against Erysipelothrix rhusiopathiae infection. J Appl Microbiol 2004; 96:1347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/9\">",
"      Abrashev I, Orozova P. Erysipelothrix rhusiopathiae neuraminidase and its role in pathogenicity. Z Naturforsch C 2006; 61:434.",
"     </a>",
"    </li>",
"    <li>",
"     Hand, WL, Ho, H. Erysipelothrix. In: Current Therapy of Infectious Disease, 2nd ed, Schlossberg, D (Ed), Mosby, Inc, St. Louis 2001. p. 499.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/11\">",
"      Collier DN. Cutaneous infections from coastal and marine bacteria. Dermatol Ther 2002; 15:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/12\">",
"      Burke WA, Jones BE. Cutaneous infections of the coast. N C Med J 1987; 48:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/13\">",
"      Talan DA, Citron DM, Abrahamian FM, et al. Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group. N Engl J Med 1999; 340:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/14\">",
"      NELSON E. Five hundred cases of erysipeloid. Rocky Mt Med J 1955; 52:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/15\">",
"      Ognibene FP, Cunnion RE, Gill V, et al. Erysipelothrix rhusiopathiae bacteremia presenting as septic shock. Am J Med 1985; 78:861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/16\">",
"      Schuster MG, Brennan PJ, Edelstein P. Persistent bacteremia with Erysipelothrix rhusiopathiae in a hospitalized patient. Clin Infect Dis 1993; 17:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/17\">",
"      Berg&eacute; F, Dupon M, Morel D, Merville P. Photo quiz. Diagnosis: swine erysipelas (erysipeloid). Clin Infect Dis 1996; 22:21, 129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/18\">",
"      Garc&iacute;a-Restoy E, Espejo E, Bella F, Llebot J. Bacteremia due to Erysipelothrix rhusiopathiae in immunocompromised hosts without endocarditis. Rev Infect Dis 1991; 13:1252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/19\">",
"      Jones N, Khoosal M. Erysipelothrix rhusiopathiae septicemia in a neonate. Clin Infect Dis 1997; 24:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/20\">",
"      Reboli AC, Farrar WE. Erysipelothrix rhusiopathiae: an occupational pathogen. Clin Microbiol Rev 1989; 2:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/21\">",
"      Fern&aacute;ndez-Crespo P, Serra A, Bonet J, Gimenez M. Acute oliguric renal failure in a patient with an Erysipelothrix rhusiopathiae bacteremia and endocarditis. Nephron 1996; 74:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/22\">",
"      Ruiz ME, Richards JS, Kerr GS, Kan VL. Erysipelothrix rhusiopathiae septic arthritis. Arthritis Rheum 2003; 48:1156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/23\">",
"      Simionescu R, Grover S, Shekar R, West BC. Necrotizing fasciitis caused by Erysipelothrix rhusiopathiae. South Med J 2003; 96:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/24\">",
"      Hardman SC, Carr SJ, Swann RA. Peritoneal dialysis-related peritonitis with bacteraemia due to Erysipelothrix rhusiopathiae. Nephrol Dial Transplant 2004; 19:1340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/25\">",
"      Hocqueloux L, Poisson DM, Sunder S, et al. Septic arthritis caused by Erysipelothrix rhusiopathiae in a prosthetic knee joint. J Clin Microbiol 2010; 48:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/26\">",
"      Feasi M, Bacigalupo L, Cappato S, et al. Erysipelothrix rhusiopathiae intra-abdominal abscess. Int J Infect Dis 2010; 14:e81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/27\">",
"      Romney M, Cheung S, Montessori V. Erysipelothrix rhusiopathiae endocarditis and presumed osteomyelitis. Can J Infect Dis 2001; 12:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/28\">",
"      Kim SR, Kwon MJ, Lee JH, Lee NY. Chronic meningitis caused by Erysipelothrix rhusiopathiae. J Med Microbiol 2007; 56:1405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/29\">",
"      Traer EA, Williams MR, Keenan JN. Erysipelothrix rhusiopathiae infection of a total knee arthroplasty an occupational hazard. J Arthroplasty 2008; 23:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/30\">",
"      Elvy J, Hanspal I, Simcock P. A case of Erysipelothrix rhusiopathiae causing bilateral endogenous endophthalmitis. J Clin Pathol 2008; 61:1223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/31\">",
"      Dunbar SA, Clarridge JE 3rd. Potential errors in recognition of Erysipelothrix rhusiopathiae. J Clin Microbiol 2000; 38:1302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/32\">",
"      Klauder, JV. Erysipeloid as an occupational disease. JAMA 1938; 111:1345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/33\">",
"      Venditti M, Gelfusa V, Tarasi A, et al. Antimicrobial susceptibilities of Erysipelothrix rhusiopathiae. Antimicrob Agents Chemother 1990; 34:2038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/34\">",
"      Soriano F, Fern&aacute;ndez-Roblas R, Calvo R, Garc&iacute;a-Calvo G. In vitro susceptibilities of aerobic and facultative non-spore-forming gram-positive bacilli to HMR 3647 (RU 66647) and 14 other antimicrobials. Antimicrob Agents Chemother 1998; 42:1028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/35\">",
"      Piper KE, Steckelberg JM, Patel R. In vitro activity of daptomycin against clinical isolates of Gram-positive bacteria. J Infect Chemother 2005; 11:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1478/abstract/36\">",
"      Jorgensen JH, Hindler JF. New consensus guidelines from the Clinical and Laboratory Standards Institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria. Clin Infect Dis 2007; 44:280.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5537 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-2ED33AB258-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_28_1478=[""].join("\n");
var outline_f1_28_1478=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Localized cutaneous infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Diffuse cutaneous infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Systemic infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Endocarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Other manifestations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Antibiotic susceptibility",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Clinical approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/5537\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/5537|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/0/5132\" title=\"table 1\">",
"      Treatment of Erysipelothrix",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_28_1479="Primary megaureter in infants and children";
var content_f1_28_1479=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Primary megaureter in infants and children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/28/1479/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/28/1479/contributors\">",
"     Laurence S Baskin, MD, FAAP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/28/1479/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/28/1479/contributors\">",
"     Tej K Mattoo, MD, DCH, FRCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/28/1479/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/28/1479/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/28/1479/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 6, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Megaureter is defined as a ureter that exceeds the upper limits of normal size. In children, any ureter greater than 7 mm in diameter is considered a megaureter based on measurements in fetuses greater than 30 weeks gestation and children &lt;12 years [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1479/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Primary megaureter is a result of a functional or anatomical abnormality involving the ureterovesical junction (",
"    <a class=\"graphic graphic_figure graphicRef59252 \" href=\"UTD.htm?29/25/30098\">",
"     figure 1",
"    </a>",
"    ); whereas, secondary megaureter results from abnormalities that involve the bladder or urethra (eg, posterior urethral valves).",
"   </p>",
"   <p>",
"    Primary megaureter in infants and children will be reviewed here.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary megaureter is classified according to the presence or absence of reflux and obstruction. Management of primary megaureter depends upon the type of megaureter. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Postnatal management'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The types of megaureter are as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Refluxing, non-obstructed &ndash; This common variant is high grade (ie, grades III through V) vesicoureteral reflux with a dilated ureter (",
"      <a class=\"graphic graphic_figure graphicRef67039 \" href=\"UTD.htm?11/1/11280\">",
"       figure 2",
"      </a>",
"      )&nbsp;(see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/10/3242?source=see_link&amp;anchor=H8#H8\">",
"       \"Presentation, diagnosis, and clinical course of vesicoureteral reflux\", section on 'Grading'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Refluxing, obstructed &ndash; This rare variant is often associated with an ectopic ureter (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/3/39989?source=see_link\">",
"       \"Ectopic ureter\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Nonrefluxing, non-obstructed &ndash; This common variant is also called primary dilated megaureter",
"     </li>",
"     <li>",
"      Nonrefluxing, obstructed &ndash; This rare variant presents with symptoms or with a decrease in renal function",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary megaureter is the second most common cause of hydronephrosis in the newborn (after ureteropelvic obstruction), accounting for approximately 20 percent of cases. The incidence of primary megaureter is estimated as 0.36 per 1000 live births [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1479/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Boys are affected more commonly than girls, and lesions are found more frequently on the left than on the right side [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1479/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. The reported rate of bilateral involvement ranges from 30 to 40 percent (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef51780 \" href=\"UTD.htm?6/24/6543\">",
"     image 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1479/abstract/3,5,6\">",
"     3,5,6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of primary megaureter is uncertain. It appears to be most commonly due to an abnormality or delay in the development of the muscle in the distal ureter at 20 weeks gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1479/abstract/7\">",
"     7",
"    </a>",
"    ]. This results in the formation of an aperistaltic segment, which leads to functional obstruction. Other rarer causes of megaureter include congenital ureteral strictures or valves.",
"   </p>",
"   <p>",
"    The refluxing megaureter also has an abnormal ureterovesical (UV) tunnel that allows urine to reflux up the ureter during bladder filling but more commonly during voiding when the bladder pressure is highest. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/10/3242?source=see_link&amp;anchor=H2#H2\">",
"     \"Presentation, diagnosis, and clinical course of vesicoureteral reflux\", section on 'Pathogenesis and definition'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary megaureter usually is detected on antenatal ultrasonography. The ultrasound demonstrates both hydronephrosis and a dilated ureter. These affected newborn infants are asymptomatic and typically have a normal physical examination, urinalysis, and serum creatinine.",
"   </p>",
"   <p>",
"    When the condition is not detected antenatally, children can present at any age after the newborn period with urinary tract infection, hematuria, abdominal pain, mass, or uremia, or be incidentally diagnosed during evaluation of other conditions.",
"   </p>",
"   <p>",
"    Both renal and nonrenal anomalies can be seen in patients with primary megaureter [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1479/abstract/4\">",
"     4",
"    </a>",
"    ]. Renal and urologic findings include ipsilateral ureteropelvic junction obstruction, contralateral vesicoureteral reflux, and renal",
"    <span class=\"nowrap\">",
"     hypoplasia/dysplasia.",
"    </span>",
"    Reported nonrenal findings include ear tags, undescended testes, dermal sinus, tracheomalacia, and aortic aneurysm [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1479/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DIAGNOSIS AND EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasonography confirms the diagnosis of megaureter. Voiding cystourethrography (VCUG) and diuretic renography are used to detect the presence or absence of reflux",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    obstruction. These studies determine the type of megaureter, which guides the management approach [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1479/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Classification'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H8\">",
"     'Postnatal management'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    These imaging studies also differentiate primary megaureter from other causes of hydronephrosis, including ureteropelvic junction obstruction, posterior urethral valves, and ureterocele. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/3/26680?source=see_link\">",
"     \"Congenital ureteropelvic junction obstruction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/0/11271?source=see_link\">",
"     \"Clinical presentation and diagnosis of posterior urethral valves\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/8/41093?source=see_link\">",
"     \"Ureterocele\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ultrasonography &ndash; If an antenatal diagnosis is made, a postnatal ultrasound is obtained to confirm the presence of megaureter (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef69128 \" href=\"UTD.htm?19/15/19711\">",
"       image 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef77164 \" href=\"UTD.htm?5/19/5424\">",
"       image 3",
"      </a>",
"      ). Although megaureter can occur with or without concomitant dilation of the upper collecting system, it usually presents as hydroureteronephrosis (dilation of both the renal pelvis and ureter). Ureteral tortuosity may be present. We use the Society of Fetal Urology system to grade the severity of hydronephrosis (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef50549 \" href=\"UTD.htm?32/46/33519\">",
"       image 4",
"      </a>",
"      ). In many cases of primary megaureter, there is relatively increased dilation of the distal ureter relative to the proximal ureter or renal collecting system.",
"      <br/>",
"      <br/>",
"      The examination should be performed after the first two days after birth, preferably at 1 week of age or later, because hydronephrosis may not be detected due to physiologic volume depletion and relative oliguria. It is important to identify the ureter's origin and insertion into the bladder to help differentiate it from bowel and from an ectopic ureter. A normal bladder size distinguishes megaureter from lower urinary tract obstruction (eg, posterior urethral valves), which is characterized by a dilated bladder",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      increased thickness and trabeculation of the bladder wall. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/52/42824?source=see_link&amp;anchor=H75090646#H75090646\">",
"       \"Overview of antenatal hydronephrosis\", section on 'Ultrasound examination'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      VCUG &ndash; A VCUG must be performed to detect reflux and any evidence of urethral obstruction (eg, posterior urethral valves). If severe reflux is present and the ureter drains poorly, the megaureter is likely a refluxing, obstructed type. If no reflux is detected, then diuretic renography is used to differentiate between the nonrefluxing, obstructed megaureter and the nonrefluxing, non-obstructed type.",
"     </li>",
"     <li>",
"      Diuretic renography &ndash; Diuretic renography (renal scan and the administration of a diuretic) is used to diagnose urinary tract obstruction. It is performed in patients without reflux, or in those with reflux and poor ureter drainage suggestive of a refluxing, obstructed megaureter. It measures the drainage time from the renal pelvis (referred to as washout) and assesses total and each individual kidney's renal function. The washout measurement correlates with the degree of obstruction. In general, a half-life greater than 20 minutes to clear the isotope from the kidney is considered indicative of obstruction. A more complete description of the diuretic renography is found separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/20/34119?source=see_link&amp;anchor=H7#H7\">",
"       \"Postnatal management of antenatal hydronephrosis\", section on 'Diuretic renography'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PRENATAL MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unilateral ureterovesical junction (UVJ) obstruction and megaureter have a good prognosis. These fetuses can be followed expectantly in the prenatal period, without intervention or early delivery.",
"   </p>",
"   <p>",
"    The fetus with bilateral UVJ obstruction should be monitored for oligohydramnios. Expectant routine prenatal management is recommended as long as the amniotic fluid volume remains normal. The antenatal management of hydronephrosis, and the management of pregnancies with severe oligohydramnios are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/52/42824?source=see_link&amp;anchor=H13#H13\">",
"     \"Overview of antenatal hydronephrosis\", section on 'Management'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/57/14233?source=see_link&amp;anchor=H11#H11\">",
"     \"Oligohydramnios\", section on 'Prognosis and management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     POSTNATAL MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no randomized trials that provide evidence for the optimal management of primary megaureter in infants and children. The following discussion is based upon observational studies, and the experience and opinions of experts in the field. In general, postnatal management is determined by the presence or absence of reflux",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    obstruction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Nonrefluxing megaureter",
"    </span>",
"    &nbsp;&mdash;&nbsp;In nonrefluxing megaureter, the presence of signs and symptoms is most important in determining management.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Asymptomatic patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the asymptomatic patient with nonrefluxing megaureter and normal renal function based on diuretic renography, nonoperative management is warranted because, in most cases, hydroureteronephrosis resolves spontaneously (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77319 \" href=\"UTD.htm?34/3/34868\">",
"     image 5",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1479/abstract/3,5,6,8-10\">",
"     3,5,6,8-10",
"    </a>",
"    ]. The resolution of megaureters in these patients has been demonstrated historically by serial imaging by intravenous pyelogram (IVP) as shown in the linked figure. However, IVPs are no longer used in the diagnosis and monitoring of megaureters because of its high increased radiation exposure. Serial imaging by IVP has been replaced by sonogram and diuretic renogram. Spontaneous resolution of nonrefluxing megaureter was illustrated by the following three case series:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a case series of 54 newborns with prenatally diagnosed, primary nonrefluxing megaureter, hydroureteronephrosis resolved spontaneously in 39 patients (72 percent). Resolution occurred at median ages of 12.9, 23.9, and 34.6 months in those with grades 1, 2, and 3 of hydronephrosis, respectively, and at 48.5 months for those with grades 4 and 5. Five patients had stable hydronephrosis without resolution, and surgical repair was performed in 10 patients because of increasing hydronephrosis (n = 3), obstructive appearance on intravenous pyelogram (n = 2), decreasing renal function or failure (n = 2), persistent severe hydronephrosis (n = 2), and persistent hydronephrosis in a megaureter draining a single kidney.",
"     </li>",
"     <li>",
"      In a second case series of 40 newborns with prenatally diagnosed, primary nonrefluxing megaureter, surgical repair was performed in four patients with severe hydroureteronephrosis and diminished renal function [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1479/abstract/6\">",
"       6",
"      </a>",
"      ]. Nine patients did not return for follow-up for a minimum of 24 months. The remaining 27 patients (40 megaureters) were followed without surgical intervention for a mean of seven years. At a mean follow-up of 2.9 years, hydroureteronephrosis resolved spontaneously in 21 ureters, and the remaining 19 megaureters were stable or showed improvement, with the exception of one patient. This patient with bilateral stable but unresolved hydroureteronephrosis, demonstrated increased dilatation and a decrease in renal function of one kidney, and a renal stone in the contralateral kidney at a 14-year follow-up evaluation.",
"     </li>",
"     <li>",
"      In another case series of 54 patients with prenatally diagnosed, primary nonrefluxing megaureter, 37 patients were followed without surgical intervention for a mean follow-up of 26 months. In the 37 observed patients, hydroureteronephrosis resolved spontaneously in 40 of the 50 involved ureters. Of the original cohort, four cases were excluded because of early nonspecified treatment, and six because of limited time for follow-up (&lt;6 months). It was not clear why the remaining seven patients were not included in the analysis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a subsequent study of 49 patients, spontaneous resolution occurred in 80 percent of non-obstructive, nonrefluxing megaureter but less than 20 percent in those that demonstrated an obstructive or partial obstructive diuretic renographic pattern [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1479/abstract/4\">",
"     4",
"    </a>",
"    ]. Of the 16 patients with an obstructive or partially obstructive lesion, nine underwent surgical correction. The long-term renal outcome was excellent except for those who already had renal abnormalities (eg, renal hypoplasia and dysplasia) and decreased renal function detected during the neonatal period.",
"   </p>",
"   <p>",
"    These studies show that in the majority of infants with primary nonrefluxing megaureters, hydroureteronephrosis will resolve spontaneously without surgical intervention. Even severe hydroureteronephrosis, in some cases, can resolve spontaneously, although the time for resolution is longer [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1479/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. Spontaneous resolution is less likely in patients with obstructive lesions confirmed by diuretic renography [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1479/abstract/4\">",
"     4",
"    </a>",
"    ]. These studies were not able to identify any clinical predictors for spontaneous resolution for nonrefluxing, non-obstructed megaureters. Long-term renal outcome appeared to be excellent except for those with concomitant congenital renal abnormalities.",
"   </p>",
"   <p>",
"    Based upon these results, asymptomatic infants with nonrefluxing, non-obstructed megaureters can be managed medically with close monitoring. If hydronephrosis increases, renal function on the affected side decreases, or symptoms develop, surgical repair is indicated because it is likely that obstruction is present (",
"    <a class=\"graphic graphic_picture graphicRef69511 \" href=\"UTD.htm?14/49/15126\">",
"     picture 1",
"    </a>",
"    ). Surgical correction of obstructed megaureters improves renal drainage as detected by a reduction in hydroureteronephrosis on ultrasound and improved renal function on diuretic renography [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1479/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Our approach'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Symptomatic patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical correction is needed in a child with nonrefluxing megaureter who presents with recurrent urinary tract infection, pyelonephritis, persistent flank pain, or hematuria. Symptoms resolve after surgical correction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Refluxing megaureter",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with refluxing non-obstructed megaureter have moderate to severe vesicoureteral reflux (eg, grade III to V vesicoureteral reflux). The management of these patients is discussed elsewhere in the program. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/62/41961?source=see_link\">",
"     \"Management of vesicoureteral reflux\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with refluxing obstructed megaureter often have ectopic ureters that enter into the bladder, neck, or urethra. They are typically managed with surgery, using a similar approach of those with an ectopic ureter, which is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/3/39989?source=see_link&amp;anchor=H17#H17\">",
"     \"Ectopic ureter\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical treatment of the obstructed megaureter consists of excision of the distal obstructive segment (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77319 \" href=\"UTD.htm?34/3/34868\">",
"     image 5",
"    </a>",
"    ), tapering of the dilated ureter, and reimplantation into the bladder using a reflux prevention technique. The success rate of this procedure, defined as decreased dilation on the ultrasound and improved function on the diuretic renogram is greater than 90 percent, even in small infants [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1479/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a small case series, high pressure balloon dilation appears to be a promising approach to treat primary obstructive megaureter [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1479/abstract/13\">",
"     13",
"    </a>",
"    ], however further studies with larger number of patients are needed to confirm the long-term effectiveness and safety of this technique.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Antibiotic prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Historically, all patients with megaureter received oral antibiotic prophylaxis (",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/49/34583?source=see_link\">",
"     amoxicillin",
"    </a>",
"    , 12 to 25",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/23/41336?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    , 2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day) because of the high risk of development of infection due to urinary stasis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1479/abstract/4\">",
"     4",
"    </a>",
"    ]. In most published case series, antibiotic prophylaxis was given routinely through the first one to two years of life [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1479/abstract/3,4,6\">",
"     3,4,6",
"    </a>",
"    ]. As a result, there are no data demonstrating that prophylaxis is beneficial in patients with megaureter. However, until studies show that antibiotic prophylaxis is not indicated, it seems prudent especially in severe case of megaureter to use antibiotic prophylaxis until the patient is toilet trained because of the increased risk of urinary tract infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Our approach",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Prenatal presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Our management approach is based upon the presence or absence of reflux",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    obstruction as detected by imaging studies. Postnatal ultrasonography after the first week of life is performed to confirm the diagnosis of primary megaureter with unilateral megaureter, and within 24 hours for those with bilateral involvement. In patients with megaureter, voiding cystourethrogram is performed to detect the presence or absence of vesicoureteral reflux (VUR). Diuretic renography is performed in infants without VUR, or with VUR and poor ureteral drainage to determine the presence or absence of obstruction. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Diagnosis and evaluation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The following management approach is based on the results of the above imaging studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Non-obstructive, nonrefluxing megaureter &ndash; Patients with non-obstructive, nonrefluxing megaureter are managed nonoperatively. These patients are followed by annual renal ultrasonography to monitor renal growth and hydroureteronephrosis. Antibiotic prophylaxis is prescribed until the patient is toilet trained.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      If the megaureter remains stable, sonograms evaluation continues at longer intervals (yearly until age 3 to 5, then every other year or once every five years in adolescence) until resolution.",
"     </li>",
"     <li>",
"      If the megaureter worsens, a diuretic renogram is performed to assess overall renal function and possible obstruction. A 10 percent decrease in renal function is an indication for surgery.",
"     </li>",
"     <li>",
"      If hydronephrosis increases, diuretic renography is performed to see if there has been a decrease in renal function or development of ureterovesical (UV) obstruction.",
"     </li>",
"     <li>",
"      Surgical intervention is performed in patients who develop symptoms, UV obstruction, or a decrease in the function of the affected kidney.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Refluxing, non-obstructed megaureter &ndash; The management of these patients with high-grade VUR (ie, grades III to V) is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/62/41961?source=see_link&amp;anchor=H11#H11\">",
"       \"Management of vesicoureteral reflux\", section on 'Grades III to V'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Obstructed megaureter &ndash; Surgical intervention is indicated in patients with obstructed lesions documented by increasing hydroureteronephrosis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      the presence of a prolonged diuretic renographic drainage pattern.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Postnatal presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend surgical correction for any symptomatic patient with primary megaureter. The management for asymptomatic patients who are diagnosed as an incidental finding on abdominal imaging is similar to patients who are diagnosed prenatally and is dependent upon the presence of reflux",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    obstruction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;The long-term outcome of primary megaureter is generally excellent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1479/abstract/4,9\">",
"     4,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      As noted above, most cases of non-obstructive, nonrefluxing megaureter will spontaneously resolve (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef77319 \" href=\"UTD.htm?34/3/34868\">",
"       image 5",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Nonrefluxing megaureter'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The outcome of surgical correction for obstructed lesions is excellent with success rates that approach 97 percent, even in infants (",
"      <a class=\"graphic graphic_picture graphicRef69511 \" href=\"UTD.htm?14/49/15126\">",
"       picture 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Outcome for either medical or surgical management of refluxing megaureter (ie, grade III to V vesicoureteral reflux) is also excellent. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/62/41961?source=see_link\">",
"       \"Management of vesicoureteral reflux\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Poor renal outcome appears to be due to the concomitant presence of congenital renal abnormalities (eg, renal hypoplasia and dysplasia) rather than as a consequence of primary megaureter except in the setting of high-grade or worsening obstruction [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1479/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Primary megaureter is defined as a ureter that is greater than 7 mm in diameter that is caused by a functional or anatomical abnormality, which involves the ureterovesical junction (UVJ). It is classified into four types based upon the presence of reflux or obstruction. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Classification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Primary megaureter is the second most common cause of hydronephrosis in the newborn (after ureteropelvic obstruction), accounting for approximately 20 percent of cases with an estimated incidence of 0.36 per 1000 live births. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although the pathogenesis is uncertain, it appears that primary megaureter is usually due to an abnormality or delay in the development of the muscle in the distal ureter at 20 weeks gestation. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Primary megaureter usually presents prenatally as a consequence of antenatal sonography. Postnatal presentation can occur at any age with symptoms due to urinary tract infection, hematuria, abdominal pain",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      mass, or uremia. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of primary megaureter is made by ultrasonography that demonstrates both hydronephrosis and a dilated ureter (hydroureteronephrosis). The evaluation includes voiding cystourethrography (VCUG) to detect the presence or absence of vesicoureteral reflux (VUR) and a diuretic renogram that measures isotope clearance, which is delayed in cases with partial or total urinary flow obstruction. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Diagnosis and evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are no randomized trials that provide evidence for the optimal management of primary megaureter. The following management regimen is based upon observational studies, and the experience and opinions of the author.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      We suggest",
"      <strong>",
"       NOT",
"      </strong>",
"      performing prenatal intervention or early delivery in fetuses with megaureter (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Prenatal management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In symptomatic patients with any type of megaureter, we recommend surgical intervention to relieve the obstruction (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Our approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In asymptomatic patients with nonrefluxing, non-obstructed megaureters (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef77319 \" href=\"UTD.htm?34/3/34868\">",
"       image 5",
"      </a>",
"      ), we suggest nonoperative management (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). This includes monitoring with annual ultrasounds and prophylactic antibiotics until the patient is toilet trained. Surgery is indicated if there is subsequent development of symptoms or evidence of obstruction. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Nonrefluxing megaureter'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'Our approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In asymptomatic patients with refluxing, non-obstructed megaureters, we suggest either medical treatment with prophylactic antibiotics and ongoing monitoring, or surgical correction (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/62/41961?source=see_link\">",
"       \"Management of vesicoureteral reflux\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In asymptomatic patients with obstructed megaureter (",
"      <a class=\"graphic graphic_picture graphicRef69511 \" href=\"UTD.htm?14/49/15126\">",
"       picture 1",
"      </a>",
"      ), we suggest surgical correction (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Our approach'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1479/abstract/1\">",
"      Cussen LJ. Dimensions of the normal ureter in infancy and childhood. Invest Urol 1967; 5:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1479/abstract/2\">",
"      Stoll C, Alembik Y, Roth MP, et al. Risk factors in internal urinary system malformations. Pediatr Nephrol 1990; 4:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1479/abstract/3\">",
"      McLellan DL, Retik AB, Bauer SB, et al. Rate and predictors of spontaneous resolution of prenatally diagnosed primary nonrefluxing megaureter. J Urol 2002; 168:2177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1479/abstract/4\">",
"      Gimpel C, Masioniene L, Djakovic N, et al. Complications and long-term outcome of primary obstructive megaureter in childhood. Pediatr Nephrol 2010; 25:1679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1479/abstract/5\">",
"      Calisti A, Oriolo L, Perrotta ML, et al. The fate of prenatally diagnosed primary nonrefluxing megaureter: do we have reliable predictors for spontaneous resolution? Urology 2008; 72:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1479/abstract/6\">",
"      Shukla AR, Cooper J, Patel RP, et al. Prenatally detected primary megaureter: a role for extended followup. J Urol 2005; 173:1353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1479/abstract/7\">",
"      Nicotina PA, Romeo C, Arena F, Romeo G. Segmental up-regulation of transforming growth factor-beta in the pathogenesis of primary megaureter. An immunocytochemical study. Br J Urol 1997; 80:946.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1479/abstract/8\">",
"      Keating MA, Escala J, Snyder HM 3rd, et al. Changing concepts in management of primary obstructive megaureter. J Urol 1989; 142:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1479/abstract/9\">",
"      Baskin LS, Zderic SA, Snyder HM, Duckett JW. Primary dilated megaureter: long-term followup. J Urol 1994; 152:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1479/abstract/10\">",
"      Liu HY, Dhillon HK, Yeung CK, et al. Clinical outcome and management of prenatally diagnosed primary megaureters. J Urol 1994; 152:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1479/abstract/11\">",
"      Peters CA, Mandell J, Lebowitz RL, et al. Congenital obstructed megaureters in early infancy: diagnosis and treatment. J Urol 1989; 142:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1479/abstract/12\">",
"      Link BA, Slobodov G, Campbell JB, Kropp BP. Radiographic changes following excisional tapering and reimplantation of megaureters in childhood: long-term outcome in 46 renal units. J Urol 2007; 178:1474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1479/abstract/13\">",
"      Garc&iacute;a-Aparicio L, Rodo J, Krauel L, et al. High pressure balloon dilation of the ureterovesical junction--first line approach to treat primary obstructive megaureter? J Urol 2012; 187:1834.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6581 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-7CC26F0507-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_28_1479=[""].join("\n");
var outline_f1_28_1479=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DIAGNOSIS AND EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PRENATAL MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      POSTNATAL MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Nonrefluxing megaureter",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Asymptomatic patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Symptomatic patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Refluxing megaureter",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Antibiotic prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Our approach",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Prenatal presentation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Postnatal presentation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6581\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6581|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?6/24/6543\" title=\"diagnostic image 1\">",
"      IVP megaureter",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?19/15/19711\" title=\"diagnostic image 2\">",
"      Ultrasound megaureter",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?5/19/5424\" title=\"diagnostic image 3\">",
"      US megaureter transverse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?32/46/33519\" title=\"diagnostic image 4\">",
"      SFU grading fetal hydronephr",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?34/3/34868\" title=\"diagnostic image 5\">",
"      Megaureter natural course",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6581|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/25/30098\" title=\"figure 1\">",
"      Primary megaureter",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/1/11280\" title=\"figure 2\">",
"      Int classification VUR",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6581|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/49/15126\" title=\"picture 1\">",
"      Obstructed megaureter",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/0/11271?source=related_link\">",
"      Clinical presentation and diagnosis of posterior urethral valves",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/3/26680?source=related_link\">",
"      Congenital ureteropelvic junction obstruction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/3/39989?source=related_link\">",
"      Ectopic ureter",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/62/41961?source=related_link\">",
"      Management of vesicoureteral reflux",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/57/14233?source=related_link\">",
"      Oligohydramnios",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/52/42824?source=related_link\">",
"      Overview of antenatal hydronephrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/20/34119?source=related_link\">",
"      Postnatal management of antenatal hydronephrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/10/3242?source=related_link\">",
"      Presentation, diagnosis, and clinical course of vesicoureteral reflux",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/8/41093?source=related_link\">",
"      Ureterocele",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_28_1480="Lumbar spinal stenosis: Pathophysiology, clinical features, and diagnosis";
var content_f1_28_1480=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Lumbar spinal stenosis: Pathophysiology, clinical features, and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/28/1480/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/28/1480/contributors\">",
"     Kerry Levin, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/28/1480/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/28/1480/contributors\">",
"     Michael J Aminoff, MD, DSc",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/28/1480/contributors\">",
"     Steven J Atlas, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/28/1480/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/28/1480/contributors\">",
"     Janet L Wilterdink, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/28/1480/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term lumbar spinal stenosis can refer to one or more of the following anatomic states:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Narrowing of the intraspinal (central) canal",
"     </li>",
"     <li>",
"      Narrowing of the lateral recess",
"     </li>",
"     <li>",
"      Narrowing of the neural foramen",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic will focus on the pathophysiology, clinical features, and diagnosis in regard to stenosis of the intraspinal (central) lumbar canal. This condition, most commonly caused by degenerative bone disease, is increasingly recognized as a cause of disability in the aging population [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Lateral recess and neural foraminal stenosis can give rise to lumbar radiculopathy. Lumbosacral radiculopathy and general issues related to degenerative bone disease and back pain are discussed separately. The prognosis and treatment of lumbar spinal stenosis are also discussed separately.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42233?source=see_link&amp;anchor=H43#H43\">",
"       \"Overview of lower extremity peripheral nerve syndromes\", section on 'Lumbosacral radiculopathy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/10/18601?source=see_link\">",
"       \"Approach to the diagnosis and evaluation of low back pain in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/15/22776?source=see_link\">",
"       \"Lumbar spinal stenosis: Treatment and prognosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Five lumbar vertebral bodies (L1-5) comprise the lumbar spine. The lumbar spine curves slightly, forming the lumbar lordosis. The sacrum is made up of five developmentally fused vertebral levels (S1-5), followed by a terminal bony prominence, the coccyx (",
"    <a class=\"graphic graphic_figure graphicRef74811 \" href=\"UTD.htm?21/24/21896\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The spinal cord terminates at the conus medullaris within the lumbar intraspinal canal between the T12 and L2 vertebral levels. Exceptions include patients with congenital spinal deformities known as spina bifida, in which the fetal conus is tethered to ligamentous or bony structures, causing lengthening of the spinal cord during development. In such patients, the conus medullaris can be displaced downward to the middle or lower lumbar spine.",
"   </p>",
"   <p>",
"    All lumbar and sacral spinal nerve roots are constituted at the T10-L1 vertebral level, where the spinal cord ends as the conus medullaris. The roots then course down through the intraspinal canal, forming the cauda equina, until they exit at their respective neural foramina.",
"   </p>",
"   <p>",
"    The cross-sectional anatomy of the lumbar canal is demonstrated in the figure (",
"    <a class=\"graphic graphic_figure graphicRef74811 \" href=\"UTD.htm?21/24/21896\">",
"     figure 1",
"    </a>",
"    ). The canal is bounded anteriorly by the vertebral body",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    vertebral disc and the posterior longitudinal ligament, laterally by the pedicles and facet joints, and posteriorly by the lamina and ligamenta flava. Pathology involving these structures is frequently responsible for producing lumbar central canal stenosis (",
"    <a class=\"graphic graphic_figure graphicRef74811 \" href=\"UTD.htm?21/24/21896\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ETIOLOGIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Causes of lumbar spinal stenosis can be congenital or acquired [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Spondylosis, or degenerative arthritis affecting the spine, is the most common cause of lumbar spinal stenosis and typically affects individuals over the age of 60 years [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/4\">",
"     4",
"    </a>",
"    ]. Progressive disc degeneration due to aging, trauma, or other factors can lead to disc protrusion",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    loss of disc height with attendant loading of the posterior elements of the spine, including the facet joints. Facet joint arthropathy and osteophyte formation follow, along with hypertrophy of the ligamentum flavum. All of these processes (facet osteophytes, ligamentum flavum hypertrophy, and disc bulging) can encroach on the central canal and the neural foramina (",
"    <a class=\"graphic graphic_figure graphicRef74811 \" href=\"UTD.htm?21/24/21896\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Spondylolisthesis, in which one vertebral body translates anteriorly or posteriorly with respect to an adjacent vertebral body, can also occur, exacerbating the spinal canal narrowing. The L4-5 level is most commonly involved, followed by L5-S1 and L3-4. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/49/12056?source=see_link&amp;anchor=H10#H10\">",
"     \"Clinical manifestations of osteoarthritis\", section on 'Spine'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other acquired causes include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Space-occupying lesions (lipoma, synovial and neural cysts, neoplasms). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/27/6585?source=see_link\">",
"       \"Clinical features and diagnosis of neoplastic epidural spinal cord compression, including cauda equina syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Traumatic and postoperative causes (fibrosis).",
"     </li>",
"     <li>",
"      Skeletal disease (Paget, ankylosing spondylitis, rheumatoid arthritis, diffuse idiopathic skeletal hyperostosis). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/50/7978?source=see_link\">",
"       \"Clinical manifestations and diagnosis of Paget disease of bone\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/9/151?source=see_link\">",
"       \"Clinical manifestations of ankylosing spondylitis in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/46/13033?source=see_link\">",
"       \"Clinical features of rheumatoid arthritis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/59/43960?source=see_link\">",
"       \"Diffuse idiopathic skeletal hyperostosis (DISH)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Congenital and developmental causes of lumbar spinal stenosis include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dwarfism (achondroplasia, Morquio's syndrome, other spondyloepiphyseal dysplasias). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/16/35082?source=see_link&amp;anchor=H14#H14\">",
"       \"Complications and management of the mucopolysaccharidoses\", section on 'Spine abnormalities'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Spinal dysraphism (spina bifida, spondylolisthesis, myelomeningocoele). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/46/26344?source=see_link&amp;anchor=H18#H18\">",
"       \"Overview of the management of myelomeningocele (spina bifida)\", section on 'Orthopedic problems'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mechanical compression and ischemia of nerve roots have been proposed as causes of the neurologic symptoms in lumbar spinal stenosis (LSS). Either or both of these mechanisms may operate in individual patients. A role for inflammation of nerve roots is less certain [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nerve root compression may result from direct mechanical compression or occur indirectly from increased intrathecal pressure, which rises as the canal area is reduced [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/6\">",
"     6",
"    </a>",
"    ]. Increased intrathecal pressure can also cause venous congestion, reduced arterial blood flow, and reduction of impulse conduction along nerve roots [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/7-13\">",
"     7-13",
"    </a>",
"    ]. Some evidence suggests that multilevel stenosis is necessary for this process to occur [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The erect, extended position narrows the lumbar canal by reducing the interlaminar space, causing overlap of laminar edges of adjoining vertebral bodies, relaxing and inward buckling of the ligamentum flavum, and rostral-anterior migration of the superior facets [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/3,16\">",
"     3,16",
"    </a>",
"    ]. This may explain the onset or persistence of symptoms with prolonged standing. It is also possible that increased metabolic demands on spinal nerve roots during walking may exceed the available microvascular blood flow, especially when intrathecal pressures are elevated [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/9,13\">",
"     9,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical features of lumbar spinal stenosis (LSS) were characterized in a study of 68 patients with radiographic and surgical confirmation of disease [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neurogenic (or pseudo) claudication is a hallmark of LSS [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/1\">",
"     1",
"    </a>",
"    ]. This is the tendency for symptoms, usually pain, to be exacerbated with walking, standing,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    maintaining certain postures, and relieved with sitting or lying [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/17\">",
"     17",
"    </a>",
"    ]. Many patients with LSS are symptomatic only when active. In one systematic review of clinical findings in LSS, neurogenic claudication was moderately sensitive and present in 82 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/18\">",
"     18",
"    </a>",
"    ]. Exacerbation by prolonged standing in an erect posture was an even more sensitive but less specific sign. No pain with sitting was the most specific finding. More than half of patients with LSS also reported relief with sitting or flexion at the waist (squatting, leaning forward), findings that were relatively specific for LSS (84 and 92 percent respectively), but less sensitive.",
"   </p>",
"   <p>",
"    The primary symptoms of LSS include discomfort, sensory loss, and weakness in the legs, reflecting involvement of spinal nerve roots within the lumbar spinal canal. In the clinical series described above, pain was the most common symptom, occurring in 93 percent of patients, followed by numbness",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    tingling in 63 percent, and weakness in 43 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/17\">",
"     17",
"    </a>",
"    ]. Symptoms were bilateral in most (68 percent), but often asymmetrical, and usually involved the entire leg rather than just the upper or lower leg (78 versus 15 and 6 percent, respectively). Pain in a single nerve root distribution occurred in only 6 percent. Low back pain occurred in 65 percent and was described as mechanical and mild. Low back pain in LSS is not necessarily associated with the claudication symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The neurologic examination is often normal in patients with LSS. The straight leg raising sign is present only in a minority of patients (10 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/17,19\">",
"     17,19",
"    </a>",
"    ]. However, in some patients with LSS, more prolonged or severe nerve root involvement may lead to fixed",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    progressive neurologic deficits.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients may have symptoms or neurologic signs of single or multiple lumbosacral radiculopathies, superimposed on more typical symptoms of LSS. The neurologic examination may demonstrate focal weakness",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      sensory loss in the distribution of one or more spinal nerve roots. In the study described above, deep tendon reflexes were absent at the ankle in 43 percent, and at the knee in 18 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/17\">",
"       17",
"      </a>",
"      ]. Weakness was seen in 37 percent and was usually mild and isolated to the L5 and S1 root distributions [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/17\">",
"       17",
"      </a>",
"      ]. A wide-based gait",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      positive Romberg in the setting of low back pain had a specificity of more than 90 percent for LSS [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/1,19\">",
"       1,19",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42233?source=see_link&amp;anchor=H43#H43\">",
"       \"Overview of lower extremity peripheral nerve syndromes\", section on 'Lumbosacral radiculopathy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The cauda equina syndrome is an uncommon complication of LSS, but is associated with marked neurologic disability. The clinical presentation is dominated by bilateral leg weakness in multiple root distributions (L3-S1), and may be associated with bowel, bladder, and erectile dysfunction due to involvement of the S2-4 spinal nerve roots.",
"     </li>",
"     <li>",
"      When the intraspinal site of compression is between T12 and L1, the conus medullaris may also be damaged, producing a mixed picture of spinal nerve root and spinal cord dysfunction (myelopathy). The clinical manifestations of myelopathy in this setting include bowel, bladder, and erectile dysfunction, diffuse leg weakness, sensory deficit level at T11 or below, saddle-distribution anesthesia, increased tone in the legs, and extensor plantar responses.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It may also be useful to examine the patient after physical activity, as this might elicit neurologic deficits. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Other diagnostic tools'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peripheral vascular disease may be mistaken for lumbar spinal stenosis because both are associated with exertional exacerbation. However, symptoms of neurogenic claudication can usually be distinguished from vascular claudication (",
"    <a class=\"graphic graphic_table graphicRef80902 \" href=\"UTD.htm?38/53/39771\">",
"     table 1",
"    </a>",
"    ). Neurogenic, but not vascular, claudication often persists with rest when standing still in an erect posture, and can be ameliorated somewhat by assumption of stooped, flexed posture, even without rest. Similarly, bicycling is frequently better tolerated by patients with LSS compared with similar intensity walking, while this is not true for patients with vascular claudication. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30201?source=see_link\">",
"     \"Clinical features, diagnosis, and natural history of lower extremity peripheral artery disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other diagnoses should also be considered in the differential diagnosis of LSS:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nonspecific back pain from spondylosis without LSS and referred pain from the retroperitoneum due to infection or malignancy may resemble some of the features of LSS; however, classic neurogenic claudication is unusual.",
"     </li>",
"     <li>",
"      Distal polyneuropathy may produce bilateral asymmetric pain, paresthesias, and numbness, as does LSS. It is unusual, however, for symptoms of polyneuropathy to be strongly influenced by activity or posture.",
"     </li>",
"     <li>",
"      The pain of osteoarthritis of the hips or knees may be exacerbated by walking. Pain in these conditions usually localizes to the involved joints, but may also radiate to the groin or buttocks. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/49/12056?source=see_link&amp;anchor=H8#H8\">",
"       \"Clinical manifestations of osteoarthritis\", section on 'Knees'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/49/12056?source=see_link&amp;anchor=H9#H9\">",
"       \"Clinical manifestations of osteoarthritis\", section on 'Hips'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Spinal cord vascular malformations are rare, but can produce symptomatic deficits of the lumbosacral nerve roots and symptoms of neurogenic claudication [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/20\">",
"       20",
"      </a>",
"      ]. Symptoms often fluctuate in this condition, but usually in a less predictable fashion as compared with LSS. Patients with spinal cord vascular malformations also often have long tract signs, although these may be subtle.",
"     </li>",
"     <li>",
"      A number of inflammatory conditions involving the lumbosacral nerve roots or cauda equina can produce neurologic deficits that overlap with those seen in LSS. Neurogenic claudication, however, would not be expected. These conditions include spinal arachnoiditis, chronic inflammatory demyelinating polyneuropathy [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/21,22\">",
"       21,22",
"      </a>",
"      ], sarcoidosis, carcinomatous meningitis, and a variety of infections (eg, cytomegalovirus, herpes simplex virus, herpes zoster virus, Epstein Barr virus, Lyme disease, mycoplasma, tuberculosis).",
"     </li>",
"     <li>",
"      Congenital tethered cord syndrome usually presents in childhood, but occasionally individuals with occult spinal dysraphism first come to medical attention as adults [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/23-25\">",
"       23-25",
"      </a>",
"      ]. Such patients present with complaints that may be similar to LSS with a mixture of leg and back pain, motor and sensory symptoms, and bowel or bladder dysfunction. Neuroimaging will reveal this condition, which is often amenable to surgical untethering.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of lumbar spinal stenosis (LSS) requires the presence of typical symptoms combined with a neuroimaging study showing structural narrowing of the intraspinal canal. The imaging study usually also identifies the underlying etiology.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Neuroimaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is generally agreed that a new symptom of low back pain in an older individual (&gt;50 years) or neurologic deficits consistent with disease of the lumbosacral spine are indications for a neuroimaging study. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/10/18601?source=see_link\">",
"     \"Approach to the diagnosis and evaluation of low back pain in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While findings on plain radiographs of the lumbar spine can lend support for the diagnosis of LSS and may suggest the underlying pathology, magnetic resonance imaging (MRI) is the modality of choice for the diagnosis of LSS (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef55238 \" href=\"UTD.htm?9/27/9650\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef52695 \" href=\"UTD.htm?22/49/23312\">",
"     image 2",
"    </a>",
"    ). MRI defines the bony anatomy and visualizes soft tissues and neural structures, such as the conus medullaris and spinal nerve roots within the canal and neural foramina. Computed tomography (CT) may be preferable to MRI for bony anatomy, and when combined with myelography provides imaging of neural elements. Studies indicate a good correlation between MRI and CT myelography for LSS diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. Because myelography is an invasive procedure with an attendant risk of complications, MRI is generally preferred. However, CT myelography is a good alternative in patients in whom MRI is contraindicated. Contrast administration provides little additional information to the MRI and is unnecessary unless either new spinal symptoms arise postoperatively or there is a question of intraspinal infection or metastasis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/35/5689?source=see_link&amp;anchor=H19#H19\">",
"     \"Principles of magnetic resonance imaging\", section on 'Precautions'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Uncertainty regarding the diagnosis of lumbar spinal stenosis even after MRI results from variety in the criteria used to define spinal stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/28\">",
"     28",
"    </a>",
"    ]. Examples include an intraspinal canal area of less than 76 mm2 and 100 mm2 to identify severe and moderate stenosis, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/15\">",
"     15",
"    </a>",
"    ]. Anteroposterior diameters of less than 10 mm are also often used as a cutoff, but provide a less complete measure of anatomic disease. Area measurements, however, are more complicated to perform and have a less certain interrater reliability [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/26,29\">",
"     26,29",
"    </a>",
"    ]. Other qualitative assessments to grade disease and predict prognosis and treatment response as well as dynamic MRI techniques have been proposed but require independent validation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. Some clinicians require that more than one spinal level be affected to diagnosis LSS.",
"   </p>",
"   <p>",
"    Another important caveat is that radiologic spinal stenosis is a common incidental finding, occurring in 6 to 7 percent of asymptomatic adults in two series [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/1,28,32,33\">",
"     1,28,32,33",
"    </a>",
"    ]. In adults over 60 years old, the prevalence may be as high as 20 to 30 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. There is no substantive relationship between the severity of radiologic findings and the severity of clinical symptoms or prognosis. Findings on neuroimaging must be carefully interpreted in the context of the clinical history and examination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Other diagnostic tools",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electromyography and nerve conduction studies",
"    <span class=\"nowrap\">",
"     (EMG/NCS)",
"    </span>",
"    are not required for the diagnosis of LSS, and are generally ordered when alternative diagnoses (eg, neuropathy) are considered [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/35\">",
"     35",
"    </a>",
"    ]. However, they can provide information about nerve root damage in this setting. The most common",
"    <span class=\"nowrap\">",
"     EMG/NCS",
"    </span>",
"    abnormality in patients with LSS is an absent H-reflex, a subtle manifestation of S1 nerve root involvement. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42233?source=see_link&amp;anchor=H43#H43\">",
"     \"Overview of lower extremity peripheral nerve syndromes\", section on 'Lumbosacral radiculopathy'",
"    </a>",
"    .) Many patients with LSS have a normal",
"    <span class=\"nowrap\">",
"     EMG/NCS",
"    </span>",
"    evaluation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/17\">",
"     17",
"    </a>",
"    ]. Patients with fixed clinical symptoms and signs of nerve root injury are more likely to have abnormal",
"    <span class=\"nowrap\">",
"     EMG/NCS;",
"    </span>",
"    however,",
"    <span class=\"nowrap\">",
"     EMG/NCS",
"    </span>",
"    is more sensitive than the clinical examination.",
"   </p>",
"   <p>",
"    When there is a superimposed radiculopathy,",
"    <span class=\"nowrap\">",
"     EMG/NCS",
"    </span>",
"    can help localize the nerve root injury and provide some prognostic information as well [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42233?source=see_link&amp;anchor=H43#H43\">",
"     \"Overview of lower extremity peripheral nerve syndromes\", section on 'Lumbosacral radiculopathy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Exercise testing may be helpful but does not have a defined role in the clinical evaluation of patients with LSS [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/35,38\">",
"     35,38",
"    </a>",
"    ]. Some clinicians report that exercise can elicit neurologic signs",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <span class=\"nowrap\">",
"     EMG/NCS",
"    </span>",
"    abnormalities that are not apparent at rest. A treadmill exercise test can also quantify the time to onset of symptoms and total ambulation endurance with good test-retest reproducibility [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/39\">",
"     39",
"    </a>",
"    ]. This has been used to define baseline functional status and evaluate postoperative symptom relief [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1480/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When other entities in the differential diagnosis are considered as an alternative to LSS, other specific testing may be indicated, as an example, Doppler ultrasound studies of the lower extremities for peripheral vascular disease or plain films of the hips or knees for osteoarthritis. These conditions are very prevalent in the elderly population in which LSS is most common, and can coexist with LSS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30201?source=see_link\">",
"     \"Clinical features, diagnosis, and natural history of lower extremity peripheral artery disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33287?source=see_link\">",
"     \"Diagnosis and classification of osteoarthritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/44/40642?source=see_link\">",
"       \"Patient information: Spinal stenosis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lumbar spinal stenosis (LSS) can be caused by a variety of congenital or acquired conditions. The most common cause is degenerative spondylosis, which typically affects individuals over the age of 60 years. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Etiologies'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      LSS is clinically manifested by neurogenic claudication, a syndrome of bilateral, often asymmetric pain, sensory loss,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      weakness affecting the legs, which is produced or exacerbated by walking or prolonged standing in an erect posture. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      These symptoms represent intermittent mechanical",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      ischemic disruption of lumbosacral nerve root function. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In a few patients, more fixed nerve root injury may occur, causing lumbosacral radiculopathy, cauda equina syndrome, or conus medullaris syndrome. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Vascular claudication from peripheral vascular disease can usually be distinguished from neurogenic claudication by characteristic clinical features (",
"      <a class=\"graphic graphic_table graphicRef80902 \" href=\"UTD.htm?38/53/39771\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of LSS requires a neuroimaging study. Magnetic resonance imaging of the lumbosacral spine is the test of choice for most patients. In some patients, electrophysiologic tests, vascular ultrasound, and other tests may be required to rule out other disorders in the differential diagnosis. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/1\">",
"      Katz JN, Harris MB. Clinical practice. Lumbar spinal stenosis. N Engl J Med 2008; 358:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/2\">",
"      Ciol MA, Deyo RA, Howell E, Kreif S. An assessment of surgery for spinal stenosis: time trends, geographic variations, complications, and reoperations. J Am Geriatr Soc 1996; 44:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/3\">",
"      Binder DK, Schmidt MH, Weinstein PR. Lumbar spinal stenosis. Semin Neurol 2002; 22:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/4\">",
"      Atlas SJ, Delitto A. Spinal stenosis: surgical versus nonsurgical treatment. Clin Orthop Relat Res 2006; 443:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/5\">",
"      Jinkins JR. Gd-DTPA enhanced MR of the lumbar spinal canal in patients with claudication. J Comput Assist Tomogr 1993; 17:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/6\">",
"      Takahashi K, Kagechika K, Takino T, et al. Changes in epidural pressure during walking in patients with lumbar spinal stenosis. Spine (Phila Pa 1976) 1995; 20:2746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/7\">",
"      Rydevik B. Neurophysiology of cauda equina compression. Acta Orthop Scand Suppl 1993; 251:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/8\">",
"      Ooi Y, Mita F, Satoh Y. Myeloscopic study on lumbar spinal canal stenosis with special reference to intermittent claudication. Spine (Phila Pa 1976) 1990; 15:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/9\">",
"      Watanabe R, Parke WW. Vascular and neural pathology of lumbosacral spinal stenosis. J Neurosurg 1986; 64:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/10\">",
"      Baker AR, Collins TA, Porter RW, Kidd C. Laser Doppler study of porcine cauda equina blood flow. The effect of electrical stimulation of the rootlets during single and double site, low pressure compression of the cauda equina. Spine (Phila Pa 1976) 1995; 20:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/11\">",
"      Kaiser MC, Capesius P, Roilgen A, et al. Epidural venous stasis in spinal stenosis. CT appearance. Neuroradiology 1984; 26:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/12\">",
"      Ikawa M, Atsuta Y, Tsunekawa H. Ectopic firing due to artificial venous stasis in rat lumbar spinal canal stenosis model: a possible pathogenesis of neurogenic intermittent claudication. Spine (Phila Pa 1976) 2005; 30:2393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/13\">",
"      Porter RW. Spinal stenosis and neurogenic claudication. Spine (Phila Pa 1976) 1996; 21:2046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/14\">",
"      Porter RW, Ward D. Cauda equina dysfunction. The significance of two-level pathology. Spine (Phila Pa 1976) 1992; 17:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/15\">",
"      Hamanishi C, Matukura N, Fujita M, et al. Cross-sectional area of the stenotic lumbar dural tube measured from the transverse views of magnetic resonance imaging. J Spinal Disord 1994; 7:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/16\">",
"      Inufusa A, An HS, Lim TH, et al. Anatomic changes of the spinal canal and intervertebral foramen associated with flexion-extension movement. Spine (Phila Pa 1976) 1996; 21:2412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/17\">",
"      Hall S, Bartleson JD, Onofrio BM, et al. Lumbar spinal stenosis. Clinical features, diagnostic procedures, and results of surgical treatment in 68 patients. Ann Intern Med 1985; 103:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/18\">",
"      Suri P, Rainville J, Kalichman L, Katz JN. Does this older adult with lower extremity pain have the clinical syndrome of lumbar spinal stenosis? JAMA 2010; 304:2628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/19\">",
"      Katz JN, Dalgas M, Stucki G, et al. Degenerative lumbar spinal stenosis. Diagnostic value of the history and physical examination. Arthritis Rheum 1995; 38:1236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/20\">",
"      Atkinson JL, Miller GM, Krauss WE, et al. Clinical and radiographic features of dural arteriovenous fistula, a treatable cause of myelopathy. Mayo Clin Proc 2001; 76:1120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/21\">",
"      Goldstein JM, Parks BJ, Mayer PL, et al. Nerve root hypertrophy as the cause of lumbar stenosis in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1996; 19:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/22\">",
"      Diederichs G, Hoffmann J, Klingebiel R. CIDP-induced spinal canal obliteration presenting as lumbar spinal stenosis. Neurology 2007; 68:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/23\">",
"      Iskandar BJ, Fulmer BB, Hadley MN, Oakes WJ. Congenital tethered spinal cord syndrome in adults. Neurosurg Focus 2001; 10:e7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/24\">",
"      Aufschnaiter K, Fellner F, Wurm G. Surgery in adult onset tethered cord syndrome (ATCS): review of literature on occasion of an exceptional case. Neurosurg Rev 2008; 31:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/25\">",
"      Ratliff J, Mahoney PS, Kline DG. Tethered cord syndrome in adults. South Med J 1999; 92:1199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/26\">",
"      Saifuddin A. The imaging of lumbar spinal stenosis. Clin Radiol 2000; 55:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/27\">",
"      Wildermuth S, Zanetti M, Duewell S, et al. Lumbar spine: quantitative and qualitative assessment of positional (upright flexion and extension) MR imaging and myelography. Radiology 1998; 207:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/28\">",
"      Andreisek G, Hodler J, Steurer J. Uncertainties in the diagnosis of lumbar spinal stenosis. Radiology 2011; 261:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/29\">",
"      Lurie JD, Tosteson AN, Tosteson TD, et al. Reliability of readings of magnetic resonance imaging features of lumbar spinal stenosis. Spine (Phila Pa 1976) 2008; 33:1605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/30\">",
"      Schizas C, Theumann N, Burn A, et al. Qualitative grading of severity of lumbar spinal stenosis based on the morphology of the dural sac on magnetic resonance images. Spine (Phila Pa 1976) 2010; 35:1919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/31\">",
"      Kanno H, Ozawa H, Koizumi Y, et al. Dynamic change of dural sac cross-sectional area in axial loaded magnetic resonance imaging correlates with the severity of clinical symptoms in patients with lumbar spinal canal stenosis. Spine (Phila Pa 1976) 2012; 37:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/32\">",
"      Jensen MC, Brant-Zawadzki MN, Obuchowski N, et al. Magnetic resonance imaging of the lumbar spine in people without back pain. N Engl J Med 1994; 331:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/33\">",
"      Boden SD, Davis DO, Dina TS, et al. Abnormal magnetic-resonance scans of the lumbar spine in asymptomatic subjects. A prospective investigation. J Bone Joint Surg Am 1990; 72:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/34\">",
"      Denard PJ, Holton KF, Miller J, et al. Lumbar spondylolisthesis among elderly men: prevalence, correlates, and progression. Spine (Phila Pa 1976) 2010; 35:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/35\">",
"      Adamova B, Vohanka S, Dusek L. Differential diagnostics in patients with mild lumbar spinal stenosis: the contributions and limits of various tests. Eur Spine J 2003; 12:190.",
"     </a>",
"    </li>",
"    <li>",
"     Levin, KH. Radiculopathy. In: Comprehensive Clinical Neurophysiology, Levin, KH, L&uuml;ders, HO (Eds). New York, WB Saunders 2000. p.627.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/37\">",
"      Tsao BE, Levin KH, Bodner RA. Comparison of surgical and electrodiagnostic findings in single root lumbosacral radiculopathies. Muscle Nerve 2003; 27:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/38\">",
"      Dyck P, Doyle JB Jr. \"Bicycle test\" of van Gelderen in diagnosis of intermittent cauda equina compression syndrome. Case report. J Neurosurg 1977; 46:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/39\">",
"      Deen HG Jr, Zimmerman RS, Lyons MK, et al. Test-retest reproducibility of the exercise treadmill examination in lumbar spinal stenosis. Mayo Clin Proc 2000; 75:1002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1480/abstract/40\">",
"      Deen HG Jr, Zimmerman RS, Lyons MK, et al. Measurement of exercise tolerance on the treadmill in patients with symptomatic lumbar spinal stenosis: a useful indicator of functional status and surgical outcome. J Neurosurg 1995; 83:27.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7779 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-183.166.191.243-DB525E7F52-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_28_1480=[""].join("\n");
var outline_f1_28_1480=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ETIOLOGIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Neuroimaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Other diagnostic tools",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/7779\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/7779|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?9/27/9650\" title=\"diagnostic image 1\">",
"      Axial MRI LSS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?22/49/23312\" title=\"diagnostic image 2\">",
"      Sagittal MRI LSS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/7779|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/24/21896\" title=\"figure 1\">",
"      Common pathoanatomical conditions of the lumbar spine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/7779|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/53/39771\" title=\"table 1\">",
"      Neuro vs vasc claudication",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/10/18601?source=related_link\">",
"      Approach to the diagnosis and evaluation of low back pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/27/6585?source=related_link\">",
"      Clinical features and diagnosis of neoplastic epidural spinal cord compression, including cauda equina syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/46/13033?source=related_link\">",
"      Clinical features of rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/31/30201?source=related_link\">",
"      Clinical features, diagnosis, and natural history of lower extremity peripheral artery disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/50/7978?source=related_link\">",
"      Clinical manifestations and diagnosis of Paget disease of bone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/9/151?source=related_link\">",
"      Clinical manifestations of ankylosing spondylitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/49/12056?source=related_link\">",
"      Clinical manifestations of osteoarthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/16/35082?source=related_link\">",
"      Complications and management of the mucopolysaccharidoses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33287?source=related_link\">",
"      Diagnosis and classification of osteoarthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/59/43960?source=related_link\">",
"      Diffuse idiopathic skeletal hyperostosis (DISH)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/15/22776?source=related_link\">",
"      Lumbar spinal stenosis: Treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42233?source=related_link\">",
"      Overview of lower extremity peripheral nerve syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/46/26344?source=related_link\">",
"      Overview of the management of myelomeningocele (spina bifida)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/44/40642?source=related_link\">",
"      Patient information: Spinal stenosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/35/5689?source=related_link\">",
"      Principles of magnetic resonance imaging",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_28_1481="TDP43 in IBM myofibers";
var content_f1_28_1481=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F62042&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F62042&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 531px\">",
"   <div class=\"ttl\">",
"    TDP-43 in IBM myofibers",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 511px; height: 575px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAI/Af8DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5t8LeH7vxJqD2djJAkqRmUmYkDAIHYHn5hXVn4Sa8Ot1pn18x/wD4im/BEIfFl0JOn2J8c458yOvqL4deC/C2qeBU1vxHJeJJJe3kck7azdW8YAvJYo1wsqqvARQABnjuaht3sjZRioKUkfLM3ws16LkS2Eg9UlY/+y1E/wAM9cXgSWTH0Dvn/wBBr7Sufhn4AtLy0tLn7VBd3ZZbaGTX7xXmKjLBFM2WwOTjoK8/8XeGdM0Dx7e2GlC6jtf7MtLgRzXU1x+8aW5ViDIzEZCJ0OOKUnKKuXTVKclGzPmaD4farNI0YuLFXXqrO4P/AKDU4+GmskZFzp/08x//AImvdtZ0GO7xLbuEnB+V1Hf3rBiupY777JqEXk3ODt3cpMB/dPr7GpVRvY6fqtPqeTD4aa0QD51j1xje/wD8TVn/AIVTrvlq4udOIIzgSPkf+OV7NDFGFM5XCYBz1/Sma19vs7CwmsostuAdGO3KscAE9qXtJXsKWFhE8DvvBeo6fc+VfT2duD92R3ba30wufzAq9b/DjVbiISwXmmSRnoyysR/6DXtcEOna3DNFeNE0kOFmiblkJp0GjWunKyaY8cKE8qBwT7g03U6dSI4eN/I8U/4VprOf+Piw/wC+3/8AiKX/AIVnrOM/aLD/AL7f/wCIr2v7PcKjrGsEjAbvkbqPpWdpst7dXpjewlELZO/G3aO3WhTkV7Cn5nkv/CtNZxk3FgB7u/8A8RTF+G+stnE9jx/tv/8AE17httRIYmvrcuD9xXGfxqrqETMFFveW9sobBIiaRj+fFJVJB9Xpnjo+GWtnpPY5643v/wDE1S1HwLqVgUWSezeVjgRxs7N/6DXuMVpsbE09zID6vsp9zbw+S8cS/Z5JBtLqfnGe4J7+9NVHfUl4aPRHiNp8PdSuZjCt7piXCxmV4Wlbci+rYU4pYvh3qkwzBeadKm3cGSRyDzj+57V6z4P0HTbQXktgxup5Pkldn3bgOqj8TUvh+OL7E0aJFC0Mzx+UnULnI3Dsfam5voKOHi2kzyb/AIVprGD/AKRYcdf3j/8AxFOHww1oruFxp5H/AF0f/wCIr2kwjcxGQpPYVPHGhw4+8pGe2aj2jNvqlM8Pb4Y60px9p08n2kf/AOIo/wCFY6zx/pWnHtxI/wD8RXtVxHiQYPcjjtTVQIQBgFfbPWj2kh/VKZ40nws1xulzp/4yP/8AEUD4W62Sf9K04Y9ZH/8AiK9tVN2FY4IPGKmVHUBHAIU5z1B+tHtJB9Upnhx+FWt7S32rTcD/AKaP/wDEUR/CrXJB8t1pvTI/eSc/+OV7bJGQpZMblOcjjPtS7yq88MgDrj1o9oyXhYI8UHwm1wkgXel7tu8L5r5I9QNlR/8ACq9cyB9p076+ZJ/8RXs8J0688UHyxKupWSbl+bCsrDP49RVu5jOQ6Kyhj0HGDVObRnCjTe54gnwo1x/u3emf9/JP/iKX/hUuvZx9q03/AL+P/wDEV7Lg5Y5A/GptzLuVhyeOKn2kjdYSmeKH4T673udNH1kk/wDiKx/FXgfUvDWnpeX81nJE8whHkuxO4gnuo44NfQxIfnoTwfr71598cGB8K2gyCftic/8AbOSqjUbdjOrhoQg5I8VjgZ1DArg+tP8Asj/3l/Oui+Hmn2uq+MfDOnX6GW0vNTtreePcV3xvMqsMggjIJ5BBr7QPwN+Fa3yWR0SMXjxtMsB1S58xkUgFwvm5KgsoJ6ZI9a2PPZ8G/ZH9V/M1JBp087qse3k4znp9a+3NE+FXwU16eSHQ4dM1OaNd7x2euTTMq5xkhZjgZr400lYjNEbpmSFkIZgu7qOOMjPOKmTsrlQipOxFJ4fvorcyyiOMBxGQxIIY846YyByRnIGKzzaPuIDKfcHrXpbNHdaJZ2uqCWCxidVS4WLIZsDluSSMDsAevPXFnWdO0I6XdQ2GkPaXUEDS7mfe2OCpyTjHr1IDAVxLGWaUlu+mx3SwN1eD/wAzyv7JJ6r+dL9jk/vJ+dXcgEe9SfKBgAknpmu25wqKM4WUpOAVP0zTjYShN5ZAPqa6CPQdaEH2iPTLwxBzHlYicMF3EEdeF5+lVrqSSS3j3QOqH7rbThseh71CqJv3Xc09lZe8rGL9kf1X8zSfZJPVfzq7nnHOfSg8dj+NaXMrIpfZH/vLS/ZH/vJ+taMMTTSIpZYlf7rSHav5051AXKj92eCxHei41DqUINPeVtvmxI3RQxPzH0HH88Co3tHV2UlCQccHIrpXGo6bZiy4it9UVHIZVJcBuD/eXk+2fpWhqum6NYWunXFjdSTyTqwcMwOx14OVwCAeo9j7GsXXSa632sbxw7kn0tvc4xbKVvu7T+dMNrIDyV/Ouv0hIbfUoRcyNbblLMwAJ9qxdQSIXL+SwKA8Yqo1OaTjYmdDlgp36mV9lf1T86T7M/qtXBzS1oYFP7K/qv50fZX9V/OrmR6UdqAsU/sr+q0ptHHUr+dXFGTQx5oHYpfZX9V/Ok+zP6r+dXgM8DP4VLcWksATeuN6h8ex6UX6Aotq6KMNi8rBfMjX3YnH8qtW+iXFxcNCk1vvHq5AJ9OlR5xwDUlvM8MyyIcMpyKUuboVBxuuZFe4024t5mimAWRThlOQQaiNnIOpX86v3F1Lc3DzzOzSuclj3pnmE9cH6ihXtqKXLd8uxT+ySeq/nUDAqxU9QcVplyen6Vmy/wCtf6mmSztvhAgk8S3IOf8AjzYjHrvSvp/QtIn1n4B6VbWOgvrOoJqlzLAV8gNblNQlZnDSuuCVDLlTn5sdMmvmP4OZ/wCEmutoyfsbf+hpX0H4Q8W+KfDehRaXpN1oTWaTTSx/aLCWSQeZK8hDMs6g4LkfdHGKlySlqdUaUqlFcq6na+M/CnizxJ4hufEdjFb2M2lw250qyu41kmldCs8gEiTbIi7fuWLBgQp7YJzPiOxk+J05ZHilfRLE+WcFl/fXeRwcZHtxVUfEvxwSMz+GgD3/ALMn/wDkmsDULzVde8QTaxrF1Y/bzbw2sJsrd4EVY3lYE7pHJJMpHXGAOKmck1YqjhqkZptDDrYsLo2+sQNaBuIrkKWgk/4F/C3sal1G1t9Rs99u0UrH5o5F+ZC3uauWWuq7NaalGgVgewKmtFrS0lg821ijcdcKMZP4Vzt2O3VaM4Pw3HrltdTx6pZxlVy8bqdyDHr3x7VDZa2/iSWRHkeCCLzGY4IIjUkbj712kaAwh44dik9sgqayb3TWgaRkhj/egowwMEE8kirU03dohxdtGc94OtLeGC4nt7d44Z3yjSNmSRR/ESf0Fb0yKztsfCrzj1qu86WblZQscPQHsAO1RRTLO3mRnbG2enenJ31KhFJWJj+8m3OmD1BPemSDapBDc9ee1SKGSVj5jbD/AAt0H0p0vO7AHzHFSXYo2Fvaws0kdtbJKzZLJEFY8dzWpJMCoVcEHk4HQ+1ULi6hs42luANgO0YPQ+1XHubYiNlI8h13CZDwD703dkXUdCmqhpMEkKeNoPWpL61Se2e3kdlRwwLJwQPY1Zl2goI9krFgAFYbqgc/OPOBZ1H3QeFoByT0G6Rp9vpkcUNnCIhGrBV9WIPU/Ws3Q768urVrjUIof7Q84wyxoAA2P4s9zzWzHICmPmBXnOe9AXMwYBVUk8BcfP3J+tFxcuqaFiAU4xgcj3qRtsaDau5cHIPrSAAtkfNhqkhjDbt7FAAevepNkytOSzLJENqsOcjPPvVcnMrkLh8446e9PuEwrAg/Nzz+lRo3ljDYkHcn+YpgWrcrt2rw248kZ/WpW+R2V8EgYyKro5jZWQb89MjPPrVsy4T5l3546dKljRFJtJIXcFA5XvTViUlir5UDac8E08RStE0qLwgyeaaoUndkEnrTBodFZWsUst5HGTdlFiMn+wOuPw/St6KJJ1EDqrbkyPYetZ8MmVViu0D8iO9PjuY7LUUsYZ4G1GVvkgDH5UPc8enNGrOWaUXoZ95ZSW92oDgwjPQYJP8AKo0QksVJIGDg+vtXT6hamTbhhu6uoXIfHXjtXJ2OoWWpXk9tp8jfaY22+ROpGcdwe4prVXNI1LaMn8xhncGG4bckZ/WvPPjbz4VtW65vU59Pkkr0ua1kjAEiOhPAOMgn1/OvOfjlt/4RO02YGb1MgdP9XJVQ+JCryTpM89+FX/JS/BP/AGGrP/0elfck+mXUPxnttZtPDc32N9LmsbrU4jbKJHaSB0LDzBIyqImXlSQSMAjJHwL4b1C40bV9I1eyWJrnT7qO7jWUEoWjcMAwBBIyBnBH1r3E/tP+Nh/zD/Df/gLP/wDHq6TyGj1j4Q+EvFGi6h4VbVrDUoRpunS2V02oSWTxRK21glt5DFzl1XJlzwODXxlG5WBFHQoM/pXuf/DUHjb/AKB3hv8A8BZ//j1eEqcKqnHyjGQOtJjV0TrczgqPNcqABtZiRgdB+p/OtBdQgj064imWae5mz8rSHy0PHzAZ5OABzWXg9aaQTzxmolBM0jUlHVAeTW74Qt4LjVNt4shjCEK6jIjkPCMw7jcRke9YZPHAINdJ4fsbK20Z9Z1eaVIjcLbWywgMWccuzqT0VTkepqK7/dvzLwyvUV9luXZb2XTrDy7S7k+ZjBN5Zfbc4z+8O4ja4Bxx1H403T9eu7XTLrR7WSb+ybuZZ7dnjDNE8fIKAn5ST97timPcwaq1zFZ2zGXh7fYAwWNCSWkzznAzx0GQagsNGh1fSbiS0vUW9toxNJbykKrgnBKHPAAwcH1rltBRvUVtfx/r/LY7pc85WpO/b/gf157l6HVJLjwve2UPhzT57u6Z5n1CNCZVUYJYAH5Rn8OTXPaSksl4kskMTsRmP7QMIxXkj347VtrZQ2vhy0ubjVj9pW7aFdNjBVzGVA8xWHUduvbFZF1d75bp72FZdwZEQMUEbYHzgDjj071dGK95QW/r6denpZdjKr9mU3qvT+vz/wA7JgMkgju4JMwyku0eCgU89vw56VPodo984trJC+oQMZ4lZlESKOWJJxnHGOT06Vk2t5JGHCvjcpTGcAA9+O9XNY1ifVbXT9PMFnHFaARw/Z4AjOT3ZurE+9VKE/hX/DfL/giVSFlJ6v8AP5i6ravFeFJoWW8VpEkdnzz6kg4GPy5qnc2gkuN1v5aqke5hu+YhRyTz1pz24j225kkTPyzE9UIPOR/d4yKZcFGt0K2wi24TzUYlXIHOc9zkHH5VpG6t/X9ehnOzvdf1/XoUmYsxJOT6mmNn1zXS6laC/wDCtvqdhpxigsWFte3jSczyuSUO3PGF4OK5rNXTmpp26GFSLi+4yl7UlFaGQtAoBpKAHE4HFNzRS96AHRnBNaM11GNM8rzGklJxjbgIPr3rNA5600seamUea1zSFRwTt1G96B1opaszE60UCikA5TWfL/rX/wB41fFUJf8AWv8AU0wO7+DIz4puflyRZvgf8DSvbYAUKH8/avDfhDcLbeJLlmjeTdaMoSMjc3zocAE8njoK9s0y+s79Ga2l5BAZHBV1PuKxqJ3PTwclyWLXEjlcn8BxUiPjCBBtB78kH2p0CKjjcBnoATjNSIY9+GxnPy5HBB6frWNzusZWu6a2o2/lQziGZHV0kK5APcEdwRkYq94dN1p9ykbXA8vO35jkH8f0qR4mJYDLAHn0FMaTMsVuGX95kFh0TaMk1SbasZVIr4jpGCI4cL8jcsBxzU4SFuJSV/3gK8y/4Tf93cX2krPc6dBcmGbcDlQejjqCOtdHF4psirLI+JIiPMEXzNGCM5ZfTnmodKS2MlOLNLVtNtbg5co6g8qKqeG/CTeJ9WMGkGa28sjz5JOUiTnnHdjzgd/oCa0PD11Brmp2Vvp15ptxFdvtWYTbCuOp2n730BBNexajbW3hTwdfDTkCOsZw5+88rcBj6nJH4DAq6cXvLYyq1lFcsd2fOGvapY6VeXKSGaK0WZo4ZZRuLqCQDx3OM/jSaZrNlqO82Uyuq/KR0IPuDXS3drbNF5V7BHLb4BwRwKyZ7XSREWgtIsIeiAj+VJSTOjVMhlSNlIkQOpHzKwGAPWqsU9r5MimQ/Y0xCFReNxPUH2rMv4LTWba4ttMnlhvYvuJHIVLEfwnPY1csIZLXTVhubVCX2vKhG4KwH15q1ojOV5Mpf2LeWWtQ3sd8rabCC6xBszSt9PatGNLueTz9xiQ8qD79/wAKz9TTTrvU7G+uHuA1uCsSglI19to9a6COYSRBsLzggA8LTk9CIw11GNmMhgCSevPelkucOFbKOzADPRjioLuWRVVUSSTceoH3fc1ElzbSYQNvmjkBC9CPepsaNpaG2f3km5Dt4Ax0JNAikMbKpDMOeWqd7aZVDRxt5Zy3+OKrR3EadTtIOKzNo6kN4N+D0I4xnoPSqpGHwF+70z0rQmdZgWbK+hAqs0Y2KCOc4z2oTKsLGQxQYAbBJNTRMVDbW3q3IxyV9qT7OdqlXClsE46jFPSMbgFJRjnkUXKQ4tJGdgyQRg8dRTPLRSV+ZW2jqP51IzP8u5skcAY6iovM+cDcc45Hegllu2uURMTOqr05P3qt6P4ee1v7/VJZRJc3DKEHaNAP58VzOs6UNRutN/eHfFMJXjzw4HI+nNelaVdQujJIDzyT6027LQ5qt73KP72JAjRuRkbWUZI/Kp7axt7cM9tbrFJIcyOq4Ofc1t2qQISE27ScjnOKuSQB48IAAev0rO5i5s5zy5GgLEFY1PyqeQa8g/aMQL4PtCREH/tBAQoGQPLkr36C38qE7kGCehrxz9qaJE8AaeyKATqkeSB/0ylq6b95EVJ+60fNVoP3S/j/ADqZzjgGmWfFup+v86f35rs6nIhMAjHQ0beM04Y6+lHJHXpxQFhFbAweRQ+3qpP40Fccd6btPpQIkjfIIbGPeu7+H/gSfxBpOr+IdTaW18K6PDJPcTDg3EirkRR+pJwCe2fUis/4UeF7Dxj42sdI1bVYdMtJDlmZ9rz88RR543n3/XpX0h+07cWfhH4Qaf4Y0WBLS2vJ0t44YxgCGP52+uSFyT1yc0gu9j5a8PS6d/px1C4msibdiggXcZHz/q+TwpH16U2zZJJVENr58saEhY8kZxy2OwH5VjnB6UsbvGSY3dCRglSRWbp6t33No1rWTRvTJJDFaNdQpawsFBljIkOGy28DOQcdunHrUHiJfKvhCGiZY0Co0RDKy9jkdz37g1V/tB5mQXHlgggByn3R05HcCrd/ZwWV3bJHc2txFOnmfuiSEBJGDnoe9QlyyXNvqbSfPF8m2nYzQu4D16VPZQpNORLKscacu3UgdsDuasT2UkUQYxkRbivmfw5+vr7VcGsSjSBaQpZIuzy2drdfMcbskBsZ9OevFOU21eJMaajL3+hJ4hh0601OC70yd57SeLzCJWDMrcqyMFxjkZx6EVm/ZRBaW1wB5wlDhlAIEbdhkjGcc8dsVJva7sWUNCscfzqHcLjBOc9yTnGep/CoNTuHuESU3Qk3ks8IyPLbp9CMAc1ME1aN/wCuhVSS1nbz/q//AAR7QMdFlm8mSNTcBUYS/IcLkgoeSehB98Vl1e1S/W+S0xAsUkMIjkcOSZmH8RHbjAwPSqIraCaWpzVGm9BKKXHpSjGMGrIsIRSU4Kc4xzRwBQISlxxSgflXYQw6bpXgyeWf7JeandsPKXOfsyY5J/2j6dqyq1fZ20u27HRQoOrfWySvc408CmmlY/jTc1qc4GkpTQaLgFL70lIf0oAWqEn+sb6mr1UZP9Y31NCBnW/DBIn8Rv51oLuNYC2zkFSGXDAjkc459Ca9l1madWW5sYIhEE+dkH75QPvYPVl/lXlHwb/5Gi5/682/9DSva7cbSrlFZckHHG4HsfpWc5WZ6OFp81MydG1SbUBby6RaTXNpc7kkaQ7xBIOCrgfMo5BzzViG21yaK6h1y9+wzs2LcwJwF/2T3+tbli6WbsFCCCQ7mx8p3Y+9kc5rTlbz7NbiWe1SJAfnl9P6Gs3LsjdqUV7zPMbLUJIL+eGLVdRNqsTb5bk7nZs4BSMDgfU5PpWpPd3sVrbWHhnTpsS2oH9o3ZGUzknKnnOeua0JprfXdBhbwxcx2du7MTMsW1iwJBHqPWptPilt7CGGeYzzIu1pSOXPqapyXYmFNy6nEXdvrGh3UUou7m5laLbNHBgRemdmPTH41s6Fquiz60zGxSPWo4szSujKOmCTg45zXQTxB2TcMkcgkd6zNa0Zr6WCe0mS3uEYFmAx5ig9GxRzqWjG6PLrEg+Fvg2A+OrE+IbnTrLSLFpL9LdJsi8xgqAD1IbBI9FxjmvVtc8WXeuQTRXhCWjT+YkJUbkwcKAR19frXktzaCxOoTTgWka2rtFdRjKxtnllXsfX86vaSlzfaXZXUt2qX6p87xSbkuFX7sgA4GR24Oac25LcwhTUJXaO5hHmnax82InqT0p82nbJHZB2yRgc+9cvo+szm78nUYhE7nCzqTskH06g11K3yvbkpMFKnB38FcVzSi46M3vfYrix04SGdIgl2ThmCjn61XuvL3FUTeRwwJxz6ipxM87K8flSoeSykc/iKiuR5gV/lP6HNLUasc7d2oa6CzL82NuOuarXFpFFKpUyBe4DdK2LqJ5JtxKkD3ANLdyTLDH9ns1kk6Eua0Ugempi3jwafb+bJczeWx2gEZJNWfDpivL1I7PTb0CYZ+0TRAKT6HPNRnUYIL5Ydb0y6tbcn93cIBLHu9wOV+tdLZyZ2TWXzL/CcdRTk7KxG70Z1UPhOWcK815sLLgxr0Ue1VNa8JPBExgYzoRg8c/j/jVD4f8AjmbVdTutOv7VoGhl2IxHDCvTNp2sAOcEVi+aLszH2kos8HntZ4SXhJwh2sp6A+lLbXnmM0ciEMOSK2fGdldw6iL+wlCTxvtlhb7lwnof9odjUE1pZXMCuFkil75Ugg1d9LnZGrfcr+ZKTiNc9BjGM0sti0doLqV/3ofpngD0NN+yTW0qyQ3AYj++M0+4F3Oqh1V1znKtgfjQaJ3HqsZiDMzKw4AXoagjYFisa73Zsf4Va0vRbu/n2RMXcjiNeB+J9K7vw94QisXWa+dZJNv+qX7gPqfWldImpVjA5Cw0u7kudsVu0hYZebHGfQVfa3u4LgB4WATAU9MH6V6asMax7VQKvooxUMtpFLGVkUMD0yOannOR1XI4f7Y8aiGEObt1wiKvJbHX0xXR6a4aDypGzMgBYjkE98VVv1FnIRja68Ke2PpS6au2Jrtmchz3AwKHqiDVkPzY/hI7V4t+1YB/wr7TypyDqkf/AKJmr2mbJ+Y9AMZFeI/tUj/ig9PbPB1OP/0VLVUviRlP4WfNdp/x7r+P86mPTPao7ML5EeT1z/M1fD2642REgc5ZutdjdmYxjdblQZPHH5UvSpJH3HgYFRuQBwfwoBoaeeP1pwGUJDLhccZ5qLnNLzjAPIpk3O9+FGs6N4XudW8Tam8c2s6db40exZCfNuH+XzScYwg5x15zXM6t4n1zWIbeLWNUur5bfzPKFw+7ZvOWxn1P/wBask4+XBO7v7UijHXGKe4tmIPYYpPwqRj8ueM1ETnrQDFFAJHTj0oFH40CJ/tc5i8szylM52liRn1x6+9Qk5pOPWl4pJWG23uKmN4LdO9PkdAuF5PrUNI3PSgE7ASaUGkNJTEPpQfamUYoA6mw1rS7bSTatpMElwy83LD5gc8cf561zkjqWYgdTmoutJWdOlGDbXU2q15VUlK2nkPL8cAUjMT1OaYelFaGVxc0lKaSgQUtJRQAooIoo6jrzQAlUZP9Y31NXqoyf6xvqaEDO8+DOP8AhKrjOOLN/wD0NK9ti+bC5x34HQ14l8GAD4puQQP+PNvw+dK9xTnBHA4xg1hV3PXwP8MkkVCiqCWYnt3NZutai+maLd58lhMuAJk3LnpyPQ9D9a0wsYxzhyOccY/Gqt5YWt6Vjuk82PHzD1A5/wA+9RFq+p0VI3iw0a1ht9Es2trVLOGWH7Qtso4jLHkep+voRUmSrZIw3p6VMljb2UERhlneLymRPMOWALbgD+GKgCgnaAcfWiTuxU1aNgJOFxyDTXQnJAxxzjsPX6VBqt7aaRZPeXsu2CPh8Dkt2UepNcp9t1LXmin+3x6TpLTobaZDgTr3Q553ZGOeO1VGDepFSqo6LVm2utadqdjfJZ+ZqKohikjhRiPmGOWx688dqi8F2N3aaq081gml28dr9naBJCwfAJDH1x61fubqPSdUSzit1htpSWiECeWGbHzSOenArT0CeS6tpGS5tribaSrQuGUHnj3obstDF+87t6kZXS7+NLm2usxEcMrY3Y9aqXmrtZ3Gnw21tPcqZPLldUyHVuCgJ646nNT2NtBbBmgjjWY/K4XGPw7etOkJwUYcEbcjqfUUrq5XI2jRtnt7K4SxtrFIFO4rsXEZPccd6sCeLcscsZROpbNcrAbvS5baO3LXVm843xucsi9yp7EV0zC1uVeJ5CQjFWX+LntmolES00YtpLpOsSkQXbOtuTlgpAY+x74qxdWZZ/3QcwHgFOfz9qxrHVNG/tJ9MsiLea1HMKgjaP5Gkk+223iO3kGpRjTZl2m1LbZGfHDAdx1zijlexne2p0FlaJDIQxUjptzkj8+lWLm6jtVVIAFfcFVB3JPanB1Ef79Mkfx9/wAxUo+zzQSW81tlXX/WqcN9c1nvuN3MqKMxamDGAJd5Yjpn8e9bf/CU3rt5DFlCnaWQc1XvLRZbePLMW28ucAnHc+9VxDiL77N05z1qtHuUkpbiXO+7fcQST1dz3+lQRfM3lmV2dc4DjAx6Ul5bTyRB4tuAcZU5qg8sseTK7+ZGvDjr+PrQi3HQ6TS9OW8+XYgUrljjpWjbeE3USNHJFknK5BwaoeDNYhN8to5O2YZU4/iFehbM4yfyqXdM55zlF2OI8KWRsNaY3crtIQYwo6ZPfFdqUINV5rWNLpLoLll6j+tW3kVQpznd0x3qGxVJc7TQ4cCkoY7UYgE4HAHeiM7o1LKVJGSvpUko5rxpZSz2iXcB/wCPdg7DGcgHrVeKdJ9Cae1ZJoWbeASdwIPOa6TUIzJbOgOFYbT7VxcDDT3ktrlylv5mVdWwCPQ8VpHVWK3R01teQTxx+e6xyycqARgAe/8AjXj37WCL/wAK/wBNkUoc6nGMgc/6qautivIBvTzzNbKSqvEN36+ntXl37Rkiv4OtQiNhdRjG49P9VLxWtOPvJkVF7rPCbM/6Mv4/zqbOOc4qtasRAv4/zqYN8wJOK63ucyegvJxzik6nkfjTicnnn6UgOCeaAFIGKQJk55pCc8ZpwJ2gdqA0I3XB46Uo9zmhyTxikx6CgXUc4Ax61GeakxkinHFGwWuQAZpcAg5qYr3HWkEbFd207fXtRcXKRlflzTT0qeOMswU8E+tMlQRuV4J9qLg42VyOiiimIOKSloxQA2il4pKAClFJS44oACO1Bo4oNAAKB0ozS0AJiiijNAAaKWkoAO9UJP8AWN9TV/iqEn+sb6mhAzvfgt/yNVxzg/Y25/4Gle4RqCx2HkcnNeIfBb/karkBgM2bf+hpXucQTJWRk3nB2q3PX0rCruetgnamSRxF4SAQPSq95PHZz2UUu5TezeTDkZO8g9B9Oa0YoJC7Q28ZZwcsSCFjHqTWXe29g2ozSWDvqWqW0LwRsrkiF3zzxwD0GfSoitTepUstC0k0M0N2beTz4rZljcK33cLycntWCPE2k/ZruaKYSLbsEkYdCTztX+83XpXOY1S28HR6DaQQXOpvc77i3iXd5QfhUYjvwST6V1kvhmwCafHfQxPfWWZZzB8kTTEDJ2jgkAAZ9qtxjHcwhUnLSJlvraare26WOm2VxZSxnY9wpkaNweQ69OPQ/hWh4h07StU0mBdVt5i1qd22xjZQM9dq+9LLeafokQCQJbxyEj9zF99vr/SrFpdm8t45rdi0cnIyOfTB9CKTfVKxapJ6Sd2UNL1G01OObSW0PU/7Nii+V7l9pbtj1H51X0WKfR9TnNt4eSxtZEEJljuCSkY6ZHrzW/EJWcpvLZORtGcVP5OY8MVPXhmA/nS5txeyS3Zx7eHbrTtQkvbS/PkxKTFbOPkJb++QenOc100EU6wQK7rLIUy0gXEZPsfSpby2aeKSLy2dJF2tk8EEc/WsJfDt/pmoaW9vqgisLRDm0yd8xJ+YbTwcg456CqvzLUhrk+EzvED3FzrVnZLqFpbxF13KrkyvzkgDt0rrYtRt31j7LbKzTrEJZiFyqDtz3zWfA+nXXjW5jXTCbuziG64MWEJP3QD3471s29pZWjSBYlt3c8MCSWH1Pb2pSatZomN22waSx1DzGYqsiDBfaNwH1HNVb7T7e8a2hnsmuYVk85LpJtrwMOhHfFU7X7eb+8W6s7exhEhME0c4YyDPdfenWmn3kKXAlv5p3Zt8TbANn+yMHmla3ULX6HV2ty1uFHmhs926H2PvVmOfzbgBAqk/wk8fhXLaSbuztjBe3X21w5IcL8xGeBW9bXECv5TsVnBHDjbknpis3Gw7dzXtixk2SR4c5wDyPzrgPFkXijw4yz6ZcS3+mKcyxbMvGOv4jHcdK777WYbbBIYEbTk4JPr7VJHKskah3ORwCeoH07/WiMnFk2uN09RPpFvNpyebHMivu3bt2R3Pc8/pWdqGnRx+YpZSxHzD09q17S4FmCkcYMBO8L0GfUelY2o3TqXmI4diQc55qepUOa4nhrRLqTxLZSW4VbSH95MxPIx90D616t0AryfSddn0pxM3zrnEg56GvRtJ1WDUrRJ4CdjH8qmVzOupXuzR7VEkaIxKg57ZPT6U/PoeKTOTUmSJEpRTRTkOVBwRnsakpFHW/MXT3MJwwIycdBXL2saTQbLkneeMsuN3vXaujTP5bBDAVIbPXPbFUfsaxBoyo3dMnnNXF2KPMNc06+8PTedon7yzkffNbAfePqP8K4b4/wCpx6v8JNHu0jMTHU41MbLtIIimBzXtviuIRadvReV7Cvn346zmTwLa7E2xyajG546MI5R/Wumn71mTU1gzxS0B8hD9f51MVLHjrUVnnyF/H+dSHvk8109TjFpvUkU8KVUMcc8YzSZGeaVxiBAR1qQsNmBSA+lNbigew05B6045UDnP0pKKYgBxTgw6U0HjIGR70EHaDn6igBSxzjpVj7VJ5CQM3yITj8ait/KJPmMQMdqGUbuMgdRmpdmUm0roGxjhgajdQAAOvXNO2nJI7Uxs/lTJY3tQaUnNIelMkSkNKOtBBJyKAG0UpU4zQOOaAF4BpMnvSUUALzSUuaOKAFopOvSlwaAExRinHgU080ABNBpKWgBKoyf6xvqavVRk/wBY31NCBnp/7PMCXHjS9SSNpANPchR6+bFX0pb2dtaYl8mMMeN2OQK+bv2cs/8ACcXoAyP7PkzjrjzI+lfSESuxwC20dSR1rlrP3j0cKrwOcTxUbjxdc6FHYO0ccRl88vy/I7AdDnHtTfEWVNuNJ1Wx0W9dsPHIFYyZxjd6H+ddIZUtMuQsLYOG2/MR6D+dYt5omja3fwane2UU11GwHmsNrP6bscGkpJam3I7aFe10xdBtL/VJp1WSUAO6KqJCmMMwx6nJyecGs9WS6hSW1ZJImG4OjZ3Z6c12tzHEttMjpHIixt+7x8jgD7pB61xlj/bDfbbvU/s+naTDFuitrYAcDkl8D07ZoT5tS4S9npYZcWMMmY7oRmNhuzIOAfU54/GqNt9tuZpLaC0NhbRMArIokaYf7PZR7029sdI8S2m6SN7mAEAsLhkJx/CR2+mKq+KksbbR/wB5a6lBbx+SmLCbcVVM7CoPb171cbbEzlLV9DqZbtLXMcaBjwp3HoR2Nc94g1WSzjieHSLeYsTnYpbYQPzPPtWha3C6hYQ3dukiwzDeokGHxjoR6jFRKj5PzDnrUqyepfIpR0Gfa72fTFMdy1vPIvy7VB2Ej0rDvbbW9WsRBc3i201ufNWWJN32kKDlQOocds9e/at1gxX92w3jkYPWrOnQy3V2MKSIsOxYbTu/rTTsTOmmijoeqT6/4eS6top7ZipiRZv765AZsdADTdLsUs7TF1cyX0rE+Y7DCs3Odo9K371ZIYlDqod8lgnQn6VlccluGY5ODnmjmvsKEOr1IR5caAQJhAeBjHFODq/8I29mHWlkVeSCQe1NCqn3e/P0pG1lYmbdKoAuZYGxwwf+Q71mSabqt1OiT6hHNbnhBPGTv9u2D6GrywsUOCQrdD6VKw+Uoyllz6/qKalYzlSUkRaXri2FrGviCKGxm3lbeKSYl2A756Z+prqryOLVdNMTpK0ciggxttYH61zN9Y2mqxrHfIJUX5ondQzRMO4q7otzd2sUdrqkkbyPny5F6OB2/Kh66rcy5WnZ7FvRIpNNtGt21E3ihyymYYIT+7u9qW+mMLGJUxbNyHILGNvTjsajnIUjGdmPqMelNgudi4XO0nGM5FZ+ZqoW2BG3xKypkHggnrWroeonTY2jDbGU5VT91hUEVxHJGBMgjPUMP51FcRbgD5gYZ+8KXTUJe/ozoB46EcXNmwlBwwL8Eeore0TxLaakow2x+4PavPri0g8hQFIkYbsjkVn2scsF15sRYFRjGetKyJ+rxa03PbllUj5DuPXIqZPujIxXHeBdWF551tN8ssXIX2rslAwMnmsmrM5pR5XYmWnmNXGG5FMTrx07VKvSkiWYviCyL2EiY3KeM187ftDWP2P4cWnXP9rRj/yFNX1JLGJYWjPRhivnn9qSER/CvT2KkOdaQNn/AK4zV0UnqkRN+4z5itji3j98/wAzT2OcCm2iEwIfr/Onk49jXacwZJ98dKCMGgMcYFOGScck+1ACoAT7UpTJ9q2tB8PzaxZajNBd2sc9nEJhayN+8nHfZ24HJyelZcoKKoZGXKgruGOD3+lZKpGUnFPVGvs5KKbWjIGHPritqTw+tvoUl9e3sUF2JVjSyIy+D1Zjn5fYEc1nTBY40EY/e55ZT1HX8frUOJZZfLiBbecAA/ePXk9/rTlzStZ2CKjG/MrjSoI4fJ78YAokjePHmKQSMg+op9vF5k6Jk5bgD+8f7o96sum+GWC42QT2wZgpT53OR8pPtVOViVG6M/oeKs7JFf8AfqQehz2qKEfMXO3CDPNLLJJNcM8speRzlnc9T6k0PcFohWjKfxKVHfPSmBSz4A5NIc8nsT26U9cgZODQLcYOARjmm7T3qceWVULvD7ec9C2f5YqS6hEGR5iP6MvRqObWw+S6uVo4mkztGcVdgtxHZSSzQuwb5UkB4VvQ1ViZ4yrIcH1rSGtTJZS2rojLKu1jjkemKmfNtFGlFU1dzdjIxywNRVKh7GpprVo4FmP3W6cYq27bmPK2roqUUppKZIUUUUAOJGeBilzimU/jyznO7t6UAISe9OAzx3plKpKnigAJ5NJmlY5OabQAuaoSf6xvqavVRk/1jfU0IGelfAKeS38X3rxNtc2DjOM/8tYu1e7zzTugedmJHGA2Me3FeAfA7cPF10yZytk5yO3zpX0DCskkakwO3OFA46+9c9X4j1sEl7O7MnU9TEDWkJDNNcPsQEknHcitgxXkVpKbBd90hVghwucHBBJ46Z5qrqN/p9pcJYz3sNvqMi4jATe6A/oM0zTrK0sxsuLzUrqRpvN3yOCCfQqOg9qi2h0Sle6idfAUkjKspV2UEIR/Wua8WTR+faafdROtrcuWaUOAjuvPlt9RyPXFS3viQ2niC30yO3nnluiWjaOJgsagHl3PGcjGBVm1vF1mzT7faSWs2fuzpysgwRgHr65+tJJxd7GV7uxztvaQWMXlQRJDHkYXHf39T704Aofnh5IIO3+Mf59Kl15rqw8hLm2nt47hyqXEYDRSkHnHcckA9uaWYGKcRywzIwHWNCyD8e1VZ7s3jOMtDMNwbSX7Dc3TNDcfNbyMMujf3c+lXVh328MisrKV5KnIPuParcOjrd3dpcOjGWI7ldwdgXPOB6nip9K8PWFpdJplhPJJczzkwQbtzRlskgAfwjBJJ6AZPFNtPbcxvyPyKVpYGaRWTaFyMleAB/SpdH1zT7m9u7KzSR44Ad9z/CWBxt+vb60+7tbFtTe4tr24lt4A9syQkiGRgxUuMfe5BHp3rBi1uSbxTc6La2yQ2cMRfdtO7cB95uBnJNHLe5nKpzW8zXvpXnffllB4APOB/jVQgkADPPXHQ1MX8uTjHHAz6e/vSAlvmXgHjjtUHQo2RGUHJ3EEjkGmeXnq+KmcDYc888c1EUBA+TAzz6UwEjQhSM9/WngNwMjI6UKowCegOOKlVdwCZ59+mKAEViilRj3K8HNWXcRQJcBUKR/MwxkKR/FjrTAuAyBhgd8dafCrqG8sgSE9SOAM9KAauhomWeyhm3xbJlDqytke4zVVxzxnPQVVk8NpPa3WmuxFpcSGe2ZGx5E45OPQHg496NMF4lmg1CMRzglTk5zg43fjim46XQoSbfK0aluSYzgMT0xnv61YQNafI8n+jzcAH+CTtg+9U7WYxN04bnJHWpNagGp6De26AF3TMeDj5wcrz65FTfUqcbo2bS3W5tA1vIJUHQ/xfjVKSIbmChg/cgZxV/w6CljHK+VuXRWkUnneAA36ir19bWU8vnrc+VJxtVm2Kx9M9j7VL0djmjUa3MuzEllqFrewEja2HA/u16VYX0FxGJEmVg33Rn8xXD6dZNBPI8sWWZSq5P61uTrbwxIXYwuw6rwQfbt1/SplqTU1dzqhJggA/N1wOtWo5Fc45BrhbPVp7O8kWeJZoV+6F4ZfpXSadcvLK7yK6o2DGxOAR6fWotYzcWjdFeD/ALXwI+Gth8gVTrMZ+p8mavc4j8oyQcd89a8M/a+Ofhlpuc/8hiPr/wBcZq0pfGjGekWfKtkf9GTPv/M0rgsx9QKbZjFornGOR19/SnnLHPAru6sw6JDNpzweKu6cgjkFxJGZIIm+baxGT6AjkfWobhWi2Rt5ZO0MCjbgQff19R2p1vevBC8eEMbElsjnpgjPp7UndrQcLKXvEk0jMoycqDn6Z/rU7XM8tt5U0jyQsNuSNzRjPTnoOpwMVe1LT722ngjSzuUa6s45mSaMbgH6EfXAI6HB6VRa3f8AfIxYSKcyBuqnp07nP5VldPc3s90XPDUY1S9t9IJjheUsv2l5Qm0beASeAo6+/Ss3U7J7O6nhnXZLHIynphsH07fSn6jdedb28EdpFbwRKCQvLOx6szHn8Og7Vv8AhfT9T8Xqum21vAItMhkubi/kjwILdVyfNbvjGFHXJ9OglO/Mtn0/X/gEycbcre3U5PczDDHIznHbP0qSWAeVFIsqO7ZDRjO5Mevrn29aYCrLlMkHoTxgVagkgS0lyzC5YgLgDGPrWknbYzjFPcpAMpIPFD9cjrUsg6ZK8gHrnOag6jP6VZD0AZP3fxFSqRghgQfX0psiqjJslD5UNlQflJ7c9xT4sneCHKDk+gPqaTBaDJMgndwc5oVnJKDvyQPbvSuxLHf96nFyYUjIyAxYDI4z+vagYqEqBtAKt2POKHUkl8YHT6UyPPmBRwx45qe7E0c7QXKskicFW6j60tmNbFUdeasT3DS2scLD/V9GySSKZPbvDjzBgHkUW0nlyhsAgdQaHZq6BXT5Xpcrd6StHUoofMV4Y3h3jJQjgfQ96oEc04u6uTKLi7DaKk8s7C2MAcdaYeDTJEpf4aUCgcg0ANopcUYoAKCMUGgHsaAEqjJ/rG+pq+wwcVQk/wBY31NCBnqX7Ohx43vCRwNPk/8ARkde3ahKQ8cUc7NIflJJPfrnHTArwv8AZ+lWHxjfO/CjTpD+Txn+le0eGnea1nuWk3SzSnA9B/drCotWz08G/dSIpdFsJLiKea0jkmiYFZW+9xznP1q8zNu+ZtyDsDirEox1G09CeufrURwAqttyp7DrWLd9z00ktiPcyOUc70Jzgk9/eus8DeG5tfcNMzppURxK2P8AWEfwKTz9WH8+nJTGM5wWGF+YgV7DpHiW20Dw9o0OvKlpLPETHHbxEhEH3SwGSCRj8SfQ1pTim9TmxdSUYJQWrOC+Kusy2mvPHpsUU1lpUCQyW0WDJHkbiVHbgqP+A1zGueK4msYbG11BbPWL+APZvIm5Mk8K5HAJ5HPGagtYWg8WarrUkTynVHaSZnfcF3HPl49O1ULcabD4qZJ9NtofIgD6dcO5CPuPK4PG4E8VTUZO5zqEoRUfkbxttb1PT7PSppWfV5YwJWtAMs3fHYAjqegFeo+HPC2n/Dnwjf3qKkmpiBnmuXO4s+OEBPON2PqefQDjvB9hf6hrtlPDK9nKuTcyRtgRIpycE+v3cH19BU/jjx2dd0670y2txFbNcKUn3582JTnlccEkAjnpinBqMbkTpupJQW3U5zRoGOkvbNc7pRy0gTrz1A7UpjWVZJ15ZSUBIBY44GT6e1ZwneDSb0ozjMRKtGcMCOeKk1a9bSfC51BUWS4lAkeMHGSFGQvtjk1mk2bTtGRVYckcNzjpyKlCYB5P6cVV064N7YW955ZUzIJApyCB789auhCATsDoeRnv70nvY6E0yMlQPlKnA9KQgMy5HU88cGpcFGBxhT0UDtUqqm4KqlV9znj296QMiEfDfMN390f4UqQhxjIDAcf/AF6zH1vTVvjFMJEuY3MJzGd30461tBAxcAjfjkDv6U2miYtPZjUjYYwzDjOSetTKqqvPPPPHNCpslRsDcqbSxGRg9qkmVXYsoxz36YFSWtSsjSeWW2HfkMAfbtTr6MPvkRQAwDAZ9RmqOvXo07RL2+3MoiiJHGcHOAB60mj6xBq12NPTzFZrSORCoG1T3GfUE1STtcym1CSIgu1hxkCmajLeLcabb2inNxcqHwPuovLfTiqja9ajVf7Okhu2ujJs2CI/Kf8ACupmtlitCZ3dNykMy9VTv9KPheo5zUlZMs2ZQyPJA29RlTtOQGB5zSarY2Oo6bLDqUvl2xw24Nt+bNZvhqzsrGxkXRpJmUuZJDJIWZyR1zS3TNKN0xeReMIRxn6VFrMzUXJWOq02QC3jS5nicKgRJBJw3HGKuXllvKyM6s68FQeBXN6LOlvNFApMdu7BZIxHvJB9B/e9K7q3sLaUTJFPICG2KG2kxuI95VyOuBxxRyt6ozlam9TGmtgkLSFmzjdnHX2NVRGuoWkcLySfId2FbaQfb0rqIdJaW2XEkZMisVGeMDGcfnVKfw69sZJhJFlASQCc/KcHt24pJS3sNyg9G9TJ09dY0ecbJGubVnwqOcHaOn0riv2s7r7V8LtLYoUf+1oty56HyZq9OglM/mJMFEOAQT1yPX2ryT9qVQvww0kISAdTiJVlwSfJm5NVB3kjCsrRZ8y22DBHwOM8+vNS9TyBiobbmBPx/nUyjPfmu04UK2NtfQX7O/wY/tx7fxV4ut9ukIRJZ2cox9pI5Ejg/wDLP0H8X06+AW8c0tzDHbRtLcM6rEiruLOT8ox35xX1Z42+M7+EtCuPCOsKb3xSukbLm9tVVYobt14jKj+6pGSO/YdgGeA+P/F19rfjrxBqNvcyLaXN8zxJnI2oPLQ/goxXLTXkzlmc5kY5Ln7x/GqyEgKo7DGKsRKrOFb5W6c1Dik72NVKTXLc2/AvhHVfHPiK30fRYwbh/mklf7kMY6u/sPzJ4FfSXxZ0XSPhN8A7nQdEH+k6rLHazXLDElyx5kdvbapAHQA14/8ABHTorHWr3xdqN1Nb6T4ci+1S+TKUa4kORFCMddx69uMd6x/iX8UNc+IdtpcOuxW0QsHldfs4I3l8YyP9kDGe/WqTREk09ThWcnHA6+lIPmf52VR1yaNvWnpGSPmIAPfNF0Fm2QjBzt5pDjHGffNOkTy5GQMGA6MOAR6ikP3cEdKYgK7djMVIbnAPPXofSgHAGD16jGKbyKVQc8DJxmkJMdLyRkc4570iYwcg1JJ5bQKU3+dn5snjHbFRqcfShDa1HMxJyxJPfJ61Ig3R5Zvu8Kveo8ZI9O9SxtsPMe4EZwRj8aGVEleUPDtYZyMgntVPJqSSQseetRd6SVkKUrljzpHjVHO4DpntUSttbJAOKco6VI6IuByT1PHSjYer1Kxbnnp2pobJ6VJKu04BzSCNu1URYZzzgU5TkHn8PWkYkexpCeOT070hCE0DrXufh3w7Ynwn4Zl1nw3pC3Fxuks5g4CyuIJTGl0xf5nlkCkJgBQoGRuxXN6j4Q0/WvH3ifTtLjjhltNJ+2x2tnKvlJdiOLzIgSSNodnGM8YxmmB5hS44r2nUfAHgnSGv0nuNRvHt1mmHl38SgiOaKMJ0PLCRjn/Z4715X4t0+DR/FWsaZZTGe1s7uWCKUkMXRWIBJHB47igDLYhlHqKzpP8AWN9TWhnms+X/AFj/AFNFgZ6B8E7iG28VXb3Eqxg2TKu48MxkjwK96slWG0MSAIGJfHTDH0rxL9n7TYNT8Y30NxEsgXT3kTP8LiWLBr2Zob2C9nkmnja2L7Yolj+ZMfez6muerq7Hq4F2jqWpWYoMMSR29aar5G1cjdzkD+tNJ4HIAA4FACjBHA6nB6fSsT0iVRtZHJz0ZWwOceoPWrmr6ldazfPe6g6yyuAmEGFVQOg54Hf6k1Rb7pB4Gf0pXbgD5SOhyetO/QzaV79SGUlAQXIB6571j+LLO31TS/KvIbgpb5ugYhyxTkqAfUVtFgVwACqjAOabGVDkncwHfGfb+tVF2d0KaU42KnhDXdTv7KfzZJUKoAsiEoJIHONp/vY461bubdxlkBAI544P4Vm6ZpM9lrer363INrJZsiBmz5RxwoHTbnnNV/BesXGqw3FtqAb7RCdysOjL9fY1clf3kc9KXK+WXX9DZt0VwYnO3kHL8AEf0rN8YWs9rpdterI8raexWNTgKHOfnI9MHpWpNbSXEFzBkgSRMhPQjIwDmq+nXEEFpH4f1ieNtUmtVdVZTtkcAjhjxnApRfVBXSvqGnXL6hplrc4XJiQsvQDjjA/pVsK2ADkgL0HQ+3tUnlJHHCmAhCYxjAH4UqMqNh8k9eneobuzeK91XEVeAWHUjbnovpT9gDMBgvnk9qeSSpBPyjqCOp7YpxUqBuPA4z60gIY44hIZSiggkFtoB59+tOACvtKYA6djin7lbOVKuDwAe1ORCcMr8gZwaAsHPCgHBOQM8GlfcmRhS3qen0xSYUDL/wAPPXOaJTvRW298Dac0FWK88cVxC0VwiSwyLteMjII+lUPD9vZQ6/fWeno6TRWyq2TlUzggD371qrHyWJI56Z6496m0C2lt1nlnmeaaR2bcUC7V7AY7YFO9os56+6KekXd5NqGoC7tYreCH91bTsf30oH3mPtVLxHKNS+2aJBfpaX6hTEGPLADn8+a2Cw+0PCXj2xSoWaPksWGSuP4e3rXLX2l3OseI7iSayS2kt5FCXnmHbNGOgIH8WPTiqVm7sxu0rG9pdvcQGzRw4kii8uWQjbvI6VsSaRdOrSRxKGydyhwdv1546VTtlS1kjEPCb1yWOWP1rnPDHgG60zQ7q+1bTjeXE8E1vJpFughllRrjfulctiVwACoOBjg9aqnBVLtmeIrSoW5Udfp2m6jZ3cc6QskqNvRyVJyO4+mRXQ6ddah5spv3uNsoxKybFVgBjB9D9O1eR6f4O8RQ6n4RmWzuIpLOOJZpJXRhBFHJIdm7dmNnRhuUBlJOAQFrc0Lw/qFr4U8cWlvodxpseoxyGyspZVaTzGgKsq4YjbuxhyQzZJNa+xXc5ZY+U94o9Ul1prFbO1trSea0beJpI5E3w5wQSD/Dx2qzc3cTpJHPdKI3DD5zgkHk/XnFeCan4S8VnTNUtpo7jUjd2Gm25ljhRHjWMMXRE3BXZDtB3HkE9aZqnhzxBfWfhQaj4cnjGm2M9nJDBBFfhPmTyyRJJgkgHnOQeMUOgn1MvrUk72R7RJH5CMIT5wxwK8k/ao1OOf4faXaNEIrkalHIQTliBFKM/TJr1u3/AOPWHMbR/u1GxhgrwOCBwPoK8a/aktkHg6wugBvbUI4yfby5aj2UYtM19vKqnF9j5ytf9Sp+v86mHtUVqP8AR1469PbmpfYVsYot6XfXelaja6jp07W97bSCWGZQCUYdDg5FMv7q4v765vb2V5rq4kaaWRz8zuxySabtUFQT9faln2EnauB25qbl8uhAODz0p7N5b/KQT/epgPHIoPHB70yUWWuXMeAxCt95R0P4VX65zRx2z070DIFCVthuTZPGyhM55FJvBOGbAzmoQaUnJ+lKw+YvecsMLRRwxK24OJiNzj5cEAnsc9MVScJ5fO7zAcDA4x/jVi4uFksrWMRRq8W4MyAhnycgse/p9KqcsSPSlFDmxpoAz0HNBHTilPBwDxVmY9gYuA6NvUH5Tn8D70zdxtxhevFDkFjhdvsO1ICV6EikFxwQ+V5g+6G2n2NOMjPjcSSq4H0qLGfrSr+p4oGWA0flh3jDsCeCSM8eoqBRnGTU8Kggg9T0GaYxwq4HT9aSKY4pjBOOelJncCOM+tKshAx1xzio85HPGTQLToP8ssNxzjrxVqBlWLBTLEYGOx9T61DHK6x7VUdMZ70Rbgxx0FJ6ouLs7o7Pw74N0vWdLgu77xB/Z80mS0f2GSVYk37AzyLwoLcc4rWm+FelRm+DeMot1nIsMqLp0pYuzFVCAcvkgj5c8g1o/DK78GQaZb3HizVYo2SMw/2eTKo+WUuGfb8rqcj5TnpXRap4h8L6ncarc3XjXS5Z7oRCAmxmUL5chZHk24PmKpKBkIwPc00Q9zltO+E+nf2vp8Ft4tsbi6u4/Ot0l053ilUqT1J25wCdpOeK008Kf2NqmoaVD4g0+1untpEu1Tw4+x4Or5bONny9fUda3NM8R+EdPm8Oxx+NbM6foy/ul+xyCYsQwdQ+MbHLAkEE/KADWlrHjTwXqOq392PFdrGt1o76UEMMp2lmJ3529BnpTuI84uvAOlahp32r/hJbOGKJ4lCQaHLFM5m4jwmdzBuxHFOi+EGnyWun3CeMbfZqFybO2VrJ1ZpwSChUnKkEEHPSukn1XwpqNtajWPG+nvPbpZ26NaW08KiCB95Gfvb2P8QIxVrVNU+H019pc+k+L/7PjsZ45RB5TyqQrs7kFkLb3Zsliecc0XA8z8T+ArPSvDV9rGneIY9SFncx200ItHhIL5wfm6g4OCODXmcv+tf6mvc/iPr+i3nhPW1t/E1pq2pahd20vk21s8K4jLAyMG6uQQCRgYUYFeGS/wCsf6mmiWesfsz8ePL7GP8AkHP1/wCusVfQl9YLcpIzp5DOTiQcEf0r5s/Z/uprPxxNJCI9hs2WVpGCqqeZHkkn3xX1HerFPtJnTDDKoWyPwrkrJqVz0sI/cscetjdQwEXMhuBkkS45I98UxVIAAOO1dnaxxx7gwQxMBwRwarX2lwu5ki+VHGAy9BWfNfc71O2hzCqdpkwSfu0xht/Hnj3rSutLuIQXjy8ZJ+bt9Kp4DRA4IPQg9M0zRWexGMDJCj0wemKjBXeYgB83+c1YHynjPTrUG11YeUeAQcsM8U0FjE8S3kUOl3iPdraMdkYbbvVjkYGBySTxnoK2rIxfaUsxKTqdtBunh2hcgj7wwMEcYrAPhNrbVNS1AzJfxOVMEUmSYpgQQfoK1LLQdTk8QW2rTX1sogQx4Vd7MSPnDHsPQVs+VR3OFuTldosapdy/apLC0eOPUECsBL90jjj2NYOvxy6f4g0bxBd3F0se5FuLVRuRG5BPsDXdSadbPcNcXEJ89wN5AxkdvesC50+HSvF0mrz/AGm6W4iS1htlTciqO7euP60oSWyFUvK1zVuUdHYEdeMjuOvBrV8K6ZaarrUNneS3EZkVgDEF5IUnqenTrg1f0Pw5ca9eiJGaGxQDzpB/AP7q/wC1/Ic+1YSalNputXF3oZjgi3ssJZFkIQEgcsCQSOuOeahK1m9jdT5ouEN7FZn3MigZJyCw6UgQEku249eOKV5GmuWlfaGbk7EVBn6AAD8KQnJbLAN2IHGKk1HllVTj7w54NJkgg8lcA5NRqxZAsYGc5yacc7gMlj/OgY5PutuYLtHBHU0I/wB7gFemWPHvTiDuXCjcV4JPT3ofTpdT0+4tY5mjEwMbyrwVGPm/HGaWgN2Vxum3VtexRT2xElq5KLjPzMM9B6dee9XNUuBYWSyzbjg52rxn0H4Vk+E5La+1eaXRdQL6LYwCxjtTBs2Sf3we/GeTg89Kn1XEt/Kbje8NpHuwOee/H0qnH3rHKpOWrItA1Rry4Y3UXl7nLrGEAHA4IPUmq2naPe2viO/vb6+a4jljCRQ/3Fzk8dBjGKZaS28N1b3ZI8uQF28zgwqBncR2xV7RXabSTO67fMkdgQ27cCeDn9actE7BGKbSJptzMdvKjjDVLFv3gs7g46bjg+9RYPmjd+Q71bi5YADn/a6Vlc7FEiuYVuYJoJWkZJRtIViCBj17VmXskXhDS7WC0guL+G6nEZR5GL5IPG7k9jW/aruf5uTnkGta3jaN7WVYo2+fPzdEGMAgU4ysZ1YprzAFh5MOySHy4lYR44UkZIz3I6VLpxkQ7oy3kO3zbgcH3A/r0rhtVvte8S2uoQ6bZXOmy2NwpgaZ9glKnv6jrW1dWMc+uQ6jLfXiSLHh7aMgQsSBnrzjI4qnG27M1eSskdHqcN/HZOdHuF83O5FlXere30rx/wDaOvJbv4ZacLy0e0vItVjSSMnKf6qXlD12n3r028up4rC4bS5pIrt02xyytvUY7Y7A14x8c9Q1a6+HGmx62qNc/wBoIzPGoC8RyjGR9aumrtHPXg4wZ4rbAfYosZJ5z7cmnqM9O3J+lQWrYgXn1x+dWYJxExbarNgj5hnHviul6HmKzG7uR/OkJOcHrT3eN2TYPLG0A8k89zUZxk4wR60IbFpGyRmkoP60yRVGRknipGxjr2qMDAyTShs9PvUhoQgk5HSlUHPPp1p6xnqOaJf3f8OPUUXGl1Yq8bueMZPNQNXqPw2+HY1Lw5qvjXxNFJH4X0uCSaOP7rX0qjhF9E3YBPfoO+PMAGYEsAGPJA4A9qFoJ6jCT3p27pwBxilIwTjBX1prY7UxCqfnBYZHcZxmkPU0opxC7n2tkA8HHWgYqxBsBZF3EgYORj8aRc4yBx60KAWAJ4p+7aWCHrx+FIYNkAqvP0puSAB+VTwELuO3L9BzUk8EcUSu7AM3QDtU81tC1G6uiq+BjGaeo2gMR9Kjzn7vSrKp50KsTgjjNNuxMVcYuWOR0oX5SQTzQVFGzONvJ+tIrUVVBOB0Paq8iYcgA4FWwg2gt64GKlijt3YiVggC4DE/xetHNYfJzaGaFOf8aUxnHAqxciETZtwTHj+I8+9Cys8PlggrnIIFO7auiOVJtMqEYzmmipniYDcRhT0NMGQfeqM2rDT71ny/6x/qa0TzWfL/AKx/qaEB3PwZglufFkkcdvbzRG2Jm88ZVEDod2O5zj86+lobpbeQQRJAGYblRuWI6dB0r5m+EHiHT/DfitrvVnEdtJAYfMKM2wl0O7Cgk4CmvoFPif8ADWGNtmsoZWBDS/Y7jeT258v9KwrXb2O/DVIRhrudEkqSy/6xoJMHMRwVbHcd/wAq1YTuhUoSyfdZMZ/KvItW8f8Agi9vLO5TXpIprN98TrazEHIwykbOhrdt/i74LRI/M1nfgAMptpwf/QKxlTfY6/bQ7r7z0uHy32orjI6KfSuW8U6lpWjXkdvfXkNtNcnEKuDhjnGD/dznqayx8XvALP8ANrxCen2OfIPqDsqtqXxL+F2q+XLql9b3dxEco89hOSPb/V/Q1MYNPVMl1or4ZI3JtPlVXwj5H8SnPPpWZd2kk0SxxHY8jYJZghAHp702b4weA2BC60AjcMotLgfl8lc5qHjr4d6nqtrPqWsyT/ZgDDJ9mnG0g5+YbBk9s1cIy6ouWJj3X3kP2E+IPGGoWa3t4LXYI1KvtWMJ1bPckg9a6SLT49M0pLHSbllw7SfaSdzEn0zxxj61z0nxH8DQPcLY36xxOf4LaZfMPqfl+tUZPiP4XY8au2On/HvL0/75rRub2RnT9lq5SX3nSeH7eXQ2uWbULy/kmYOpunDKh9QB6/Wur8NXE2oXUcWrXlnZFpOJY2O1U9w38Xb0ry1/iN4YwSNVyx65t5f/AImtfwf8RvAkOux3eu6v/o1spmSMWczebIv3V4Tjnn045pcspPVDqOlGL5ZfifRvjDUtN8HeCbqaWUWtuiCBH6ne52g+5yck+1ePtEHjWSBhJalR5ciNuU/iK47Wvi/oetrdR6prH2m0uZPOa0kt5TGrD7uPlyABxx6ZNZelfEbwzprm1tr62TSZDkxG2m3xk+h2kH26Vc1zbI56MlR3knfzPQGKkLuXOBwKjBwdu0k46Dv9K5+X4neBZGYtqRO1eGFtNlv/ABzr9aqJ8TvB84Eo1SWBxkbJ7aQn8CqniseSXY7FiYd0dasi7gsjEjGdvoKZOy28YdlkZchRsGc5PArkm+JvhKOOaZtR8+RF+WNLeUGT25QAfUmoYfiv4dkitXS5jhZ3Pnx3cErlFxjgouCfemoSfQHiaa2aOn8Ma/a63rVxY2QOyFS3muQNxB5IXrj3rY8R+Hb7WJNMl0zUZLOG0ffKFzhj2xjqRXG6b47+GGgm4udKn2zuu1lhtpt7qeoBZcfmagHxO8OXviaG8n8ST22mpGCLb7NLwe6kKpBPvVcrveKsc7rJq0pI9VszAZpI7RfMcN++eOPau7+p9TWbfRKssjyuBDb5kllYEA98DH3uK4XxB8VfC/kWttomsvFEsgd5Y4pkcc85BTDfia0L/wCLfg2e4LDWcx4x/wAek35/cqOSWjsNVIN2uiexlsPFlpqAjsZoLN/kEs4KrcfQDnbW9Egjt1tUjWERKuEA+UDGOPXpXF/8LT8Ik5/tXBHAIt5sf+gVHD8SfBaSFxrLhgdwzbznnvxtxQ1J6WZtCVOOvMvvR3QQYHO0HsP5VNBEXzjcwI/KuIj+Kng9W/5DQ29x9lm6/wDfFW4Piv4HtwzjWGZgM7VtZvmPoMpx+dRyS7G3t6X8y+89DtLMNlcEcZYkY21ZvpESBY1JjTjIHBYDpz2rhf8AhcvgYQLt1rDYzs+yT4B9/k61nT/FzwdICTrefb7LNyf++KOSXYhVacnrJfedpPK8hA3k4OQCeKrT7sbiFAPJ54xXGN8VPBj4D6xkHri1mGf/AByhvip4KZTnWCePlH2Wbj/xymoS7Gyr0l9pfedlHK6k7c89q8y/aKcN4IsiVG46imWAx/yylrWHxS8G7MHWDu65+yzf/EVw3xn8baD4k8LWtpo9+Lm5S8SZl8iRMKEcZyygdWH51pCLUloc+Kq05UpJSX3nk9qpNupHv/Opdv05qK1uI4oVG/Ddxg+tSC6h3csMfQ10ni6BtPpRyvqKf9ptS5+fC9sA1G9xC5yZR+R/wo1BpC57daeigkZOBUHnRf8APQfkf8KUXEXeQfkf8KYkWpUTcNhyPXFMAHYYqIXEI6yD8j/hQLiEf8tP0NKw7osKeeuK7L4X6XofiPx9pOm+KriaGwnkCBIYmZriQkBYiV5VT3P8utcN9phP8f6Gu1+GXi/SPB82sa1Msk2vxWpi0ceXmKOV+GkY+qqeOD3pWK5tLH0X+1brFtoXwt0/QdKEUMN/cpAkUGAqww8soA6AEKK+RFYYGRlfyol1JplC3F7NMoZnAkZmAZjliAehJ5PrVdp4SeJBj0AP+FPchaFh2jckomw5JxnIxnt6UjIAR83GO1RxXFuGG9sqOwB/wpXuoCfvj8jRsVpuO2sAOmKTGKj+0Q5+/n8DSG4i7OPyNAibK5+UfUmkZhnioTNFnO8fkaQTRZ5cfkaYrlqGUqx6HIxTJHeVssTxwB6D0phngB4kz+BoFzDnlx+RpWHfSxYt0BkCk8HrVmeOJUxHLuIwMY5J/wAKpJeQoBiQZ9dpp4voMH95huxCn/CpabZonFKxMsbYP90dxSBioIwc1Ct7Auf3mQeowaDe25HDYP0NGoXRYDDbhuAO/pVuLSbhrL7fIUihZfMj8wjdKoYKSo9uuTgHFQaPc6UtyZ9RuWxEu+OIQlxI46KwOPl9earX2prdMC8u7vyCQvJOFH8KjOMCofM3aOhScUuaR0e/RraKyubOR3niP75JFDNIAxO8D7q9htOc9c1b8T+JdJ1pnuf+EftbTUGZdrQNtjVQOQ0YAHJ5+h5zXD/aYuf3mM+xpTcxEAeZwOnBrP6rFyU222vNlfWmo8qS+41Lq5gnmEiQLHCMbkQ4Pv196pjyGSTdvR1X5AOQzZ756cVXFzEM4kHIwflNJ9oi7MOmMYNbqFlZGMqnM7sftz05rNl/1r/U1tJfwSQwwTMiohbEgU5GfXjmsaYgzSFSGUscHpmqTd9iZJJaM6X4eeHLfxRrctjdTvAqwGVWTHJDKMcg9mNejt8O/h7E/k3HipobhGKSJJqFuuxh1BBXIP1rjvgqyp4snL42/ZH6jr86V9hfCnVpdK+FumPbaTqOqyzajqEaw2Kxll/0y4bczSOiqvHUt1IAyTSd27XNFFRpqdj5r/4QT4ZGR418WzCRU3gtf2+0+27ZjPt1qzpnwr8HatBu0nW7u9dCpkEF3C+xW6ZAQlTwevoa+pp/iboMNj4au2W8MWvEeTiIZgUsiF5vm+VQ8iKSM8sO3Ncn46nij+Ld1E5Akl0ax8snpkT3hx+NRNOKvculKM5KPKjxGT4LaAJSi3WrZxnBmi/nsqncfCLw9BGGa71UljhQJY+fX+Cu1v11Hw3rGvX93LJPoCQG9jj+86PnmNf1P0qezvU1TTrHUTFJF9qiEixSc+WD0z9fWsuae99DujRpSduU4NfhL4cZRi81ZXJwB5sZx9f3dOj+EnhoYE93q/PVkmjwPfHl135RYyPvZ4xjqaYvG8EYP94dR7UvaS7mn1Sl2PJvG3w30fSWtrbRp9RnvJkMy+dIhR0X7yrhB8+OlWdP+GWh3mnQXAn1VJJED+W7opwfbZXo1/ZxXsUazlg0UgkjdfvIw7j/AAq/fRqtwjBchl4P97nr9ar2jsl1M1hoRlqtDy8/CnRgRm51LB/6aIP/AGWnj4U6LtDfaNUIPTEkf/xFeiOi79qEjJ3D3qJzJCoMrKQRywGAvvU+0l3Nvq1L+U8/b4U6KGYC61E8DH72Pk/98Ui/CrRCg3XWpCTI48xD/wCyV6HtVoo3UFkYdu49aQrtRtjYYckEUe0l3F9Wpfynnq/CzQuN1zqanv8AvY//AIipE+FXh4yLuvNUKEkECSPI/wDHK7qRiwyMbjz0/SmqxUkjO4Yxx3o55dxPDUn0OPvPhV4TsrNLm41LVQkgyqiWPd+P7uo7P4XeEdQt5ZLPVdS+TglpY8A+h+Qc12ep+Xf2KWt1GrKXBDj7yfj71DaaTaWJZrSBo9+C/wAxIOO3NVzu2+pgsNG9rHJWvwa05Zf9KvL6SEn78TohX8Cpz+lUz8KbDaXH9pbVkKFWnjDFR0YfJg16dC0scgaKSRTjG5CF/MdDSNPa2lyl3qc2yOTETFjlG9CV7H3FCqSKeHguh5+fhHoRXK3epsf7okjyPr8nFRP8JdEU/wDH1qZxyR5idP8AvivWvs9vdgNBGssLfdmgPIHY4pJNKnKB4JNy+jJuA/H1qfaS7lKnR6xPJ/8AhUuiFQVutTB95Iz/AOyUq/CXQt2DdapnqB5kfI/74r1CayvFIUGMLj+7yR7io4rC8Cb/ALQoC/wuMZpqcu4/ZUP5TzdfhDorPgXOqYHX95H/APEUyH4S6Eyv5l3qSPGcMpmj/wDiK9Hj065yyrKQjncwzjrUOhTxXt1cQLp8qJAQrSTLhXweafNLuS6dL+U4eD4OaBNFOyahqJaNdwAkj5/8cq2PgloMNpJPe3mqxtjMUYmjBb6ny+K9PW9sUvV+zRpJOT82xMIo/uj/ABq6kUd3ds8jSn1STAAH171PtJdyfZU2/hPLrH4E+HZoN019q6uOTtljx9P9XTovgP4dEUjzX+rHr5YSWMZHYnMfFekeJllXSfLtpzZgDMkm0swQddo7nFcveeLNTvNJsh4a0ie5SSc2xa5XDlMD5wvXHXk04ynLqKVGmuhxOt/BbRo57C30e91GSebEknnSxlRGD8xBCDnHSuW+Lvgfw34N0y1XTL++m1aaYboZ5UZVh2tk/KgOc7f14r6KsLCBUjjWMxpahV3k/M5zkj6Zryb9pCwsk0SK/gtoBczX0avcKvzkeXJ8ufTjpVwm3JJkVaMI020jwu0tIpbcySOUAGc5AHWoxDBux5n/AI8K6v4SuR8RPB6g8HWbIH/wJSvve+8XxWPiK20u70nVYobi6Wyi1Bo4xbvM0ZkCj5/MIwCN2zbkEZ4rfU89taH5wSW0CsR5o4/21P6ilW0hYZDPn6j/AAr9DvBfxEsvFd1YQwaTq1gL+ybULSS8WHbNCrKpI8uRypy68MFr87rWd2YIduAPSgLok+xR+r/mKd9giwCGep4rl4t4UDDDBBGeKYJXzU6le6QixjJxl/zFKlgrthN7H0H/AOqtBPOLx3BjVlUggMuVOOxHei5SeKZpCnkCXJCpwAD2Ht7UuboXydbaGcLDcxCb2IBLAdgO9ILOPn5mzVxZ3iSWONtocbWIHUensPX1pisAB61WpFolZrSIHgvj3I/wq6lhphtXLXFws4+6MAq3+FLKJIkVZUZVPIJXGfpVU/eyKn4luNNQequRvaQgcM9M+yx/3m/Op8GgrVmZALWLuXpv2dD03fnVkcHpxT5dmBsznvxRcdioLVM8lvzpTbR9i/5ipj0FKRigRXW2TOMtVq9sLWDyxDcGZioLkDhT6e9MopO9xppJqxB9mT1aj7Mnq1T0UxEH2ZPVvzo+zJnq1T0UAQ/ZY8dW/Sk+zJ6tVgUMCKAK/wBmT1b86PsyerVPSqKAIfsibc7mz9aRbRDnlsVZHIpOfwPWgdiH7JH/AHm/OqtwixzMi52jHX6VorjOKoXoxcuPp/KhA9jtvg1H5nii5HH/AB5uef8AfSvrLwBoWq6/8HdMsdJ1mLS4zqF+bnfbNKLiP7ZPmPKSRsoPcqwOOO5r5Q+Ci7vFdyO32J8/99pXtNpaXNrAY9P1bXLWIu8vkW2q3MUaFnLMQqyBRkkngdSazc1GWp2woyrUEo9Gz2K/+FsOufaX8R6iZJTpyabappQm0+C1jUseI1mO8EmM7WJH7teK4j4m+HptZ8YXGm316ZL1NB07ddxp5ZaZZrv94FydvzDOMnGe9ZWkQ3Fzem3m1/xKXaMyqP7dvOMHGP8AW1Z0IR2moPNdveTX9zGqia8vZbl/LQuUUGR2IA3ueMDk1MqqashU8LOnO7Lc13bgyabKwNzHCDsmIJuUxhjt7/SqGoBPOEaIqxIqlFxgYxwB6VT1C3a48Z6dLeWjNHEzPb3MT42ttwVPqCe1aWtRsCsybTvzuye9YPRndS3M1lbcMruAOMZ5pJEwctjYePWowGzlyDG3rxmpxKyxbBzk4PFI6SAgDIGAOwPT8apaxHc3GnyJYzm3uo2EkEnUKw7EehzirkinGBGfYk8Y9agLKI8FgCOueAf8+lNEySasVtCv/wC1bESPE9vdxEpPCTzG468dweoq7J8y8/MRwcnr+FU9Xt5bmyf+z5FhvGGY5QcbiOxNS2BdrWEXbRrcMg8wdQGptLdEpte6yy5+VVQngfdNMLgKVIAbtn+VNmGzGMbs53ZprMS/JU59O1SUwYFRuwBg8c8/SmbOAGx149RSBgcjcflOCOlCvFGyiRMZI4PJpiI7uVIrSZpFUBfnYk9ceuKthy8KPGcxuAysO4PNVb+BL21mhjBAlBUK3b8aPDyyJpMMM64li3R8c4APFVbQm/vIug8HoDjrnqKS7t47+0a1nUvG4AznkH1pFIZ9qt+NWoGC/LtHPHTp7g1N7F2uRaNaxaWpWz80eYwLB3Lc9Ohq42oXltepdw72tWwsgB5jPcH296rycN93B9ant7h4m3hWIHDd8r3zQ31ZEoK2hteeiSrPOBJEVyg25Ye1VbrUWlk2wQxgk9JGzioNVkH7tVTGEyCD0yfT86yw7EAA5PXA9KXmKFJNXZNqWsXunbXFhHcxsfn8psEfT1rb0jXLLVLMCNfs0iffSVNrZ7c9CKwDKxchiTj361OjujldgdXzkgfgcjtinoN0bmn4k028lgjnsby30uNGBkkbj5SOv51ppKtnbxRFhPPtG6Vucn146Z61zGsW1zrGgDSBeGJHdcSEZLKCCU9s461DF5//AAkksqu7WNzDuVmHETphSDTtdERhaVmbuozwalk3kMbnODjI46ZBrJ0/w7plhq0epwrdJdx8oTcMyj22nrVhjiTnBHoT2qaMAD5BhSM88kGpUmlZG7oxNhr6JwYnZQmN2AMMD9O4+leUftDxQr4GtHgcMn9pRgjPQmKXtXY6vpbahd6fM85iFuxban3mHse3auD/AGgY9vhK3cKf3moRszKflJ8qQfnV00rqxzYmNqcjzX4Tn/i4ngwf9Rqz/wDShK+7JPDGuSeOBrsut6fcWcbBba0uNNdmtYyMOI3WcKHYZ/eMjEA46ZB/PDTp5rVre4tZpYLiFxJHLExR0ZWyGVhyCCAQR0xXTf8ACf8AjT/ocPEv/g1n/wDi67DxbH2T8OvhQfB97o832/TGGmwPDu0/Svsc15uXGbl/NfzcdQMDB5r4Ch+WRS2R34Fd9a/EDxYscqz+K/EjsR8jf2tcAg/991yy2uIwSMgdASTip5i1B7kLc89qQHHWnsNvFNVdx9hyaZNi1FdypbtF1jJzgnpSSXEkqhXbdjpmoPp0oB5pcq3K55WtcdNu2pux8owMDn8aSEgOrMNwB5FDHdwetNAIPtRYV9bo19R1V57RLdpN8a/cXOQorHye9KeKQClGCirIurUlVd5MAaCc0YowOuaozAGnAZzjg0w4zxSigQgznBq5Zafc3aSPBGXWPriqgPNbGkTwLGyTTeS24HIznH1rOpJxjeJtQjGc7T2MmRDG5RxhhWlomhXmteaunosskS7im4BiPYd6j1u5t7m8JtVYRgbQzdW9zVO3d43DRSOjDupwaXvyheOj8xpU4VLS1j5aDry1ms52huY2jlXqrdRUOKlneR3JlcyMedzHNRkjuMVor21M5Wu+XYaOuKXigYzwaBz0zTJA4zxTifUUhwpGeDQSMfzoAXHoM01sng4qUSoIyoXn19KYRkD5fxpDEB+WlUcHJ/GkPyjmkBBGCaYhxBHP6VQvDm4Y9On8q0ABjGM+9UdQx9rfbwMD+QoW4NaHc/BIZ8VXYJA/0J+v++le7wwnkh2ZCMdOa8L+Bn/I3XJyMiyfGR/00jr3iPhsrlSM5HXPvXNV+I9fAr90NVxFMk8OfNibcjD+Ltg+3ajxTYfb/sV3ZMyTlHCHpjcOn4c1LGzMclMBTkse4q5brJPpSiCTY8U5Vm6jg7uPbnFQm07m9VdRLK1W2s7O/vpCZLVNoweA2MFj+FS3uLq2eRQCrKJEwevrVXW5YdY06e2aTbB5xR2TGGIwcfrVOymTS/ItyS1tgR/Rf8R/LNJq5EU1qSSId3fgdeuMVXYFR8o3DH3q0bqJonwHbAGMqMjH1qqVKRvmQYHXPf6VNzdaq5WCnaVPOfeqGoWkV9bSW86b43UgjOOPatAsm7904HHIJ61E7Fn5OF7N600wdnoYmj6bLpaTKLhpYCw2I3VK2CQ7Hfzu44OPypTGMgp8xPP1pGDckjC98etU3fUlRSVhzwSSR74wZIx128Mvrkd6YEAJZASPTFZ2qW9zPsNhdPb3KElJVOcexHcU3TtSuLi2uV1izK6tbDPmWw4nT+8o6E46jrRa+xm5OLsXGl/fMFQK/Vgvp0FW7KBJLbM6ZZ2zhjyKy4ry41C0E+kwedJG+wpcKYWUH/Oaq6jea01rKNMhjmlBwF3FVPrgtyaOVgpq2hb1GRrSOb7CVkuApMSSEBWPvSJcRWFs1xMzB44zLOFGQxPLe/Haqfh3TpYv9N1iGEam2ctGxYKvYZPf6V0MkkMmUKB0K4YNzuptpaCs5albStQs9SsVv7KVZYJvusBjB7jHYir6JtYBSdp6AnrVO00+3s7cfYIkhj3ZaNF2jJ6nFW0ZjEu7IGeFx3qXa+hrG9tQJ2zBAOc5557U522iKNIiZZW2AnoDjOT+FSJGojdpMFAeWIxtq1pckEtw8qSK0duhckc9eMk9KQpySRmtepd6lqMce6S3tyiBgcj7vOD60hKgEKQOOtWJrCKG+vpbWNEEzpIdp45Xkj8ahC5JGOOvXt70XVy6V3FCwqqqzZ+bGcA8U9W8uMyMwEQx8xwMe1RAeW3yZwc9aZd2i31rLbyj92wwQD/npQXYtXwlOnP9mkKzgZTHVT2qfSNzackkiyDzVaZopOqOW5Ue3B/Okj+SEgn5doUZ61b8xSwVuHxvXJ6juP5GhPoRJWaZDKdgPykqemB92pUKuAE4XntmnMxjkAYgtjHXtTOHyxUkDjavBHvmki2yUnackcgZzjivNP2gWVvBFkRnP9oR9sceVL2r0XcEYjYxXAOMH/OK83+P+V8E2akYP9oRtjH/AEzlq6fxI5sU/wB1I8Ntv9Qv4/zqQGo7b/UL+NSAV2M8MlRgeO9W5JlWFBGxDYwRiqAzTwcDrUuNy4zsheX6DOO1JjIbIxzQvDdeRzT2B34bA3c0xEQ64oJwaVuDwaT60yRc5FA4HtQKOCPegYuPam4x9KcF/KmkenSgBPpQDzQBS4NAhpopSPSkoEFK3X3oU4PIqcBSvTmkOKuV6OaVuOKQ5xTEOB5BNaMsVq+lrNGxFwrbXUjr7iswGr2mpFI0iy4A28cd6ie177G1Jq9rblEjHTmjJBq1cRrGcDP41X3GqTvqZyi4uzGZ5pM0/ANNK8+1Mkms4fPnVSQB1OTjgda6TWG0xdJt4reRBOPmkCqeT25rmoxgcA5ofP1rKdPnknfY6aVb2cJRte4xjk80gUnpSmlWtTnHop2joSe1Zt3zcN+H8q1EyOf1rLu/+Ph/w/lQhy2O++Boz4uuhkD/AEJ+f+2kde9xqyR/eJB6Zrwb4Fbf+Evut4yv2J8/9/I69o8OzX0tpJLfxmPdIxhU8ER5+UECuaruetgX+7SNVRt+8m7d8rY5x6VnPrEVmFilgea3v74Wkmw4ZA6ld39cVP4imuYdKkNhG6zHaAQMkDvTdOsL3zdMgdNgNx5sxK7jwuQfrnHP1qYWtdmtZ9CwujW+i6DDZWkzyRxXDvlzknvVF382HGMtnK4H8PQ/1rodejCwqhBLFjIVzjoMHFc7GpBLnhQcD1xUp31Y4bWNRXdoURcKDGGODyOx49Ac/nVSeARjqScbcjn8KxvEGtLp9ppuoG2kAs5WjuJojkoD0JHdSOua3i6SxrJESY3G9CPmBB54HpQ421HTlrZmeFIkUt27etSkbg2AMqPpTyf3eV+YA8ZPQVDOrmEiNirYJHFI0ewi9cMABnsc0m5wNx3bBySaqaR50djtvWJkBOH7496vIyiMjcSW4z2oZJWxt74HQ7f5U/eA6lSVdTkNSyZRxnA46ZprHKkncGzwKAMPxk+q2iWl/okjosbZuIuqY+ndf5VqWGoWuq2C3dnLG8Y+R9ufkYdQc9/SrEbgbgTtYZH1ptlpttbTTPaRLEZ1DMgyASO4HT+tXdONmY8ri7rYbgZG70/L8aSMAkncdw5B7H0pFADMFztHIx2pwAyQybcH86RqTQswOOST0/pVqOQqzYyST1qnAeAPmbdz2q7HJDsyyspxjHoKllIz/Ed/9liiQKXjmLCUEEhlAPH411Gnx6dpei20NtiG3mjDsp5Y55xnqay4lkXO0ZKrncfyx9ahklDStMoBK/ukYHgKBg4+ppt3VjFw5paF3XtRtLXyrksfLkAhOBkL1I+lUraaO6G+DDxjIPqPr6VVukjvbT7NOoaCTOQfvKfQViaJ4a1Sw1R7uG7Eq8KFJ+aWMdmHdl4w3cdaEoteZrrTt1R1Kg7sDaR64xmpAnUxZ2nkbaqardvaT24+xXDQSrnzkQld3p7H61Fqcly0SxaYv+kyAEmRSAg9T/hSsac6NIARuHOORjkdfaiYsZI5o2IAbPle3f8AOqmmactpFI1zdyXF053F5DgA9MAdhV4gJg7wxBGQOgo2Yr33JnYPggfIDgZAzg1R1LU4tNeHzlJjmYR7l6IScDOaW3NympXLzOn2LyVMWDgq+75l/EEVYu4FnRkmiSVc5KsODzkGnaz1I5rqxPufcOdgzjB5FeafH4bfBlqAc51BCefuny5OK9JjZsbf756ehrzX4+A/8IZa8cf2gnXqP3ctXBe8jnxLvTZ4hbf6lfx/nUlR2/8AqE/H+dSV1M8YKkjGccVHUyEZx2pMqO4kqGNwGUg+hpYYpJmcxxu+xS7bQTtUdSfQVqXuboWC3DgPLgbuuFJxzV3wnqB0XxE0ay4tboPYXDGINuif5T8p4z3rKVRqDaWpv7Fc6V9Gc2w55pvWp50EUrxjJ2sVBPcA4qE4rVO5g1Zh0pVODxigdOlAAP0pgSZGMj8qj+tLR9RSB6iodrA4zjmrEkySAkIqHHpVXoOKQGhopSsrDvXFJgcnFWkiEgHl43HA2n+I+1V5wyOVdSGHVT2pJg4tajMA9K0rXT2nsmnEkYCnBUt8x/CszJ6UvmMOM8USTa0CEoxfvK4+UYYjg4OKjoz7UGqIeolWrB/Ll3k8DtVcD1pwYDtxSaurFRdncsahukl8zcCregwKp4xVmWYyqq7QqqMDHf61WPXFKKsrBUd3dBTgccdjTaUVRKHscc0m7PSk5I9qQ9MUDCigUdKBADVC6/17fh/Kr2ao3P8Ar2/D+VCEz0H4FEDxddk9PsL/APoyOvfYSDhgFB9BXgHwPBPi26x2snOPX95HXvdu5jUuSCuMhj3PpXLW+I9jA/wiHWdQOnRW22Ga4eeZIkRFz1PJ9sCuyWNo7iPjGyMsWPVSegP4VyOlanBI0t39rBhsV3yhFyST/Dn1J44rs4JHi0hLm9XybmRd0qE/cLdF/lWctFYqcryuc/rzs92Bu3sqhXJP41zuVdz8hAOdoY9Oa0rsrKXbcF3Hk59O1UfmW4UFMupIO7vTSN4KyFxH0ki8yF8o6gZDDHQ+oqxdwPY6azWSfubaMbYwOsXUEe4FQjlWfbj5uBnIx7VbsnSGWO3kkY2zoUXcT8h6YzSuTOL3RRgljuLWGZGDRyDzEbGc5o5PUHHoTginR6fHYItrDGI442bAHY1G24ZDYIY8nNHoaJ3QOBjv6HjrScbQwwvt1oD4OQwKZwMfyqPdtyMqM9yelAhmRk8/mOtIHUj5lI560m1gp2uPxPWoY7iQSlJo1TA+XB4b6D+lOxNydcKAq4Ppn0qdJGYqQRlBnIFVAeGbd93qP6U5MtgHbkjqO5/woBlt4g/7+ILskP3R2NRoXfcSgGDzx1rM8C/2jpd9qEN9G09lLukRs5+fsAO3Hb2rqNdMFtCZGtZtzLlvs3zbSR3Wm1Z2OdVHHRlC2RCpJLbgeBS3l5aadaebdFYxnAOclj6Yq5ZaZdSwQ3CRtJHKgZWZwAAR/OoL/wAIf2lf2s9xKDHAceQpzuJ7ljSVr6mjqJLQhmvYZ5UsreZRK0YfCnLAHjJplwyA+XEcRD5FBq+umfY7m7kGnrC7RhjcMBuYg8Jn6dqyri0czFwjBOQe4yP5UO3Q1oyTHQMpJAGSF2k9akuoZb7T5oLa4kglcEJMpwYzxjFVYVkeEkqqydlc55FXoMqIw7K8jsvyr0HPPXoKnZmstU7nOWb61r+on+0lmsNPtH8tI8hZJSu3cT7EjNemDQ7a80W6v7S8kb7IiCRXg2oWb+FXzyRkZ4FUNR00peM6nfuwSVOcDHGR2rSvNavNR02HTH062+ywLhGiEi7SB94gPtJ9yD1q+ZPc5V7qXI/U5wxsFw4OWz26VLErAKyxmQnhVx0P+FTCynRk2oEQnG5jnn8Kfq+hTalYfZ4tTnt8tlnhjIbb6AnpSRU6lloakUBisFinRFeQ5L44BNV5dMuIkeTMOzHyyb9o/wDrVbjknbaCLogAKu0j5sDHPFW47N4WD3qRjdxgHfgfjxS2M1JvY5nULw2MAZIGumHCrEoGT9Wrzb45C7l+Hljc3UQt9+oxjyMhmU+VL95h39q9rSysJL1ruKzt1usBGl2/MVHQZrzT9pkr/wAK8sAitzqcZJxgZ8qb9a0hJcySMq6fs22fONt/qF/H+dSVFbf6lfxqWupnlBSpwaSnKPm9qBkkEzQzxyDkocirOoWk1p9nM4I+0RLOpJB3Bs4PH07+lUD161veJLvTLq00NNJtkt5ILIR3hVSvmTbjljk88Y5HrWcm1KKS3NI6xd2WLuz0q90SC80+6FvqKELe29zIACSdqtGerd2b0zXOHgnPakJz9fetuz8L6reaHLq+n263ljApNyYHDPbAHq69QD1B9KV40V78tPP+vuHJuq7xWvkYYp2M0Mu09RTSea1MyUj92Ocmmc7uTSBselKxzQDYhNLmkHTFB4oEPRypGDginswkG6Qs0hPJPeoTg0oPvik0VceoCnJCt7HpUGOanJGzn7w/WomFCExO9KDx+NJS5piF7g80j5ByOlPT5j6VYngCxJkgNzmk3YpRuroqg5GcUZHelCgdDx70jj0piEPXikpQKXb6UEguR14rX0fw7qWr6ZqWo2MAez09Q9zIXA8sHOOOpzisluvBqxZXc1us0UVzPBb3ChJxEx+dRzgjIzz2NRU53H3N/wCr/h+JpDlT97YrGkGacOm00Y96sgaeKoXP+vb8P5VoYrPuf9e34fyoQmd78E5fJ8V3TAEn7GwAH/XSOvcIdVsYtZt7C+uv9LkUtHBCpYH3J9P5V4D8K2j/ALeu4nuprV57N4opIlywcuhH06Hmvofwzo0Md9HevAZL0QLEJD8xKKP0yf5VjVsndnpYaT9lZG74a8P6fpokFtbIlqreaUb5g0nXc2euO3pVzxDOxSOLerFmy+D2xT9V1D7JFZ2qMI7m8nWKMd/Vj+ABrB8WXUtveW8cSbu0ncjP9a5tZO5vFalOf5yV++mc7T1/GoiY5JAq5PGMg/nU88al8BgCR949vrTfLX7N/CByM5pnYQlAoGwtsznkZI9qrX8wtdPuLhiZXiTzNiHaW284B6dRV/lgGiTJAAHOAMe3eoJY45oZoZcmMLyCeuf/ANdCZMlpYjn1qK8/sqd4PLGpRkjefuSDoMjtiiRSh2hCPp39aZpvhy1k8OtaO0hiim8+CUH5lwe306VevoQCWwVcD15qpW6GNOVvdZn4IHAKrnHpzTHPA24HYcZqU4JJA+Ydc85qFiNuMYPQnHNI0EIQ4wOAMY9/WmDBYAAseueuKU/dDNk56dMikZgXVQOp55xigVhgPyZQ5BGOOacuBnLHB4zj+dBx8uR36Y71JEyg7pcBACSTwAPrQGyNHT4jJOhTJ2HOMdwKd4d0DUm1a4ur+4byZwQ8Q6j0IPbitLQ42iTzUj3bsgN22109upZF/gQ/gTS57bHJVlqQabp4ggEKsDEp+XI6Vsw2UXlZdQqj9arPJKkY+zwFznA3dB7mrKLOVRiUPHOOgNZu9zFtkLQQSqR5bY+nP4Vn3eh21wo2kh16H7p/HFdCqEqPl2nHao/s21GbDZ/U0rsFNrY5BfCyR5eS7mZB/DgY596aLG100l0j8yTqBJyWwOK64RebGxwFxwVzzUDlIoS0abnHCqf4vxp3NfbN6M4TQn8TeLNSMFtpv9mWythpZ4wWkA7DPavULvw7FY6Zb2RkLTO3mTyKANxA4A9FHOBTdH8RWGh6Fd6nrrLaW8bqj3JBbljgLgAnj2q7LqlvqszT2UqzW2BslU5R16gqe4reVowv3OdzlKduxltpMaGPyTtVOoPem30Mdrb749qzkcB+fyq5fXDwWjuiHzAM8DpXOXWpPeSQC6VBgkbgMBSaxWpvG7dy1BDJdMVQKZW/uD71M8iVbx9PcM84AbkHaq+5ra0i0MdyJgm1VXaoHcVtRwxoWfHLHJOOvtTQ51nF2RwXiDRNTttKvjpUoOovGRC6r8qMemAe49TXj3x5stZsvg5p6a+7TTjWYikrtliDDPkH8q+ptoIHArwr9sKMJ8MdPwuM6zESfX9xPW1N6pHLVqOUdT5Lth+4T8f51IRxTLP/AFK/j/OrAOec8V1M5kiGpF449aUt2pAOeKQ1oNcAds1PfRW8NyY7O4NzEAMSmMpuJHPB9DkfhUKLulUNnBPPtVq0gWWR2EscUKMF3u2CATwQOp6c4pN21HFX0KZx+NdD4I1tNH1grfSXA0i8Q2+oRwnmSI+3qDg1z77fMO05Hr60+GMO6BmWNchWkbovv61NSEakXCWw4ScJKUdya8gaNzKsMiWszv8AZ3ZTh1B7HvjiqrDFWXaaeDyzM0sVsCUBJwq55wD0Gear9qqOwp73QmOKXNIpx1oI/GqJFzSjFN7UueaAA8Z4pAeeKXd1FJ9KAFzximg84NOHXNSwwmaQKmNx554pXHa+iIgtDoVOCCD6GpUleBjtwD0IIzTTIZCc9/WjULK3mEfHJpXdm6nOKRsAADqaaCaB3toDEmjO7r1o9c9KcgJIwDQIfGgJJY4UDOD1P0qdxAske5m8vKltq8gZ5xToXMUdwhVCkoA+ZeeDkEVteB/Beq+M9Uez0uPYUiaQyyKfLGOik9sngVjVqxpxc6jskbRg3ZRV2c7aypb3kcvlJNHG+7y5BkMM9D+FeneCPD1n44ttYe8s7iE28SwaY1tHnaRk7COBIeeSTkU21+C3imTV59Pnjgt/Ji85rt2P2cg9FDY+91+nWum0TxrpPwpvrvSTYSajc4VmaK6WSOM4GFQ/nk9a8fHY2OIhyYF81TS1nsrrXsduGpOmm61uXt3Z5N4z8Lah4R1ddP1YILholmwhyMN0/HisTywEzk81u+O/FV14u8RXOrXq7HlPyRg5EadlB9qy5b9pLCO3dFwhzu7mvXour7OPtfi6nHNU3OXK9OhRI5xVC6/17fh/KrxJzVC5z57fh/KuhHMzs/hAk7+KnFpaPdzfZyVjDbV++nLH+6P8K+rtDtJbKzM88u6/nChmjX5UIzhQPSvnL9myHzvHV6MZK6c7Af8AbWL/ABr6otbSTYCpDKeBXJiJe9Y78O0qZlLo0UkllcXI82ey3NHI55DN941xXji9u7HVkMEZkjPJb+It/hivYtB0d71ne5LC1U5cnjdj+Ee3vXKeK9OsdTMryx7cuSDF8rKO2PwqY+7aUjWNS8rI4qGb7Q9t5UbO82DtQE5J7Y9c1avLO9sJAL20ntA/zKJU2Ej6EUtstvZz28SStZwRtjzlyWj9yBz19K3fEVxaTaLpNjBLE8tuXZlt1cQjcc5/efNuPftS01Z2qo00rHOHZIQXO1hyCOc8dKamQV2HkYySKk8sI4aQsNvAI6YofTbjVbS5htLlbON0KrcbMlc99vc9aSKlKyNHw69pf6VctZzo6idoiUYHY3cH9KddR2sqfZTcJ9qg9Dlsn+8PSm6LoUHhjw5LaeH4Va6VGePz3+a4lI+8x96v6HoWUtdT160gXXTHiZ4jhT6Y9eMcmhtb3OJys7s5e5tJYHPmZ2Z4YDIP41mi5hMzx+dG0gOCqnvXps0UGGClBg8hT/nNc7qnhbTtQAa6tIBN/C8Q2N+YoT7lxrnKkEksqkdQeMCkdN21fmI6n1FdC+iGPZGsrbVwpzgkVOmiDdwZAT0YkDindGrqo51LfHzKCuBg/wCAq5B4VfVL+CTUGA02IbhbZI8xvV/YeldQmnW9pEZtnmSDnJ5P4CpbeFWR2Zt3OcZ5B9aXN2MKlXmVkTxHyyoRQVUY+QYwPp6VfhVrkjDMCOnOKyY5XAZIsRtzlsck/Sp9OmuYWCPMN+eQVwSagwcXuat1eW9gGSWXLsuCBWjbFpLaPykXawzt9fesW/8ADqalcJK0zK+fmI7muotoEijRFHyqAB60iJcqStuV3yqDdwcdjVF7qSSTZErPk/w1Pqsclw6RW5y+ct7CrVnbraxhFyT3J9aNhK25UGlbyJJJpFY8FVPAFW1sYhEscg8wf7XNWV6cdaGxg5qWx3CVIntIrfyIxEhLbMcEnuapPpyYUW7eT22pwv5VbPIPUA0DPAHTHpVczerKStsUPss0JIDmQ9Bv6Gq8+kSMWkiRVJ/hHSt3ZvXa5BPtTI5gkvln/WKAxz3FNFKTT0Kei+bDCxkyNzYAP6mtlM5BDZHvVeNA6sSpHPGT1p7EBQp6e3aqREveZb85AdrNg/pXhf7YLO3wu00uoH/E5ix9PInr26BEcguBxyBXin7YuP8AhV+m476xF/6InrWn8SOeoklofJFt/qF5/wA5qwoyelV7XHkIT7/zq1CNzhc4BrrZnHsAhcxs6j5F6mhGVVORk9uasXssaQLBGTnq1U4lDZJIGBUx1V2XJKLsjWstRgg0LUbKSwgmuLp4zHct/rINpJIX2bODWWjEB8AEMNpNdnYeFor/AOG17r8N6Xu7C6ETWcUG4hH/AI3bsOPQiuSs4xLeRw/KBK4Tc7bQuT1J6Ae9ZUqkJc3L0epc4yXKmNYxiBRz5h+mMfz6054Qlp5rTRiQsFEPIYjGd/pt7Vq69ZaLbCePTtQkmuoH2Mphwkg7lG3HODnrwRzWD1b5jjHGTVwlzq6v80TNcrs9TS0adLLXLaa4EM0Eco81WBZJIzwwOMEgjPSjxFZ29nrF1HYTGawLlrabYUEkZ+6cHn2/CqUL+WN6kiQ5TGARtI561um01zWPDctwzi40zQFEezeMwJIxOQOpXd1PbNKXuzU2/L/L8dBr3ouNvM5yjvS8HpSEVqYhnNABPOM460nSigQucmlJzTaBQA4c0FiMYOKQU1yCeKB3FLZySeTTQTSUooEPD+opwKnqaipRQ0O5KpXAyamFxHEp2qWb8hVWjkjGeBzStcalbYe0rPwT06Vu+F/GOveF5XfRNSntQ5BeMHKPgYGVPpXPd66TwF4P1Xx14kt9F0SNfOcbpZn4SCMHl2+meg6nipqU4VI8k1deYRqSi7p6nT2+teN/ihPPZ3erXDadZW7XN9N9yCCJFJLuFxljjgdSfavNt+VG3IU8jNfW3xh0fSPhP8Arjw/oQxcapMlrJcP/AK24Y/NI7H/dUjHQA4r5F6UqdKFJcsFZeQSnKXxMf34pcmmijPvWhIpqjc/65vw/lV3NUrjmZv8APahAev8A7LEZl+IOoKP+gXJ/6Ohr60023Czqsyv5YbnZ1xXyp+yT/wAlI1H/ALBUn/o6GvsC0lSCdXdS+BlQPWuKu17RXOqlf2Zpa6Nuh3UFrJ5MjRmJCnVCRjP9a8W0FtRXX5tF1ItOFBaK7KnJx/CfWvVHcysWb7zcn61AyKMkgA+tTOtzPYulF00cZqmgyTZaRI5D7cH86xX0eYDY7uq578Yr0Od1VsEqT6VzmtXcmV8r5Qv3mC5OKzTOmFaS0Oci0fMqtJK8y9AACR+daYWGzUmaJmmIyIlO7A9z/Ssf7TcyXJMzyYB4X7q4+lKt843qxBiBxtVfmJ9RT3Ohqct9jRTUJvMbMMEQk4BB+fA9alluxHA7XbiHnht24kfTtWNDo2tahqEQgtnggYBhJKnb3/wrvNP8LWcAR77F3cgAFmGFH0FMwq8kNjzjVvFWl2Uy29zdoG4YK45HucVoabrMmpAnTdOublMkCRUIU+/TpXpsVjaQsTFa26MwwSIxk/U1YCKFwoAHoKHJdjB1uyOAg0rUnxJcpFAuclEG5iM1Yhsg0+znzF7lsZrsnTI6VnXlusMgmKgk8H1qb3J9o2ctrFvHdxmwmkkjRhhmi6qexBqbRfD1ppGmfZ7RpXkYlnlmbLO3rWrizgfzrhwrMCwLDP0H1qG1vDJOr3EYESn7/pTu7WHruiidOullBVGJ6ZFbthpe0RvcfM6j8zWjgOoZec9CKlXIx3NK9yZVG0OjUDtTnYIhJ6CnDvxxUckHnqqvuCZDcd6ZmiO2hKyTSno+MVIRyanfrgcY7CoiDUspCDp0pGPIwPrSkntTfTAqS0gpQMnigCpEHPbmqQyWNckAA+lU7jadR2A87R0pdUvhZwMsfM5Utgdh61j/ANoRQW5mlcjem4yngKPr61aQ4Rb1OmSQRx5lARVHJPHFc3J4w0uW/mtbCWO5mhG6TDfKo+vSuc1/WE1mxazkWUW0i4ByVZ/y5rHs7S30+1RbS3WOPOQAvOcY/E+5qklbU2p4Zt3kdo/id96mOENk4X0/OvHf2odbn1LwBYwzx7SmqRtkdD+6mH9a7bdK+W4QthiWGMDsa8n/AGhXm/4RW0SQYiF8hBA4J8uTPP8AStKfxIrEUYxpt2PD7f8A1Cfj/OpNxzxUVuR5CevP86ea62eQOUbzgn8TUiqFYb1O01CoNSh8gBuopAjsPBHxA1PwdpWs2Olw2rf2kgjeaVNzRjBBx26HvXHkqykAYx2qa6sLq1tLO7uIHjt7wM1uzDHmqpwWHtnjPQ4PpV3wnFb3Ov2VtdTQwW9y/kSzTAbY1bgtz3HWsnCFFSqJeb+SNFJ1GoNmVjkA4qST5d0ICOA/+sUcntwfStnxh4W1Twpqn2PV7cxFwXgkBDLNHnAdSOxrCGDx3q4TjUipxd0yZJxdmaWnaeb9VghuLWOd85E77NoA4O4+pOABzW5aaNLY+BtT1O5uprOS4lS0ghSVdl0oOZUZQc/LhT2FcicAMDimhiAACcdcdqiUJSekrK66FxqRW61FYDtRu7HmkXk4pWQjpWxkHB70cUzkUq8mgQ7HPSlxweKkCAHB9PWo3+VsZoKtYFxjFNPWlwe3SmnNAmIeppcjGMUnNKeO9Agwe5pM0hbJ9qQUAOzRmkooAU+tel/A+0t7TWb/AMY6rcvBpHhqEXMqxS7JLmZuIoRjkhm69ux615oPSkoA7v4kfFDXfiHaabDry2yCxeV0MCld5cjG4dPlAwCOtcMMY6UmaKAA0DFJRQA4VSuf9c34fyq6KpXP+ub/AD2oQHtP7JH/ACUnUf8AsFSf+joa+swHEp3H6V8l/sknHxI1E/8AUKk/9HQ19a+cS2GQ9cA4rgxPxnZQXukibsnPSo7jkAg/WpmVdnJxgVz+varHpkbNJI/mHhVXuT04rnWpqlczvEOoXNqEFiu5m+8WXt7Vx95dXUt6FPmy3JGFCgsRXoWiaGbpBc6kCxchwhPP/Av8K6AWyQYWGOOMY6qoFXzJG0KqgrW1PPNH8N6ndFGvsWkPfdhpG/DtXW6XodhpnNtD+8/56Pyx/wAK1ioH19aaec4qea5nUqSnuHWl600CnDk8fnTRg0AUscDmlPy04cZA703GM469aomwhFVr+AzQlVbaw5BxnBqOHVbOS4NsbmH7Sv3kVs4/Guf8Y64IrZ7e0lbe/wApkjGcZ6gGgqMJSdkUtRiVpXmkYshUEL6n3FULO9v5r69hubMRWsKqsEof/W5HzfL2x60aOk+oyIYv3jNgZJ6Y9a2b2wl05g0hDK5zv6ge3tTOu3L7snqX9BvEEQj3hkHII7c4wa24g+8lgOeRg9q4lBGZWaBAnPzMDXT6E87AiRmaIDAzzzSMatO2qJ9X1BNNtnmuUkNsq/M8YLEHOMYHNW7W5jdVTO1scBuM1HPI6PwPk7+9QSy72w0BcMuA3cUXM1G5puozx171C3euft/Ea285troO7D+IDmtJNWs5F3NLs4yQwxUtMrlaLeCKMcVRk1nT4gS84wBu49PWqo8QwSgG1QsD3cbaaQ1Fm2qE88AetVbvV7SzB3N5jg7VVBnLfXtWFcalPcTMBKrRgY+QEYJrOkukXZGQGUH5gOAMd/rVJFxpuRHrPiKLRoVu79gsjtsUnnJPb8qoao4uI4HdCypiQQsflYkcMfYdhVf4g+FE8U6dbxyTNEkM6yEocZXHI/KpGRJYIPKMpjWMKBImSwAwCQe/H61ppZM66UPesRtmQyHlf95vu+wp8CO8TdBsPDFeBikt4Aq7k3EKDgHHy1aVRwVI8sjDA8c+tTc67IjaNkKrwVYgZxnNeYftFIY/AtogIKjU4+cY58qWvV1XaFwzccqD/jXln7SEZj8C2Qydo1KMD3/dS1dP4kc2KVqUj57g/wBStSDmo4P9Uv8AnvUinHSu4+fJyuFA7969d+Anwgm8e6gura1G8Phi3fk8hrxwfuKf7o7t+A748feUBCD0xzX1do3xcf4Y+CvC2j+MIGu9WubM3HlWiIhsoCMQK6jAZjjnoRz17pDbPFv2htXh1T4p6lbWKpHp2kpHpltGnCxrGOQoHQbi1ebZxnvUt5cy3l5PdXDbp55Glkb1ZiSf1JqGgRYuLqe4KmeaSUqoUb3LYA6AZ7VCD3ptLQtNhtt7hS9e9JRmgQtLTSaUEdxQApNN6U7cMe9Nbk0AO30BgTk/hTKUUASbuKYxyaQ0lAASaGJoo4xQAgpaKKYBRRmikAo60UCkoAKKKKAFAzT1XIPrSxqMZP5U4N1FIdje0LSdOm0+W5vr1I5VyVgzgkAZ6+9cpqBQ3snljCcY/KrjMcADpWfdczt+H8qiEGpNt3NalSMoKMYpW69z2H9lRmT4gamU+9/ZMmP+/wBDX1np8zuGaRvnX+E18mfsqQif4haihJH/ABKpDkdv30NfWVij2sji7VQDwjDncPU1y4j4zooW9mWruQpA8jY2gZORXI6ZYLruvJO4Jht8sSfrwKl8QavHLdtapIVWM464FdF4W01NP0qNRjfJ+8ZvXPQZ+lYLRG7XLG76myAqLgYAHHFNVlkBGOBSlQRg0kK7S3pUGJFJGQfamgVbxxTGjBBH60DuV8c49aa0kSYUui+xOKnCBUIX8Sa4vxB4XvbrUXubK9RPNj2EyBiysOhHYr6iqjqCSZ0UupWUTMGuEJXrtOa47xB4wure9lt47YfZXAVJCDls+hrp7DR4bS2i3lZbiNRulK4BPc49KvvEkqKZI0cDkAqDiqTsOPLF7XPJWtdW+1K0FrK8MvG5UP6kV0GkeH7u8lClWt7dcZd159wBXeKNgCoMAdAOBUGoTtDZyujDzQh2bj3xxT5jR4iT0SOQ8C6R/Z2taiZZhI6AxoVJwwJ6n9K7KXAjYyhSg55ryax8d6Ja6gNMutT/AOJu7+UwCH5pCem7p1rsLaVkRvPkZ3X+8en4U5JrcmcXN81zZikhuZJM28aRZ5BUAk+tXYHjhhVIhhR0rl4tRNxBJ5CNHNkqGcYBHrVy1jcwp5kxyD94nrSJcLG9NIVjBABLdqz559rh5zsj7AdqiMsqqoEiklsdaS8trp4S0DKZT3z0oBROV8Q+JNKs9WSzliuJ5nGX8tOIwf4mq7AYZVVFbJPA3IRkVWl0fEomv7LzJd+7JH3j6n1qQ215dhwSYIl9MjiqbXQ39mktyydMjdkjeJlAGASeR6Uup3Flols1xcZKKuR6/XFXNMYRQtGzvIwHBYdKpX1jHqAlWZ0eN12MCCeBzihb6icew3R5Y9ctkvbSN440yDEy4yfWrRs/mVvM2MnfaGB9eKjsCNMt2WAbEUDHpj0qxJALmIsinJ4Zc4yab30NYpx3ItWVE0pkQBuAct3Ge9ZMkWUIQ7jnIOc4rWIkkuo0k3CNMDb1BJ65rNSE2skkaKFUE9upz1zQbUlyuxApIYMysoHDAnH51YKZjDHIUdFpgBMigYVsnO7kGpET5mDKOcY68mg6LkkSgxZAADZyK8o/aTUJ4CsVDZA1KP8A9FS16wuDICqkL3968q/aYx/wgdjtOVGpR9v+mUtXT+JHLi3+6kfOcH+qX8afTLf/AFK1IBmu1nz4sbtHIjxna6MGUjsRyDV/X9Z1HxDq1xqmtXcl5qE5BlmfGWwABwOAAAOBWf25HPrSUAFORdzAdM+tNqVFJ5yABQCGEYpMmnuctxwKjoADSN7UtIRxTASlpKWgAzSg0lAoAU0oJoA4oxSAKUg4zjjpSHpxQCcUAKgHelbHYU00c0AHerum6fJfXCRIVQsM5c4GKpGrUV7IkWwct2bPTFTK9vdLp8t/f2JNU0u40yQR3IUFuRg5qhUskrv98k/U0yiN0ve3Cbi5PkVkJRSkcc0DpxVEDhjaeKktLdrmYRqVDEZ5qGr+kXYsboXBiSUqCAr8gEjGamTajdbmlNRclzbFaRdrEdMVG3tUkzb2JzUXSmRIKo3P+ub8P5Veqjc/69vw/lTQmeofs36lcaZ8QJZbZUZXsnSXdnhPMjJI98gV9fSyPcQrMVZsL8oBOA3rXyX+zHZm98c6ki43Jpckgz7TQ/419YxTNDGFcZCqM9gTXFiPjO/D29mYWtW0LHzljAlYqCzemea9AtiGgjKjjaMV5mmsW994m1fQWt5o5bYq4lc5VkIHIr0LQ3VtLjhbrD+6IPXjoT9RWElZam1X4Uy9inIvA9aRExwCfpmq9zqNtajBcPKekaHJP+FSYehNczR20LS3DrHGvJLGuZPjCyk1CKCGGZrds75yuAPcDqRWJ4pt9UvNREzBpIo1LAKPljHp9fes3S7K+n1O1jHmHzGILMvRQOcmqUUdMKC5eaTPS2lDRqYjv3DK46GmlWdgXIwP4RU1vAsEKxr0UYpzDmpMCBkGMGopBtH3iOKssORWNq+r29mSDh2AJ25xQNK+xFqV79kgMhl2AccjNec+IvGVql/HYKtxfXkuGKxnART3Y9AKj1HVtSfXLoTQ5sSCUy2SOmB61l7IopWkQDzHOWfHLGtlFR3Oqlh76smjls5LpblNOtkuk584opbI7+uferD3bO+HmdfXH86oM24kr94dQaVMK3OMHk/Whs6lTii3FKZM5lccDJ8wjPuKgsL/AMQWeogDUfO09iciRfnX0pBtAaQK3pjFSlBlcHBx1J6UXG6cXudBBr1yGCymJ2PPK4q6/jG1siguLa75cITHHuAyOufSuXPMe11BY96tR+aqhDgrnr6n/CpsupEqCex6ZHqNtNbq0TBw3IHc/hWbqd2pXyjGeTyucHFcerttjRXxtOQAeQas+DH1C4srqPW50e5eVmhViCVTPTd3/pRy6XOf2XI9TZX5cCGMoCOuc5ovLWE2MhkZwrD+BsHNKh3iSEJtmQ/KOhPHSqUjy/YrnzFbYCrAEfdPcU0PVaDbKVbSOOIR4jUYC7snHvmsrx8Y7jQVuYdQksZI5QFlUE7D6HHb3q+FkeULFGWZzhVHJP8AjWpa21x5wjnsJSpHzK8fB/AitI73Q5JJWbMttG1jUtN0Ge31gJMBm9kWE4cKpYkevAwe2TW9qGmP5zujLKqxhpR0Yg4wf1HFOtrPU7maKS9vEiihfECxW4BMfI2P/eBBORWyiJb3NztEjyyJtLGIEcYxkegx0rRpPSxyxqyg3qcxFp0ztKQ0YEcjxOHkAxtfaT9M4FV3iETmKVdjRuQ2GyQQcGuovBLOrSQplypJBi27vm3Z/MZzWJNZ3kpkmNrI3msWc7TjJ5PIqJRXRHVRryl8bRTwMjyid+ea8q/aYH/FBWH/AGEo/wA/Klr102txgYhm46ALXkn7TalPAlmhyCNTjyD2/dS8U4JqSDEzi6UrM+cLf/Ur+NSj1qO35gXjpUnauxnhA3J5pKOtFIBKUc0UZ46UABpKKKACkpaKYCUUtFACEUY5pacB7UrgHWlVeRnpToY/MlVMhc9z0FXQqxSsNgcH7v8AjSbsXGF9Sm0JCqQDzTFUk4HWrtzMmMqDyc4qpvPNCdwkkmRlSO1LjtTsn1NG40yBuB0pMHrUhPPNO7CgaRG3GKQ0r9famigQoArd8G6Lba/rsOnXmoPYrLxGYrZriSWQkBY0QY5Oc5JAABqPTPDOvapZi70vRNRvLUkgTQQM6EjqMiuk8Jad458L6lJfaX4WvGuJYWtz9p04yrsbhgAe5HHHYkd6BoPEHw7/ALH8N3eojW7a7u7ZPtLW8MZKNam4a3WVZM4JLqTt9D1qlpvw98R35X7LbW7bo4JfmuFXCTRvIhOe22NifTFdJcweMNR8LNot9pOsW1o7ktFa6IBsTeZBCsmQfLDsWCdATXRXWp+KPsNjaaToeu2dvb2cFtIzaGryTNHE8W5nzkjEjYB6ZpAkeZ+J/BGseHNNXUL82L2rSpFvtblZcGSPzIyQOQGTkH25xXLY5r0DU7Dx/qemtpt34e1NrYvBJsFiVbMMXlR89fudfWsAeCfFQJ/4prV+Bk/6K3FMGjn6oXP+vb8P5V0up+Gtc0q0+1apo2oWVtkL5s8BRcnoMn1rm7ridvw/lQhM9q/ZFQyfEXVlHU6PLj/v9DX09hmtiHX50ORmviz4PeP/APhXPia51f8As3+0vOtGtfK8/wAnbl0bdna39zGMd67S4+P1/Lr7aiulypEWBFqL75Meh/d8/WuarRlOV0deHrRpq0j6ZFpE+sW92ECyeX5TDpuX3+lXI7aQaizQLKjv1lRsbh7j+tfPY/acB2lvB4JAxn+0v/tVSw/tQmO4eT/hEcgjAX+0+n/kKsfYVOxtLEwex9C6r4Wi1WwltrzU9Vijfkm2uTE4/wCBDmrWn6RBYwJDb7yqrt3yuXcgerGvnj/hqskYPg1f/Bn/APaqT/hqk5GPBoA/7Cf/ANqp+xqbWMVWXc+mY7dIyxAGG4I7U6OCKMkxxqpPoK+ZT+1W3bwav46mf/jVJ/w1U3/QnL/4Mz/8apewn2J9su59Omo5HVFLHoK+ZH/aocqQng9Q3qdSz/7SqrN+07JMriTwrncoBA1LgfQeVS+r1OxSqw7n0DrOvRxxFLR98p4PH3a8q1Ky1D/hLZNYvtQeWPbtgs1HypngsT3FeczfH2OQEDwuVBGMDUP/ALVWVJ8aS8pk/sNgeg/037oHQf6urjRqR6HVTrYdWu/zPWJWU/6rAz1yc1GxYlkzu7k15MfjEm7d/YB6Y/4/P/tdL/wuNPK2f2Ac/wB77b/9ro9jPsdf16gtpfgz1gK330UZPWpY0LKSEz2xXkv/AAuZdgX+wD1yT9t6/wDkOnJ8aQr7hoB/8Df/ALXR7GfYX16h/N+DPXiPlwcqVOc5pV+8GzuUH0ryIfGtdrK3h/cD/wBPvT/yHSJ8alVcDw+cdx9u/wDtdHsZ9hfXqH834M9jHzk+YMcdh0qcKRGrKflbn3rxgfG4AAf8I+eOn+nf/a6VfjeFUAeHjx/0/f8A2ul7Gp2KWOofzfgz2ncokJC4OPzp8Mg81XUhm/vYyQO+K8WT44oOW8OsT0/4/wDHH/fukHxvRXBHh047/wCndf8AyHR7CfYTxuHejl+DPo3Sp/P2CViJB918dfb61nPolwfElxqct7cOPJaFYDjywD/n614bH8exGFCeGyAOf+P/AP8AtdaD/tHs6BW8L545P9odf/IVNUqi2RhPE0G9H+Z6v4lW5fwvrUVmsxvlsJ/K8hT5hfy2xsx3z0xXKX3hXWtH+Hd2l8+rG41BYJLK20aS5nWynWA4aTcwkJdjggfKrYJBFcZN+0MzopTw0Y5lIKyLqHIP/fum6b+0LJZPK/8AYNzK8nUvqrED6Ax8V0UlKCs0ceKlTryTUtl2Z3MVv4kXxvqs2pWniGbTXsZHv0gaTztjQxeXDC24RsUcPhowGPz57VdFv4hX4K6fbWyah/akWrRC3kuVl8x7cXOUd0zvWPZ/ATkKOSa4R/2k5mZSPDbKoOQBqPf1/wBVSj9pKXfv/wCEbkyeuNTPP/kKtOeXY51Sp/z/AIM1fFdv4zmsrm2kt9Wkuv8AhJbu4M2liZUm+WIRxRjkojfOyO2VUqeua1rm4u9Q+KkWp6npl9a288OnvFBPa3knlPt/eKrRMqKQ2NxkBHfArmB+0tIAM+GHPGP+Qn29P9VUp/abbaVTwtIqnqBqnX/yFRzPsS6UP5vwPo+UHe/c5PQ14H+1OuPBsDAjnVk47/6qWsRv2kmKgHwu/HQ/2lzj0P7quH+J/wAVP+E60SLTzo32FkulufNN15ucI67cbB/fznPapd5NaG0HCEZWlujz224iX8alNVop0SNVKMSOpDD/AAp32lf+ebf99f8A1q0OcmHSlAJPSoPtSY/1bf8AfX/1qUXag8Rt/wB9f/WpATfhzR2NQ/a1/wCebf8AfX/1qQ3Sf882x/vf/WoAloqL7Sn/ADzb/vr/AOtQblf+ebf99f8A1qAJaKh+0r/zzb/vr/61BuU/55t/31/9agCaiovtSf8APNv++v8A61J9pT/nm3/fX/1qAJ169KniiaTCqMmqYukGP3bcf7Y5/SrkWrQw25SK1dZWGDJ53b6baUr9CoqLfvMleBoV+bGT2zk1EzEHIODUH9oLu3GJif8Af/8ArVGbxDk+U3P+3/8AWoSfUba6E5JPWkqD7Uv/ADzb/vr/AOtR9qT/AJ5t/wB9/wD1qZBPRUH2pf8Anm3/AH3/APWo+1L/AM82/wC+/wD61AE9Lk1W+1L/AM82/wC+/wD61KLpP+ebf99//WoC5ZJ9eRTSpxkDNQfa1/55t/31/wDWpRdoP+Wb5/3x/hQB7h8I9A1rXNKtRp0r2lrHCWW9aSZRDILgljGEIV32jBDZGDXba1batJe+JHsbfxFHYs0Ek0U6SsGdZiHRdrbmVlIbMWNqgDBNfNdj4q1bT7YW+n6lqVrbAlhFDdsiAnqcDirY8deIAAP7a1nI6H7fJxSsxpn0pokGux654Oa9ttcbUY7fZfl9/wBnaIq+CTnaCp2hlI3Mcc8GrXiPw/M3inXru1t9QLNock8DpNLs+2FmUbRnbu24+X9K+YP+E68QYI/trWMH/p+enr488QKABrGrYBz/AMfz0WHdHuzadq11pkEGg2Wsrpsn9nLPDffaIw9yHPnEZPmBNuNxXj0rYv8ATPGGkXHhayjjur+wtdQSWWa2nOCXdv3TbzvMca4ALcE8ntXzd/wnPiLOf7c1k/W+ekHjjxAAca1rHP8A0/PRZhdHsPxNiu4/h74k32+sRac+q2j2/wDae4OrEOJE+YnJBwSw+U5GBxXz3df69vw/lW1f+KtW1G3NvqOpajd25YN5U92zrkdDg1izuJJWYLtB7ZzTRLdz0X4CWGn6h4zuY9VtLW8hSyd0iuY1dS/mRgcHjOCa9103wrbaxG17pfw1hvLMTS26yw22nRo5ikaNiA8qt95GHIFeEfAaz+2+NJh5gj8qzaTnviSMY/Wvrn4f3GoW3wmS60q6htpItR1F3aTTZtQLJ9uuOFiidHLZI5Geh47iHFSlY64zdOipJdTzM/DO/t783Vt8NXmXO4W066YEzn1Ex4x2xUF9oehweJmsta8E2eiTm1jmaCW3tpEXezhWVoiwxmJxg4PtXe618Y5tJ0zwlPdnRYJ722F/qcctwBtg81IyIRv5k+Z22ndjynU881F8S2WT4mXsarvd9GsWjI5GRPecfjmlNWVysPWc6qUkrehy8HhHw1EZHfQ9HmUsWA+xxYPpjjgU0+GPCxiVjoejIScBWsY8k/TFXncKd0SHcwwT2HsaX7JHPDHIGPnRnMeGxg9/rXHd9We1yRtexkXvg3QJIkMWgae3mHZ+5s4xgc8nI45rifFXhTR9MvoZ/sdgsMQ+WEQqBIeeWOOV+tepQQyI0cs8shkCsPLyNuT6+tc74y0uTXIk063iQ+YA5Yr90A81pSqNSs3oZVaKcG7amBpOiaDf2TKul6ObiRAIAtvHmVvvELxyQO/pTBoOiecsq6RpyugH7prRCM9wRjmuwsdEsPDl/YNKmmQ2VpbtELq5f99K56hR0XHc89cVptommalsniljgdujwSh1kHbINOVRLroZwUftIztD0jwhqiG1l8N6Nb38XVfsMR3DsR8vIqPxN4L0Vo4VsdB0iGQPlytlEMr7fLisrUtLmg1S5t4ZEnlstvmeUfnQNypI68+1dp4ZvW1HSj9qIkMTeU5YcnjuPWs53j7yYckN0jz1dA0W3Cx3mh6YJGJUN9jjA4/CmS+HNDkYMNJ02LacEfZI9pH5V1+u+HZ77UILmK4P2NUZWiYZOccH161l3tpc6bHHJcKGhY7d2QcfUenvV83Nqnqaw5LWkitbeF/D7Ij/ANh6YVHB/wBEjOf0psnhjw9JJgaJpqHPGLSPH8qu2pAAljLfdyNp6D+oq7BI4haRwG5wCKzba6mjhHsZcfhTQYjibQtLy3AItIyM/lxUjeFtAaUo2g6SCPSzjHP5VqrPubbn73UHrTZGe2UOvY4J6/nTUmR7JLoYz+F9BOwNoWlKW5Ci0jzx74p8Ph/w2ZBDJoWjpKega0jy3uOOa243Vd7ZUcZAfnJ7EVj6hHFek7SVMbkqScFD3H0qld7hyx6IYPCfh8uHh0TTNjEAo1pGQT7HGR9K1Lbwj4YkMqSaFpQWRWQP9hjDRn1xt4qxZqbVY/OBkOPv46/hWm7SvDtHzbv4uM49z6UczIqUo20RHovgrw0lqtre+HtEkmRNjTHTovn7B/u1U1fwD4egtCzaBpI8vKyNFZxjBHIPTvWxpdykJi35wo+Usck56j6Vm+MvEctk5htrdbmUGOSaBlOHgZ9pYEdSDgflTjzN2RzOCi9jItPBmgSyxP8A2DpJicbsizjIx+VX7vwX4chUONA0dUUjc32CI4Xu2NvNdBFbDTmlgi8wpkERn5toxnr6VIJC8cqbg0bKQG74PSnd3NrRktkc14g8G+GLa9+z22g6MibQVc2kRLqejD5f0rodE8KeBisMl3onh/yvIHySaZArnnBc/L096ZHp15r9itxezBb+0fywzptVox06d80is2kw3C31t5s2wAMRvKHtgfkcVpvpcxcFKNupuReC/BV4ssVp4R0AFRvVzp0OT3xytS6t8NvCd3ZILbwx4ftgrBmKaZDuPfbkLVXwbqHlXksEkRkmuh5hklbGWHVeBW3e63mzaWJmbbJ5brGvLAHkDPXHNTqmYulaVkjitS8GeFLbVIJIvCmj/YpI+jWMJ+YHB/h6j0ry/wDaT8N6HpPgixutG0rTLR31GNDLaWyRllMcpxlQOMgcfT0r2vxJYW1ndtLbyu8d0vnLlyxQjGFA985rxr9pCcP8ONPjUBR/acTFR6+VNz7Vot0OpFeybSPFfDlu2qLpthpWlw3Gouwg3MiNveWXy0zv+Xq6AEkAfhmu+s/gN47jnRrjwjI8anlftloc/wDkYVF8JfEUPleD9CNrGlx/b9nIJ1jG51+1xnDN14x0+lfW/iLX9Z0fxnotmstlNpupXKweU2nzRtCpRiWN0ZDEX3LxHsDEHjpmoo3nzcytq16ruc1ZqHJZp6X/AOAfJM/wI+ITt+68HhB7Xtrz/wCRa8ujjjZVcxAx8Zwo719vfCj4ka14nv8ARY9bFksGq6fJcoY9MubLZMpU+XG8rstwNpZiUxjb718X/YRBpNldtNC3nqcRq3zLt4+YfqK1bUbIyipVG3Yg8mzjGSN7YyAEGAfenWVnFdXRV48RhWdzHHnaAMk4HaomHcA7TToJnhZjEzLuQo204yp4IPtRZ20Y7q6uh+oSpc+SgtrSJIV2L5MSjI65ZurH3NVfKiwMKpz1G0U/hcjqaQinFWVkTJ8zuxnlR/3F/Kjyox/yzQ/gKfXTaFrWiWfhy+stR0IXmoS58i8EuwxZHcd8H+dRUnKCvGLfpb9bDpwjJ2k7HLmKMHiNP++RTo4ody74129+B0pTzz0zSgmrJW53UGh6TN4b0h7GewjuJrzy5ZLuFdySEcI+Qf3fv69a5rxXpFvpnia/sLZ4bqOKTasscOxX9cL2Gcj8K0vBEtrJrNlaX8ENzBPMqOkxIUZ4Bznjr1q/8SdRtb7xre3+nkm1ikWCPc5cuI/lzk/SvNpOpTxPs2200306vT+vzPVq+zq0FNJLZfdv/mcM1uqsQ0YBHYrToIovMw8IcYPAHNW9TvHv7x55AMnjAGKdptxHCZVkjTdIMCUjLR+u369K9ByfLdrU85Rj7SyencdYXVvZyuos7W5iYYH2iBWPI657VRMcIZ96ID2AUdakk8tXPlhxz8u7r+NQyEbzyfxpxik2+4Sm7KL6Do4UCs/lpxwMoCKWCCFkJkCqoH8MYJP/ANb3pYSN2DnB7Vr6lfi/WxeTToLO0t4wm61TBkUHBYhjySevvUybTtYcIxa3M65SAyM09vFCXXfH5KAqfQY9OtKtpZz2m6BW+0Iu6RGQYPJztI9sdfekv5Fmuj+/MscaLHExj25UdAR2IqTT4iba5midlmhAOD0Kk44Prkih6RuNWc7WIrO0gdiTFuXP8IBIHrip59NjggtpmWBo58n5cZABwcjt/hTPMeA7ZFYRy4ZsjBIz2/H0rRgEt3O0VrcKxiDNB5zqq7QvK4P8RGMetTKTTv0LhCLVramVf29qsgNvGuw+oqp5MfPyJ+QrTvbPyHRFmSQMAyjBDcj0P4j8KoYxwwNXB3W5lVi1J3ViIRRg/cXn2qxdGCbYyW8SbVAIRQM+5pzWzCDzUG5APmx2qv8Ayqrp69iNYq3cRIo8/cT8Vq5cWMAto590CmSMMkSjcxOcHPoep57VBACZVXAO47eTgc+/b61r2llbssnnsWYKNvksODnGD64x+oqKkuXU0pQ500ipoUEZ1WLda2sqgMWS44TAU9f89awLxPLuXXAGMdOnSvYr34f31r4Ti11LVY7CdM+c0mSVPAGPc15Dq0flahMmANpA4+grHDYmniJOVN3tp9xrisPKhFJ9z0b9nfaPG14X6DT3/D95HX0n4I1XwLN4LtbDxN4j02xv7HU9RdU/tn7DcQlryfukiOMq3TPINfM3wBk8vxldtjP+gOP/ACJHX0AJnkY9RgfpW0p8sjWjh/b0Er2s2d7pOqfCjSbW7ttP8QeFoYLu2SznT+14mDwqGATmQ8fO5OOpYk5JzXF6tfaFfeO5Y/DV/aahp9po2n2sctrdi4EZWW6AUuGJLAFepzyCetMt4PMYEdcgZA5qZ5VtpQ5+d06JgYX3PvWc6vMrGlLBeympc1/kYxnmvvFWo6ZBby25iUkXToWimxjlvQ89vSr9ta6uj7LiyR0BwksTgA+2Otc9bJrtx4gkur7Vd9kpYRW6MVXBPGR0yK7HTI5kcGSdxxlo8ZJA9uxqKltjqi5wWug4aZqE0itK6xJ/dUfMPqx/oKr6rqumaDZXF9eealnEQrPjLzP2UVSuNX1BvEUsMM9mlrbnftOXkYEcAkcD6ZrP+JKzal4RP2I/vopllkReoA9M++MmpjDVJkynJxbOa8SaKPEWs3F/cXkKMY9wju32RRoFyFHp9MDJPJrjINMn1Oyt53vZUK/IpRdgVR04HQj1FaPjl7wzWE8yboZoljmQfdc8bufX0NatpDHa6dJEiHy0UBCx54HeupNxgkZcilN3WhZ8ITT65qUFrNK0Gu2MTRefIM/boB0UkfxA4IPpXdatfyWthCbWVQ0wHmOoGd3Tn8jXlNhb6kvjCyvrGZljO1Qu7BDAYxj+teo65aiDSy+C2ZVbAGAv4fiaxrJcyLo32ZHoWtSQSJDfOJImJCyO2WGa2tZtrK6KS3kAZIB5iurH5fU/1ry3xHoketQW8kV00LxNyB0IJ5/Guz0G+kgthbSNJNGqDYz5Le/Pes5RS96L1NZxd3poLNYpHvkt8/ZgokLJjawPHH+PSp9sSxBYmKnggjv706GwjsvONsZTp8zbkSPrbsfvFf8AZJ6isq4R9MLJO6yWmQFZAcrnv9P5Uvi6ijLuTzosaN5uWVDnch5qVWW4jZFkbaw4amLExRQrBo+oGeGHsafAREdz58tSAQ3VfcUGzehGsDEKmHkYElOcjPYVZjNpNEZvIUu+Fcjqp/8ArVYtZdgZgFJwcFTg/j/jUYljYHadqkksVwMk+vvTvchRdx5uAXRFUbByrKc7quozNEqKofb1I4zWIY/JlDHLIzDBHb1rYtXjMiEBuhOew9KNi2TRwbi6vnGM47g+taVjY2tzcQXskWbu3Ro4/m6qSCcjvyBiqz7S+0oSPVj3pkUrQTpcKSEU/Mvc+9CZjOLktC54liFzCk9ux3xgnknDL/8AW9KoabcK0BUKVKruTZ0Ixk1W0C31O18R63Hcwm50e4l+1W8uclC33kx6VY1S2ayuCsD7VYhomI4Hsau32TONja0G6Fnqb27yR7ZtojMmcbs8gds960Nd08z+fcu+14QRE8bYEj+jZrljH9stxuJDqdw9VPUGtC51VZNC8mWOaG8hIyqgtGP9sf8A16pbiqQalzRKWh3k0d2JGDByQQucM2Tzj3rvZdONx4fcWxaSedAd8pwVPfoMZxXH6bPBaiBY5EnmOMlFO52Y/KG9D+hrqbLUbl55YVVrYZ+UTrge4BpyMqib1Rcm8ORtFaSoGF3Cg2sWxkg5IPavnL9p23MXhaJwCFOqIGwfl3eXLyB2719J3OpuunzLEs0kyD/WKg5I9PWvmr9o2W8uPASXFwEeOTWYx5oGG3CGbgjtwRx7VVPcybmqUuY8j+Gd7BZ+MPCU15LDBbwavaSSzSsFWNFuFLMxPAAHJJ9K+z31P4Vvrg1Z/FGgtdi4F2FbXwYBPt2iXyfN8vfj+Lbn3r4ZgsgmiWV2J4yJXeMoM7kIPf8ADHT1otbhra4DrztNWpKzcTjcHdc2h9v+HLn4TeHZ7OXS/FGiq1lG0Vqtx4jNwlurDBEaSTMqZHHygccV8PlY002ylW5WSR1KvDtIMWOn1BHOR9K1odVtzcyPLb58xcEk5wfUVXmSJICysrs3OwnOR/Ss3Nt2asbqjGKbjK5mB8jH8Oc496UttbcpwemRUZPzVcW3uEs3uBA/2dv3ZkZMrnrgHsa0dkYRuyoo3HinBFaNShJkJOVC9B61HtGOau6TqE+l3yXVqYxMgYKZFDKMjB4PHeiV7abihZu0tin25/PtQPepmlLQorImBn5gBnnrk0xIyTzlQPvEjpTuHLroAOdqnpn05rYu9CMehW+rW1zHcWssjQsMFWjcYO0569eorLiQDDSglD6Dqa6O8sLyLR7O71NoktUJihjYgs3Gfug9qwqzcXGztr951Yelzxk2r6fd6mPFayR2huZYz5G/y9/o2M4pt5cLMLeGJBtjXbwPvHNQXLSY8s7kThtmf1PvUcL+XIGPOO1Xy395mbny+4vmXtQw0QMkXkTDjGMA+lUIJmgmjlQAvG4cBhkEj1rXj1ES3KtcKCNhABPGccZz29qxSdzE4xkk9MYohezTQV7XUov+kK8jSM0h+8x3E+9MJyaVjkcU2tUYN3eooyG4PStLQryaw1BLiCSON2DR+ZIgcLu4JweKziOBU9oyR3ERmQMgdWYHuAelTNKUWmVTfLJM0NX0ieyu4I7q4imnuV85vLbeVUngtjueuKXT9Ku5nuDbxm4jtV8x3QEqo9T6fjXZxeHR49vDN4f0iKxlluv3zrIxiXPAVM+w3HOPasrxBpF14MWWyuZZRfXEW5445MbMnID46EAZI5HNefDFqVqV/wB52/4Z/qeh9WUZObXub3ucqSWgeaWVGZnzg/fPXke1amhXclvrFrPpVq09ypbbGYllaTPGNmCPun8+ayrOCS6uY4I1Lu7hR9Sa7C/0T/hG72ZNP1YyNGyxPeQAoYmx86jvjnG7vW9epBXpvd30Iw9KpP34rRdSjqDDUbu8AjiUOyoz3IPmxS9wMHv0PYe1c/cQNFM6OIwVP97Ptj611ekXmkafcXbzL9qd4yIZpAQVbP3xz1pgmZY7iz0lY5ZryI21xhARICQUx/cYY6+vFY06rg7KOh0VaCqLmclzepztvdrHbSQMgw/OeuKzXGGIHTNWriDybkwS7o2RtjbxggjsR9arsMHAPtzXdFLddTzajk0k+giY3YPStvQrm2gvoI7kI8HmYfIySp68evpWF0JqSHmZBxkt0JxRUjzpoVKp7OSkj1qx8YCGxvrbWYptVsAgtobOScqLdh0dQPyxXi+sHOpTkeo/kK1JZ98jSAhWbqF9fWsbUDm7kOMZwcZz2Fc+EwkMPKUodTfGYp10k+h6N+z6obxpeAnH+gP+P7yOvoW4hNrY3F1JFIUiUuQoBZsdgO59BXzh8DZNUi8XXX9iJavdGxcFbliq7d6E8+vAr3+/tG1uzs015j5kX7ww2rbIt/0747E1pVXvXex0YOUvZcsRNI8X6ZdR2LLc21h57FGhupFMobJAGBwAeOabOk0tz5J8wEt0I/p1pjaLok0McT26zxlQMNABnZnBJAGDwaTT/Gcs2rtbTaWzIkgiil6byO69toHeocVLWJ0Rk4bmxZ2b2StLM0S5OIweWx3Jz05pZ5/OTbCxwSCxbkt7motQlklmBd845wBwo64quvm7X3IpQfcO7HGehrFu50Rh9qW40WyMxAIEeT06bqV0WRFBXcyk7T0HTFPdypgJwMkhwoJ7du1NeXy2PIOTyR2FJXLvzaMx7zQl2qbV0ZOhhmPA+jf41havafYEMmputsucZc5HT2rsvOLsFAUrjoBj86wvEWnPe2/7ksPnDsDhlYg4wVPBGM5ranU1tIxqU3a8S94a0KJDDfNKk0GwPDIhwv1rqbjzGt2eEIWCkrnoxxwPfPSuD8O7PE2l6poWqmWya0mDE2R8oSxnlfoPUD0FdfpE1tbaRY21u5EK/ul3HJyOMGs6qfNd9GYxlzHEWdvqk1gbq+sRau0jARqOw/i2+nX8q1tPjVYWkmd1LYVEA6jvXVyOEkRm5BYLkdqxtRljlu5AQBs4A6Ue0v0NYXfusY15LhY4HEUY4yucj8atG6gvIzDdrsY5Gex+tZZ3bgIOSODkAYFPjywO4j0bPIqS5U49Cm8UulTeU5Jt2b5e4Aq0t2jo0bYMX5kHt9atZjljMNwd0bY9yCPT0rJVUF69mu6KRRvUP/Gnqp6H8PxrRPmVyE+V2ZbtoDHny5PkxgDufx70+22lsbWEgOCPUetLDiJAPmIPBU/wmpHiwRuPykZVh1HvSua3RfNv51sUDLtcZ4P+cVYtEVdgLffXB3d6zrJpvM8tiPlHp96tWGKIgFnyuc89s0m+hLuhUUtuQhueMN3HsaFDJMGzuXHc1btoJHlWGPMkr8JgZyT2A9au+INIbToLKYXEc5nDFtgwAQQCAc8jJ600rq5KqK6i+o/Qni3CPn5TtIPX2/Kn63CrW7lXZXgB+YDkgf1qrp4SGRAzHPIzjjHfmjWNbsrDWdMsr5ZTNqYMMLquYy47N9Qf1qorU556SMHTNQjn1BpkmDxFgjKvBBx1rSvI5yVmtmzLbnKqQGBU+1Zd/Yw6bO62sRjtWBbYOXEgOCpPXI7fWrdlc3SwL5cTGRTyHGG2gZOPXitXvdGkWmrM1dLWyNjNeQG4vHmIaS2QELEwOclh7jPtmrmoX6SI82lvuvJEEtsr5CbwTuTceA2OnrVHRrmJ1kewKtbT5M8G3aTnrkVBHp+zktMxjbd5e7aHQ46HtnvSuupl7N3uWrPUbu4/s+O6jurcfNGZZPukt1BA4P1ryz9pqaBvh7YR71a5/tRPuZ27VilH0zytejSG3uCi2wuonhm3NGH3kA9cE9fbjpXmf7S9tMvgixnnkV/+JhFGgAxtAil446n1NaRtdGdeP7ts+frMH7EuRwQSMcc5xTz37c1ds0tl0K23O7zylwEVhhcE4J/wNU5FK4UjBxTUrtnnzhypMZ0NO3nPU0w0tWZ3HAAtycA1ObqY2ItPMbyN+8pk43Yxn8qgjjeRtqKzMewGTUsFs0kpikbynAJ+YfpUu3XoXHm6dSEAdzUhQFQQM460hjI68d6cyyIq5VgrjIJH3h7U7iSJIYHYjK/Ked1a+mXF5Zzw37WwuIoWyqyxeZHIf7rA9etZduCsZkdC0anbk9Af881rQ+Ims9MlsYwt3buGEaTZ2wlurqP73v6VhV5nolc66HJHWUrB44tbWz10f2egiSa3iuHiVwwikdcsuRxwe3asFZCJN7new6bjmo3dnYsx5PJpFGTgHn61pTh7OCi3eyOepU55uSVrl9Y2uw8kkitJjcxY4wKt6D4c1PXmnTSbN7mSGMzOVYKFRep5IzWmljpNnoQkniuX1GRTtGRtU+oPpiobzUtNW2A02W+t5Quzys5iwcbs9+ev1rn9tKV1TXztodywsIpSqyW17X1MqOVbWyu45YSbiUCNHIBC8/P9D0wR71nEfLVu4ea7YkKzrEuNwXt6mq7IygFlIB6Z710x033OKpq7LYioxTiKTAJqzAVCRTmPOTSDFKeRQUtjuPhvfaxbXN8NLMipNbtFJcRoS0AALAqR0PHTqe1YnifVH1K6hlaaaUrGsbGZgX3Dg5xwKx7W7uLNg9pPLCwIJMbkZx6+tWNUu21C+mu3REMhztVcKOOg+lciw6Vd1bLX7zr+s3oezudJ4M0i1vL6B57pTh0EcSkxPM5YKAjEYOCckegrpvi9ei48QXEqWculeTCImjY7xcncRuBHAyOn0rE8MsNHsrESvLPqFxcBk0+ZP3KKB8khxyW+Y4HHUV03jHwNr9jFfaoYXksJXSaSCTp+OW4IPb615VarBYtTqS7pX66rRdPw+Z6lKnbD2irPr/XX8zzO3WCe7gXa6R5w4HzYHr1Ge9b934f1Lw3qEF9DEs1ooWaKcgSRsM4BI6Yz/CasfD/ws3inW4Yg7IjSB5nRc+XHnBYfnivW9Y0Pw/ptrHb6HYS39rbyFZ98zKJMcAITwwHOfrTx+ZxoVVSWt91b9bq3z3DB4P2kfeWu6a8jwfxNMt5fTyFFFwxzLhVAZjyduOAB29qwzhowoILAZHauz+IGmRad4p1GC1T7PbSHzYxIAAoIBCkDOGzxj6VzWt6c2nXIhllVpcBpAMfIx6jjIxz1/lXp4WrCdOHL1V0edi6clOTa6mVjJqw8OIo3BVtxPAPTHqO1QjAJ61JKV/gNdbONbMarcuTjI5xjjFZt+ALuTaSRxjPXpWpEF3sGI4Gcmsq9x9qfacjjnGO1NbkS2Oq+F2uv4f1+5uY4xI0lq0WC23GXQ5/SvojTLqS40yC4kRohKA4AXlQR3HfmvC/gZbw3Hi+5FzCkyJZM4DLnB8yPB/Wvff3q71bD5BU7j0H88fSsazW1tT18vT9ne+hNZ251C3+zvLh5o2jaROACRjI9DUehadHo1o1lZ4niifb50h3M7fxn2HbA9KZoupW8eu6dZWsXN0WYsVK4CggkfiP61p3Ua2czW8IULEAFAPO085/MnmsZXWnc6W1KoQyLun3sT5foO1RXLKkeFXKE5yeDnP61JtBY5IYjj1//AF1Xml3kq2Cq8nvWZuPaUuGVcF2GBjiqzIpZUZlaRTuBBq1M6rBhQrHopPGPpWb8sblm2AhcLg9KaJSbL33SW2KQOSc8mqFw6sc5Gfr92q73MpvI7aFWdWQM8hbAVf8AGnLFl1EblS3VjyB7e9HLbcpNBMl0fDOox6XDvvnfYroADzjqfYGmanNL4Z8FRPqciy3US7RtP8R+7z3ra8PyM00yLuWPeQ24Y5wKyfHv2bUYjp0w46sM4/L3q0/eUXtucsk23Y09Bu01jw/YXMbNh0DnPqD0/Oq94THPL5ipuZt3POfSs/wm7abHFp9rGPsqkbQxOVz1Naup+Q07vC6yyohDRqeWxzx2zWbXvOxUHy/EUzLKrjO1lUfePY1MCxjG4qR3weprI0vV4tUSRUEsUkbbXimG1lNaIYOoUlVGc5xRJNaM2TUldD50UEsRxgHC9TSw3un3t7/ZV2yJc7fMiJ4K+u0/zFMc5AIYOfz4qnd6ZbX08E8qEXEB3xSocMpB45pxavqTOLa0NiKydQQ77nT5hnnIpHLFF2RHAJx7eoqzLcRw2lrcSP5KyH5R0GfT25qVYluELw/JIeW38/lTuYxk1uZ8bG3nyB+7x8uDkj2NWfP2OTE/zMc7eoqCfbbHzZZQsG7G9jwD6U2LEpzFgTLwQf6ev1o5TaMlLc27S7lUxyQs0UyDO5HIIPsa0tR1u91C3traaTekO4gsSXYk8kkk59B7VzUIlWTdFkxn0/gPpWhEp+8GBbvz3o2BwjdMt7tzImGCEjr1/OtRLWC6+yTXUCS3Fs3mQP3R8EdfcH9KradbGVyXBfb255Pp/npV/SSrJJFIQjBt65PQD/61NGFWSe3Qz9WtSb5J3YJHINsp7b/4T9O35Vh37PY7TIjybeF28nPXFegL5KxfZ5pFcNkASY5B7VyXje1ntdPS5sbdriGD5bmBj/rIz/dPqtaQfQzUrkmsXNskFrGY5BqAIdp7VcRhW7NmpBKfLZtxEqsBx0z6/jWLpFyGjlS1nkkiuol2SOMhsHIU+45q/bGQW873CFWQbjIR+QPtTaNqasi/F8qjeAQx446H1H+FeT/tLup8B2ahsk6nG30/dS16tayoQN+0buVIbrxz/wDrryn9pkK3gWwdQVP9pRqQf+uUtEPiRGJd6UrHz5p7lI0ZcZGfvDI/KtGK0e9MskIXKguy56D2rMsh+4T8f51dhkaEq6EhgcbhW0091ueRTa2lsQSKVYg001bvLlbh2cxKrn+70qp3pxempEkk9C5pd/Lp1yJoQrHBUq3Rgeop9pcBtRimchED898DvVEV0mrazp02kW9pZWASdUAeUjBz/WsqmklaN76eh00HeL5p2UdUu78h+o22jT/axZXrLHAAIWkXBmz147fj2rnpJpUyhfdgbRznaPb0pioCjMWAI6D1NOaMKiscENz15FOnT5FZu/qKrV9o+ZRS9CIsW6k9c0mKkChgAqHd7c5pu0k4A/CtDnaGgcHnkdKFBpxQhQxB2ngGrEZiWHDD58k5z2obHGN2S2SXV9IIYmd2xwue3erkOnx2Gr20esxStahg0yQsA7p32np+NZccrxEmM7SeMj0p8l3NL5XmOT5YwvsKzlGTem34m8Z0+X3rt/gddfajpureIRB4btLbw9p88X2ci5k3opPV2cjgnHUdKytQ0SWPQYdTe9t5P3725gDEyLj+P3U84NV/D6WbajC1zMsSq4YeZ90kHjJ549a9+8dWnhHSPgrN5M9jcapqTJLG1rIHzLu3HHcKOa8+tVeHqwpwW/f/ADe7/rY7IQjVpOVR+lvvu+yR81MuKRRzxU05GOAM+tW9HtY7i4kjmYKNp2FjgBvc16Up8qbZwRpuclFblDYfUfSkfA9K1LqO1hvJFV0eMcFhkg+4rJkxk4PHrRCXMFSHs9GEBImXbtznjd0/GrEiqojfLOjdyMcg8j06VUPH41qWd2gtYraS2SYJOZQwYq+NuMA9Md+nX2pybWqJp2ejLNlu+2rGbye3ilBMcnLHpx056qB7V2fhnx1rEon0vWHGrW0sbRiC6bAV+gYMOR261z+l6qlm11d21ssNzJOI47hl+SGMjjaOzA4O7NIt35OqJp90bO8gnGxZyAFHmfxbiOME856c15uIpRr3jOCdvv8Al/w56tBqlyyU+vy/P16aHQ6Jqmr6Uf8AiX2/lyqPNae3T2I5ZSQBnj6jNWvAkeveM9bjtZtSfT7OKVVku5sukLyPtVVGRud3IAGecZ4AJGZp+g3VjqXlW+vw2up+cB5cZPlsBwzb/u8ADA5zmuy1vx7c+FTbroyT20tu0dxIkEzQxzPuBAmUEb1IHOOoJzXNCVL26jyKXN1t+Ou/yZ11Y1/Yuak4OPmvzR5t47hbTNZ1fRp7mS8uLPUZo3uXG3zCrFS+3JwTgd+Olc8nlPpzp5LfaEkD+YH4KYwV24655zWh4j1288Va9f6tqjhr+8leeTDnaF7Im4kgAYAGTgAAdKzbMy290HQmOWL5sEcqR6g17HKkrR0PC55TacivMoV22gqueA3UU3OAOasOyvbsrAlg2Qx/XNVycoOuc1omZNJbD44zIRu3AN/FjOazNQbfduc5HAyRjoAKvpu5A6njrVC/GLtxjbjAI/CmtxSeh6P+z25TxpeEf8+D8Yzn95HX0Va6hKgDxsuw8DKZwfr1r5v+AYc+M7ny2VT9hfJb/fjr13X7DVL6/tns9SEECqPNAJBDZ6lR1+lYVI807Nnq4NL2N7X1O4ntZLu+0+eCCFfLLmaTbyOBgA+5rlvEGv29t4leGSVQYohBJ/sucEbvQHPXtXWaRfJDY+dLn5egBySOx/Gud8UeGLDWTNq1s4jubgKsrPyvy9Mis4tXtLY0d0/dCBphbSNOyqcjMajJAPbI/nU6W8n2lUcx8D0P+eKggh+z2kVtMVndIwjSkEFh69OntQBJG/lw8EjauTnFRK1zpjzMtSQjzCqszEYAI6VTmtVmLNIVXZgnPI2+1Sy/Iq73O4cZJ5J/Cs+9DxgHz9m4cOOf0pIeqRaMUdtFm2yTnJDN0P0PWuf1fXIIL4WnmsHVA25PXt+dawIktyTK6FgUBHb3xWbpHh61ufEf2pleWOJRIS/G9+nPvWkOVXcjGpzdDY0u4h0mxtYb+c/arqXfGgyWOT/nrWP45SSVp7iya7QnjzY7cyBT0P0+tdbcafDcXwvZ4VeeFNqHHIGakkjuHhcRbogwwHJ+774qPaJSuiOXTVnJeD9C1XRQ9xq9x58bDMfJJGeuc1R8bXltfaPcWzRzRgMsgMON3HoK3NF8L3OlRal9p1qW9a5TCCVjweuT71xGrX15puofZr3TZvKJ2pKASGHrkcVtBKc7pkOyjZnQeF9Y03WdNt45TNDdwARNLIvMpA6sR1NdR9iJQeWquDyGWuCuLK6urN4NNDJO+ArIvQ+tdr4SttQi0WManITdg7WYsOB2zWdWK+JM0hNx90R7UmU/KyHGOmKhnMVlbSXN1I0NtEpLsV4UetM1+5162uYI9D+xSryZTcTDcv4dh781NfSRLH5Wt6lDcWsymP7L5SjJIHU98H6VEY7NjdZvRFtY11rT/swljn0qZMo+3DjuuD6jrVSyt7rQYUimnMyhtqzsOWz0B9Ku6dqNlZWwhjhKRqMBVHCj6VLcyQ39oWQh48fMMdvcU+Zp26CUbPUbrwF/pV7ZwQhbkbdpkxhjwcjtmuf8MWt7GJ0uzvwcxjfnZ68/X1qxeaZcPH/xLbsxOBlIpDlCfQH0rCk1y40ydLXWFaxmkPBzujfHfI6VrBXTUSWlHW56Fa2MoQ/aWBljXlVPOe2Rn9auR6eyBUyn2iQZxu+XHbPqa5fTdUe2AkKqbg52uGDjOOCcVysHibU9OvzcmWV2V/3qOcrJ6/ShU3MTlKPU9j0i88rzrfARzlmk5yMDGBUdnep9peIksFyp+lYmm+J7a+0+a6htvLVxhMfXn6mpdKdpZWaYEytL5hz6Z6VHLbRjUb3bOruoLgFltyTlMKzcLkD17VyFpqniex1HUv7QtpGis4/PXywWicDqoPuOR3613CytFYB13kyOQpzwCB1qSwupbcFZXR3k6Rlcrg9c01JLRoxV+W6Oe0WfS/EUD3+jsm3jz7VsKY27ED0q4kW4kGNgqjJXsaybbw1NofjoXXh6FPsVwxWe3d9pUMcnb2K9MdxXU6vp1w2JbI75EPzIeMr/AJ71UrX0LhPWzMW3kjhklj3ReVIh3RuPu57rjnPSvKP2nImXwFYtn5TqcfHv5Uteu2jqsqqyGK5TOUYYL+30968m/aeUL8PNPBXa51SMkZz/AMspqqO6JrO0JHzlYqrQxhm2g5BJ+pq0itIREhB5z9ePeqtmT9lUAnBzkfjWjYCMA7mTzDzh8YGDkda1k7annU1zNJjr22W2gjePe0cnCl025PfFUMjPTFdj4v8AF2peI4At/cW7RqqoBFbpH8i9BwM8H3rjiMdKyw8pyheorP1v+iNMQoxlaGw4KCCTjHY0uVAPfPpVzRLa0u71YdQuDbRODiUDIU9ckDr9KjheGLzVWJZUY4Vm4YD19Aa05tbWIUNE+5Eqsy7gAAO5q9qGgavYaXbaneadcw6ddf6m4dMJJ9DU73WmnRoIIbSZNUSZna6aTKOn8KbOxHrTb25F7FCo1C5c+WWliuCQiuMnEeCRg9eg5NZuc7qysr9f+B/XkX7ONt9TNt55IGJjO0nvjmh5cHcjHeDnd71EfahWxWtluZczWhIgXevmHAPWpbhIV2lEwSMHLZqABmZf3bMT0IHX/GpY7e4lSV4oZHSHb5hC52ZOBn6nil5lJ6WsCQmRjsACj3pGRBxzn1zxUe/C45B703dn1NOzE2rEsSMzhVOSasyq9pMYblRlewbP6iqasw6Nj6UzPqc/Wla7GpKK03LF1Kj/AHE2c+uafp8zxTh/s4uUHLxtna3HfHNVP88VNb3MluxMTY3DkdjQ1pZCjL3rtkcjtv8Am64wc0RgNnPbke9PuJWuZmd9u9j2GBURBUkHtVLYlvW41xUkbJgFwcA84POKZnPGKI1znPQc02K+uhv20IvF8g3KS7VTaq9SvoAemB196tiziv4oYljuy0I8tXZQVcAnoO2K5+GZbeUZiinTJbDcHoQOR09cVpwa7JbwRx2ReEGFo5VbDDJJ4XuFrknTmneB6FGtStap/X9ep6lpltpVloyW93HIoeBnEsse9thwcKcYHQ8+1cRr50m1ikaG+W9kHCW00LDAIwCCepGP5daz3155QPNuZIkaIRuIGA3Lkbhg9Mjn61ntDPqD3TiVpRao0uJpAAYxjgerc9K4cNg5UpudST1/rt+R6GLx8KkFTpRX9f11KIuGjjkjjAG9lYnAJG05GDjg5qS2kae7eeeRzIcuWByznvyfx5qvLGF2MHUq44weRzjkdqV5GllbqST1HGRivWsmtDxFJp6iz4zjGAfmFQqEKsGLbsjGBxipGI2ZGNxOPwpkZASUFA5IwCf4eeo96a2IlqxoIVskZHp0rNvD/pD/AIfyrTYEEEqwB5BbqRWXd/8AHw/4fyqkZyPRvgCiv4wvRIu5f7PfjGf+WkdfQEEMU1sks3n7WBJiI2E+zd/yrwj9nNUfxrqAkGR/Zr98f8tYq+iXBX5lKs3p7VzV5WkevgVekZ+lCWK+vJbm1tkSRFG6JznjoMHjAFWftMEELpaxERkElW53H61VW3eK5dt7bZ8deQCO1WI4yox8mzjkjrWUnqdXs0U5njypjP7pgOD96Insfaq8shTBG4Rp0Ld/oa0vKVJzITtkGRnbkEe/rUcelGeQ/Z5Sik8pjcM/0FGjGpOG+xjtMqIX2l26Yxmq0syzbWZDtXgjHFTfYfEw1eWEWWnJpyPzI8mWZfUY5zS6hYeIbi78nTYbC1tlORc3LCRsD/YX+tVy+aBV47pDbWxe8kcKAAD905+Udq39OtBZBYY2wGOWJHf1NTadbNFYxLNP9ouAMMYxsQnux/wqvq1zHbLkOC7HLjrkegHp6ms3duyIdRzH6pqVnplsZb2eG2iBzud8b/f/AOtVC9162RkWJ0kkkAZfm4wehxXJ+JdFl8RzWly9wgigcvKhBYg9senHanf2TBHqj3glleQjChjkKPYVapwS1eooxlJ7aGh9qe4kZmkLsTwQcAVKkh5wZGc9ArcVLbWQlYdQM+nWqY1uwtfECaP5dwb1uBJ5eUX8T/OiKvsaTnGGjLkz6lEqtYsr93jcnpjmqU013NDIJL3ZO38MIwkY9vU+9W7qSRmaLzcpnJI7/wD1qh8pQCBwM5AoT0JVO7vIy7DS4bS5e4jZ2mk6u5zmtMWcV24E8auqc4x3pXjwwGBn+lXrZQBhV6jGamUm9Wa8qirJELxKFBOOBkY71mx2t7Za62oWd6BE8Wx4GUnnsQelaU0rMSFxgnHFEa5XD4yT1NCbQ2uZWZQgv5bucGcGJskOkZ2qT647VFpGpaNrl6NO1K0Mk0UhAW4T7pHT6/WptXgdNtxbgEZHmr6D1FNt41+1GRvL8xRgS45+metapq1zCUL6I3Lzw7p0W57eFIpM7sIMdO2R/Wp207TZo4vPMJlPRWABbHb3qxYyyTRRh1BABBJ6j/PpUlzoFte3NvcTRqLi2+aKRsggkYxx3qE3s2S2kJbaY8bERW67V+6Ix8oHtXQ6Jos+9jIC0jNlhu4x7ntWfo1pPC4DFkZFKquevvXbaPCVfcW+bBBU5GDQ2zGrVstCw9iZYo4WmjREO/AHc9azLrT74ShLZFwwOZN2SPTArckuAI2WIgSdMnjFT27l4UcsjDkHHA+tJHPGpKKM+1sJGtrSSeRRIqbJd4Balg1G1N3cWHnxtdQtiRM/MBgcj16jpWpvCp5ixqx6+9YWp+C9I1vUItWlE0N4uCZIJCgb6j9K0ik9yeb+YvXVnDKEju4N+T8syD5h714b+1vpX2H4fadKswljOqRJk/e/1M3X8q+iFtUVFXblVGOvXjrmvCf2xoFi+GOmspz/AMTmIcnJ/wBRPWkFqZzqvlaufJlpn7Mn4/zqZGUNkqCOmDVe04t0P1/nUvGc9a2MEydczShIx8xPC5qOQFWKk8+1MBGR6Z5rcu5bKC2uLOSFLqdWRYZ1OPKTqenDZzznpiok3F2tc0jHmTd7FbWtSg1GSCSCwisWWMJKsTEozf3lU/d+ldB/aXhC502BZdEltb4skMrW8jMnljG6YBj/AKw8jHTnNck0fUjGD2z0qPoeOtZzoRkkk2rdm/6fzHGrKLbaTv3R3Z8WSTeF5fD8VhpqaWm5YZWgDXKZfIcv/exxkVxksDK5ZN5j37fMx1/+vUcUzIysmMqc8jNE9zLOxaWRm3HJHQZ+nSlSoKi3yK19X6l1KyqJc26NGfSzFbrNI2xXGVXqaoxxoAXcbkHYHBHNXLbWriJFR1SZVGFEgyMe9R2upT29hc6fhGsbiRJZImUZDL0Kt1U4JHHY1S9prf8ApDm6N049vxJrKWOSOXy5mtrqMMYJSxwUwQY8DgEg9fwrqfDGryaFo+pw6hp0E02q2y/Y5PLQ+WjZVpd3bG3AHrkkVyixXyaLJd28ix2LT+S0ayDfuK5+7124HJqvNdpJY29vFbxxGNWEkozulJOct244AFROkqt47q/5DjVdOzejt9/9dyqxzyOAffNMyRxT5ZAx+UbRjGKj610I5Zb6C5pOtJQKoQ7NJ3oJ7UUCHKcGrEUL3EkcUalppGCoB/ETwBVYda6bwNrFpoWvWmp31oL1baQSCBjgORnv+v4VlVlKMHKKu+xtRipOzdkRax4S1PStJXUbhImtTM1uxRwdki9Ub0Pp6isAjB4r1n4weNNF8Xw6fNo8bwJDIy/YsbByMmQqOAc/LkcnBrzA26zRzywuAsShnErBS2Tj5R3xXPg6tSpS5qys/wDgm2JpQjL93t63KYA3AkEqDzzj9aeQVfGQSDjKnIqMdM4zxxVi2i80Pt2kgD5WcLnPp612PQ5Yq+gqfupgJYwSG+YM2BVl7yRZ0aWFTCvIhZsgZPPPX8etGoiGMQqoDyGIbmD7gWPr6cZGO1VxPGVCtBkBNo2nknPUms/iV7Gyfs3ZMl1WSzkv5G0uOWO1IUKJ23NnaM5/HOPwqGaMYjkjCqjDlVfcVPTn0z1pbl0wgimMvG7dgrj/AGceo9arDpnNVFWS8jOUtX5jpGJYjI/CrFs9sLS7WdH88qDC6HnOeVPbaQc+vFUyeaWPBOGyVHJx1xTauSpWdybzN0IVgCEBC44wc5yfX8aybv8A4+H/AA/lXQRJZiwuizk3eVMXYBf4gfXqMVz93xcP+H8qIu7YTi0lc9P/AGcWUeOrxHJAfT5Fz6HzIz/SvoknAKlcg+tfMvwRknh8TX0tq6LIliWw5xuHmxZAPr/hX0sC00KsGx0z659K5661uergH+7AAFCHXG04K5/WoZJGg3iSJ3iY/eQZI9yv+FWCihge49TULsBwPlx2JrA7rFRruKQL5Tkg/wCy2T+GKsW1zcxSLFaAM0ikmQ/djHqae0ogjeYDhOR3waz55TFpojLEPcHzH7bR2FUknqZzbfukWp6rLFlUkO3HD46+pP8AhXOagl9rUo8m8eGQsC7xsQXA7ccCrTo092wzuY8YH3WPYY9a3sWHh7S/tOp3Mdup++7HljjhVHc+1aJ8u25MoxS1LOo3Mttp+Y2ZRGqxBjzgAcmvPDFrmpaxe3HnExnclsqnIHoxNd3JJFqkFrcR/algmG6NYn27x/eb/Cr5eOEDCqFAwx9APf1qIz5E9NSLJo43QtHvtF0i/hZhdaxdBTHCH9Op5/nV+1ZrKwW61aBYJ2/5d0JJz6Z9PesjXPEF3aa+tvpllGsNwUMl28gZnycbVx0A9KTxNLqYlSKNReg8mZhtEftgVpKLk7y6ihK2iK+o+LNQt7yFLG3bDnLKo7dhnua6iWUyBJWRTIF5OwZBPbNcdpWqwnUrlGG22txl52GMHv8AhW9ouqw6zYTT225SrFWQnkeh/GlVjZaIqnyue5cSNTId2cjniiTCnJOcccjmpIYzIwLMVxzxU8kQaMn5d3Bz61gdLfcpsuQGHTuamUEQc5H1pApLYbAX0FOU4Qow3Kf0ouHkRBRwQg68CnHcHORx1qSFSH9z1FEic4C8+tVcCv1l287WXBHrVJoPIeRAR8oycj+H1rVWPnLce54FZAa+TWbxbu3DWbGIWsg6kEYZfqCM81cNSaklGxuaE4mmubaaXKS7WVgPunHOP05rttJEN1bvtjMksZKiSQfdwOvv0riNMtZobgSIwZQSN3GRx3H+HrXe6XMLnTEdVKOp2eX3B7896Ujkr2vdGrpkCxQ7yoEznlyPmx/nvWpbzA4WH53ZuT1/HNV4QTCY9wV9u1QOucVPZRpAsaEsXYc+9QcjJLizZoyyiJXPUgZqWGT/AEZUnypj43gcN9KlaULEGTDEHJHtUYmRoiJ0KoT8oI5A9TVInViw5UsIGKqBjcefx+tT25IgbZIGAGA/QfWo4zJPEp3koQR8vp060+ALGM+WGVRgL/jVoTJLQMiqxYZGTk5NeG/ti3CzfC/TcLhhrMXXqf3M9e3R+akRkiHmI5Hy9MDPQGvEv2xkVfhdpp2KrnWYunp5E/etYbmdTZs+V7HTbgaZDdyQSC1kyFlx8pwSP6H8qrkYYgdqv6CL28sUsrSSTY5w0Yzg/McZ/E/41e8SeG9U8M3UNrrFt9nmmjEqKSD8pJHb3BoVVKfJJq72XkN0rwUop2/UwDwa2vC1xp1vqW7VdMOqI6GOK3ExiHmHgMSOw9KydhL9M/SkxhxuHHoaucVOLi/8jOEnCXMXNWijt7+SOOOSIocMkjhmVu4JHFNsLCbUHkW32l0XeQTjI9vyqqilyEQc9AK9V8PeD7zTvBMmswR3Q1d3D2n2RTIxypwrDoo6k9+lc2KxMcNBcz1bsrnTh6DxE22vdW9v6+48s2shwRTG613EPhN7/S79vt9o2qWkazrEGCiRCTvG4nGQe3r0rkLuARqjq+5SOuO9a0sRCq2ovVEVsNOl8SKqjFP5qy7IbBV8tPMDZ3jqfrVUEY5rZO5g0o2VyVuACrFZOQe3FQGpUXzJFUZyxxTJUaORlcEMpwQaFvYHqrjO1FL2pOKogTml6UUlAC0UlLQAoqSI5YKAWyQNq9T7VHTlLIQ6kqwIIIPII71LKRautyXriWD7OynaYXUptx2IPIpksX+tZPmRD1Cnp65/xp81zc6hePcXU7T3U7HzZp2yWb1YnrTDe3CxzqszJHPgSopwr46ZFQk7LuaXjq2QRqGDZYAgZ5704JtWKRtm0kgYPIx6iogQMEU7dkngc1pYzTSJpQjwxbGG5idy4Awe31qTSrC51C/W2tnihcgkyTSCNEUdSzHoKZZ2Vzeic2kLzCCMzy7cfIg6sfamR3DRqAu04zjcA3X61Lu01F6lK105bEupyl51jaO2VoB5Re3HEuCfmPqff0xVRmOaQt6U0nNUlZWIk7u4Uq9aTNOBpisWk81ISwU7Cu0nAPB5/pWNd/8AHw/4fyrr9Pu5J/DWoWE1xOkSlbmJFwUkZTja3GR1JBz9a5K9/wCPl8e38qzpybbTRpUjaKa6npn7OrRp41v2lVWA06TAbGM+ZHX0NawSrcO/yhXx8qn7px0x/Wvnr9nMZ8bXwzgf2c/X/rrFX0RdzrbQrn5mLBW57/1rGt8dj08F/BuPuYzErFVbJ4FVwcKxlYBR1YjgVU8aXOqW1tGmmTRxXEj5LkAlkx2B7jgZqLSka60y5fUJbeaXbyjKUUtj5QSe2cVChpc6lVdthutazpllpzXV5dwpbhgFVTlpG9APSsPTdRg8Rq81mHlUvtC4xgf0HSqV18O7vVpbK68Q3aRRpDtmjtsKM5OMHpgjHQZratjbaVbraabGsFrEuyNQMMfcnqSfU1o1FKyd2ZQlOUr20FltVt76Kd71lWNSptol++3qWPIH5U+K603XLuKDU7KGeezy8YwWK56+2elULSaa4ZmVAjk4JJzxnrUA1K307xPY2sUDy3F5LmQRqflTn5j+VK1/Uqdkrs6LxRf3lhp0Ueg2JkupG8lCo+WEY6kdv5VxGoeItR027sNPjukudmDO7r5jysW54/hUdAe9eg3+mvcRM9tK6l12jbyB9RWdbaKbF4prm2hkdV5YKA2fUmphOKjZolxvqmZut6IL6Wyv7RY43TiVQuNwySf8KNRUAln6gADB7jt9a17y+vt+xICEm+VDj7g9TSTS2MMgtLgJdTEjMYXoT6+lLmelylaJw/hzVJp7i9+1WMUEaOAAU+8c9Dnqa6XTtAtdPnkvbMY+1AbgG+Ud+KydR1yabxJPpOlaPYPHbffmnyvPfGKaniuK21BofNhIBKuqIQB7e9aSUpbERkup0hURORI+PbHWlR45GI+UDHBIrM0vUrXWZC9qTkHHlyKV/I1qQwSbn3RnjtuHy/U1zuNtzoU00EIRJduWI7nHApzqqjgDk8KKx9Zv76C0luLWKGKCLmSSck8A9VA/rWh4fvItW09biG5guGBw7QjCg+lNxaVxqScrF2JSFBPJxQ5WSUA/pVhlZjgJtI+X1qrcXNnpnlpdSp9olOFjzlif6Cklcd0tWYnjbQ7jWIbK2gufIhEu6bk8rjH4mtaJHitwJHyigKvP8PQU+VjK+7IZhjJI4A9qWWN3j3AfKODV3dlEUYK/MVnZTIFRmUjDbl7Y7H1Fdf4TlEkgjblZFDAZ6EHk/wAq5fYnlY25OcZc81ueGXKXcCpt3bsZI/A0rk143hc7sDyzGwYjc+Tt61IJBHKonJ2EfIwXg1YgCuohYKxUhgx7U6zWGZXSbDeWRx1x6Y9Kk8u45cSxb4Wwg6H3qR5ITASxVj/dWopPLdikW0BD0x0J6Emi3tYTKxQuOCGyMDPr71SC3Vlm2uShEaW4Ee3PULg0z5ZggtHYB2IIUY3evNPuEt2tiEchh8pz1xTUkhV4xAzYHygnqKsSV9UXLaA26sHYsc5KjoPp7V4Z+2TJn4a6XHjLDV4izZ/6YzYH869c1fxJo2i31hBq18ILm8mEUCkn5m9D7fpXjn7YQZvhzp0m3bH/AGtEqg9W/czc1rDdGU07Ns84+C3g/T7bw2vjLxVdRx6IqyIImJw4DlTnHuOneuT+J3ix/GPiWa9t4ymnwKLe1XbjbEPu59z1rn9E1maLSY7O4knnsgkgW3DDarHOGAORkE/WqSXDRxmP+A4LL2JHqK4aOBmsTPE1pcz2j2Uf8+7OidePso04aK2vqRjcjAjKnsaa7M7kuST71PG6sm1yCvUe1RPggYAHqK9K92cbWmjOm+GN1pdl440y415PMsUkGV2bxuPAJHoOv4V9T634l0GHQLq9a9tmsrLa0qQlSsgOQoGMZ5HGOuK+LlYq4ZeoOasGffB5W+RIgciPOVz9K8XM8lhmFWNSU2rdP66nXhsWqMLW16Gjr2pvf67eXZhitkuZPM8mHIQDqMA9M9ayJn3HAJK5yMmldkVcIuWBzuJ6/hRPO88m+YhmxjgAfyr2YQUEopaI5qlRzu29f8xmcjpzTcHPNTKjFSQDj1p6RRtbM2/96DwuO3rVXsQotkUEhjkDAZI5GauQq91Izvy7dSao9GrV028gt4XSVfmIyre/p+NRUuldLU0o2k+WTsireWbQjJxj2NUiMnNW5rgFWC5wxzz2qGOJ5GXAwG7npVRulqTNJy90ixTo42kYKgLMegHU0+aJomAcdeQR0I9RW94N1CDStRF5LHbSGMZVZ84DdiMdxU1ajhByirsdGmp1FCTsjFvrC6sJRHeQSQSFQ211wcHvVccVv+MvEF54k1T7XfuJJFUIrAdQKwQKKMpuCdRWfUK0YRm403dADzk8ilPJJ/SgCgVoZgBznqKickk1KTiomGDQhMQGlz6U3mkpkkiuVJ2krkYODjI9KQ03oKM0WHcXNFJS0CACiiigZMszFFjZ22LnaueBms28z9pfPt/Kry8GqV6MXL8g9DwfYUIG7o9O/ZwCnxxehuR/Z0nGf+mkVe4XejPqPivTbyW4nENpC7mHHyA+p98fyr52+DOpS6Z4slaCBp5J7YwBFzk5kQ8Y+lfUF1JbPotxbQ3qS3bJ5Uxs3VzE3dM9AfrXPUTjPm7nqYRp0eXzORAvI11O71fUGuVd9yoPuQxj7qjvnpWx4evLC4WR3kWVkQM1sw9ehYdqy9I8N2mh+dKhlmuZl5knbfjv937v86vaa1sr+TEiLHJ8xWKMAnOOnGT+JpSs9jsSko2saGr3ct9HBgrHEg5ReAW7VkvBsZQVV5ieq8/p6Vr/AG3+z9Ra1lgbyiBgyIDuNaV1i306We2Fpa4iZxK0e4KcdduecVntsHNydNDkLPSdSgE93eI3korERwLukYeir1J9quaZc6teaIbvT9INlLv8qP7ZIC+zu7YHB/2ay/BrG603ULvQ9Vl1jU5JP3rXSGFWJ9Aeijn0zW/aNqOn2k8ut6latqEx/dW68RQAdAAPzJq56adTFScjTskmsrFDf3kc1xnJbaEUD6en1rPubm9tLtru4uLBNFAy8jfw/j3qh4fvr7V7S9tPFdnbIoJSOWCQYcHuOcg+9UmTTfCxXQ7q5m1OC9yIrd4y/BPUk/0qFHXXcbeh0qNa6rbR3VrMkkLD5XibIPtWBpfhfSrHUbq+sleSZiQ0nnl8E9eK0G8M2GnaLeQaWH057gZ8zeSR/h6cUzwzo1voOlQpbBvm+aVslgzepzU3snZjte10ZV7pkkUkqLEAD8zNtwX+p71RbTUlJ/0ZSx6nYMn8a7bXZtSj03Oj2kEt3kBRK+FVe7YPU+1QWwdLWM37Wsd2wDNtHyq3tQpO1zWNTpYw9M0iRQYxEWXuAK6b9zYadLPqjhLeJdxLDJwP51C+oyWssSpY3EkZI3SR9F+oqh4l1XQIZBbarczB5BlVeNsAe+O1Sk5Gc5XKH/CQ+F79BCl/bQLI+wJNlAxPseCKurop0b/jz8iFWJIVEAUtjvj3xXnWs/Cy4u9RFzotykthcEOGJ5iU85HqPpXs9uptktrOLMiwxKjO3VsADJ960nyxScXe5EJTv7yPL1vfHNvNAlzbxzzzz/L8oKxovXJHQEd/St+HQrNdRuLpQzyzOX/ec4JOcDPUeldZri4t3VztZhgt6j6VkQFlhVx8xxz3/Kh1L7KxtSp6cz1I4oVLbVB3L1J/lV1wz8KQi9cDuKRN28SRdP4lNXkWVoAPKCjkkeh9fpWZtJme0RYbVj2gdSWGfyqxoq41GExryGz9TTJGZBhAGbJyQvXPpU/h4BdURwd4VBjHAA3DJ+tMU7+zZ6IESF3kkdtjEYXHT2FOhRSXYD72SAen41NLCk0bRy7s5z8vQHrS2gk+yuSAMn5S/OfwoPIuOj2xJz5SjP3QacQzzKSCkY/unr7EVVihjDYihlYhtwbbw3tmrquXkZpY2VlHCdz7ZBqkDI7tniUraAkMOGbkoPasmJXDZLE8nBXkkVv27TPuBQgE8KOlMlSSOU5gUZOQq/qSadrl06nJoed+IfhvH4r8W6ffaxPKLW35EEbYLHsc9q5T9sKOOH4Y6VDEMImrQqvfAEM/X3r3K3hlhZu4b73cYrw79sNV/wCFYaayrjOsRDk5/wCWE9bQbbSZjXnzXZ8m2ZxAmPf+dTEj8fWoLX/j2T8f51r+HdLfW9as9MhdUmupBGjMcAMemTWspKCcpbI5oRc2orqZ69KGPGK7D4keDJPBF9Y2V1cxSXdxCZXjQ7vLGcA59+TXIlRtODzmsqFeFeCqU3dPYudNwlyvoRfSlz69KUZppzWxmJT0xkZGRSKelKud4oYy/wDaprZilq5EJOQKgLbmLOi5PoMUPICmOd1Qk5qFFGkpPa41j81avh20tb2/WDUtSXS7GQYluGjMmB1Hyjk8is1V74zjkj2rZ/s+2uoDLBuRTyPmDbRnnjqPY9/apqysrXt5lUabk7rXyO3s/hQ+p2M9/peqW0+m7Fe3uidgkzn5WXJKMDgEHpmvOL20uLG4eKYMpVioIyA2DgkHuPevXvCXjDRNBs9IFgtxbqsix3duOYyxbJkOeTxj8RXe/FfTfDfjDwDqXiG0WYX9lueN15aU5GcKeinOeK8CjmOIoV/Z4lNwbsm1brbXpfr+XY9TEYOm6alT362/I+ZBBLPHb+XGcO3lqxPVv6V1HgjRdGu7u7XW7oRCIbVXft3H1z2FctHDMYGmjPyxtggHkH1qsST1r3KtOVWLhGXL5rdHn0qkaU1OcObyezLWqiBNRuEtG3W6uRG2c5GfWqmeaG6UlbRVlY5pS5pNjqDjHvRRVCGnr6VEx5NPkOOlRmhIlhmjNIM0tMQGiiimAA0tJQKTAWigdaCeaBjlIHWqN4QblyOnH8quA1Ruf9e34fyoQmem/s6RST/EB4YZREZLNwW8vf8AKHQkf7PA6/4177Db2Nhdz2ljBHaQhiFUDYGbux9z614R+zW9+nxAuDpgtixsXEpnJAEfmxZK4/izj9a+qrmBZiDcwwvu4/eqP51z1pWdj08HLljdnmGsvKmqSi4nMds5GSGGMfTuTTLu11eGzSTQdMNxNMAkZPyrGDwC3sOteoW2kWgfdHZWgfrvwrflU9wJIgWjiQnqCqg1kquySOydS+iPOTZ6t/aVxca9YxJaJsjtcPuaRsDc5I5xnPWqvjTVr6DSruTTHtYVEaxxea4VoznkhjwTjoK7s3GoMpE9mcHhirDke4rFu7ARPEqaVaXNqX3FZz86MOhXPFOMru7RP2bM8+TxDq+g6RbtqU9jdalIQ6xCMK4TnJJGNx6Vv2lw2oW8GpweZ5M3zyEdV7AfXPerviPRZ7jVY763s9HnmXGyW7Vy8f1PTimajqGnRzW1jc3cQ1CTClrRTsBP94elaSaktFqFN8j12JIpzLIkVxp5VCuYzjd8vqx7H2p9xFc2rK8FzkL0SVQyr9O4qe0lmiuJIliV7dB8skbBl+nHQ1narfTf8utrLKrnbvxkD1P/AOusUneyOn3Wrs0LHU5722G8CV0bYUC5JP19PrW1bW7MVeVWSLGAnoPf3rlPDeuaHHcNbRXQFyvEg5HfHXvzUniNvEd9eSy6FcrDpyQ/usAbpZG46npjrRKnrZ6GDl2NfU9QxuSPZH5hOWJ5OOK4hL+21O7MMN5FcEnAXJ7dSKbaQX2lwvFqtw13cOCThtwVR94Z9+azPAMdjJLcXlrBOJA5VfNIIUH6DrWigoRbCOslHudZBvhfzLVWiYff8ts5qnrWt6Ve6lp2l+ItOhupbkkRuCd6AnAJPXBroLe1CKswRgWGAu3p71HdafarJFNJDCbkcRyOoJX6HtWMZ23OmpSjJWWhuaQbC2s0t7OI28UY2LEASuPYmnarcCx065uY7eaZosHbERu+v0FZ1qzWM8EhXzGUgkeoPr/Q1u6jd6aII7t7gW/mnCk8DPoSOB361O+tjnnHkduhjxzG60izl8uVo5UMgaQcnmqioySKYsbjwy+v19DW3rZlPh+WfTIhcTwjekYz82D2H0/OsHSr9dT02G4KKJHJDDPQj+VNaptG1KX2TUihDMm0YB+8T60+eGYlsDBZcZ3cUiMV2ja7Adh/FxRPPswqk4wMc8/j70kU07mLrepRaU9tBcyHddN5cQUZYnufpXR+F7dpLvzcEkYQjHvn/D86xry2hu7cLeQJNJGS0Qfqp9Qeorq/BEEqQWsVy2blIQ0r9mYnJ/wq9LabmdeTjBo7Bzho7cMxflmJGP1qwIzHJlixzwqsMD8KQFWDGUEBeQx6Y9qcpVyVLK3HHcmmjyBH3Moj8xg2eSOBipVtmBXK7iOck804RtHaOxcR4+7uGfzqNZriYJhCGP3l7fnVWFe+xYceWVDEE87cVE0ZnhCplXBGMsemakEHysrvnJ7Dp9KsRW4Q4DdRz61aVyXJRIyjkMgcZxxz1rwb9sfzP+FXab5pJP8AbMOBjp+4nr3yNR5pXGOM8HrXhP7Z7E/C/SwANv8AbEXf/phPWkVqZTelj5Dsxm3T8ev1qVWZGDIxVgcgg8im2UebRXP3ckfrTvc1oTqrGxreuXWuLDJqVxNNdQrsUu2RtwB36dKyo2y/P05pgNAOTUQhGC5YqyKlUlOXNLceRhyOMCmNjtSkkdqjBNWiWO/hzS5z35pGB4o3HaV455oEG4kdaVRgZzU7WskMhiuYpIZcA7ZFKnB6cGq7AoSD1HWjfYbTW447uCMgEda1NPIuUKJPBZtFHyXbasmMknP97oAO9VtJ0++1e7W0021mu7kqWEUK7mwBknFVpUZWKOrI46qwxUStL3b6mkJOHvdP66lw3MpmRYAcYUBDz06Y/OvfvhvrVha+DtQnuE+0yW0YlljnlAYy4O7b3yfmwDxxXz0oa2dWBBIwc46H6/1rqzqptiNSuY5Et5oxDFFCw5IT+InrjOeeea8zM8IsTBQ87/8AAPSwFfk5ud7/AILuck0p3SGPKq5Jx7e9RYqxcrEI0eJhk9VH8NQd69VW6HlyvezGk5paQ4zRzTIFpaBzSSHHHakPoROcmmU4mm1SIFooopgFFFFABQB0p4gmNuZxDKYAwQyhDsDHoM9M+1E0MtvK0dxFJFIuMpIpVhn2PNADKU9KOB1I/OlBzjFIBuKpXP8Ar2/D+VXjVG5/17fh/KhAz1T9m2WSLxtqRhxvOmSKCW24/exc5r2rw9rM0us6hpOb6drcb5Lm5XEec/dXP8+9eJ/s3hT43v8Adn/kGyYx/wBdYq+kNhlCuMtyOAOBXNVlaTR6+CinST8wRpFYMWJ9x/DWlDfPAu0sSB/e+Yf41kW7yfaLhnCCCPCA4OSx6/XtVS+ub8yfZLVVVirFmJG7aOCR6day5WzslGL6Gpe+JLPShCdRndbeSTb5uwsiemXHCj61txSWupW7SWzrKuOdhByK5wBLTTzDJmfgJgru8wnHboB602za30hUeHybKOMY2RnCYIJPy9h3o5UzGULao1LnS0cN5LvGCOUPI/EVgjQYY9QS5+xRyyRghXhXJB919K2NP1BdTjt77TLqJrNwQ4xuDf7SnqCO4NaCyW7MBlo3BA3Dgn3+lK8ogndHM+FNBsdB+2hbpg08vmBJM/IfcY6+9VfGmtjw9YC4OnyXpmk8tXgxtBI4LY6V213BBdRgyAFl6ODyK5zUbIpbPGk4gviSYZSuUfuAR601NN3ZK8jzzWLJbOzN9a6R9n1O8i8xgx3Mp7gDse9avw+l1O3sx9vldmd8hH52r/8AX9K0Ba6vczS22tWpjmQ+ZFdRndE49Ae1cT4vs9Zm1u0t7FblIw6+X5Ybk5HzHHXFbr31ys091Rudnremi3u1liG9GO5COv0/CqFlamLUCYHhitOFESqQd3c8d61Ghl0G0vH1q4WS2LebuAJ8vjnHvnrVXw1JZa9pr392TaQLMYYZPPA809vx54qLaPqNTta5oEvh9rHaoJHcH696q2t/dABWgDxv/Gp4H4dRWpa6ZBFdNAt9dK4GTvww69uOatalo8cUJaTa0afMxSM5P4LziseXobqvDqUH3bCoMRcKSUDZI9Oa4PT/AB00/iE6XFaJClw3k+Yz5IboD6cnFejT2q6jZIYELqT8rRk5BHr6Y9647XfDMHhaS01OOwjnvpZ8B5G3LH6fL3bv6CtqKjs9zCvNu3KzrvhjqV7qGn3EOtWs9rfWj7H86MjzPQ/WtzVNKiI821SKNXfc6quNzdya45/GmreXfQyQPHq2lp9pkUx7o54MjIHoSCCMeldd4f1iPxB4egu0ga2a4XIikbO05/8ArdaicGnzWsjKM2ne42K5VYnhX5XJ64/SqrxRKA8rfMegUU+Z57K5kF2gVf4XBGD68niq89z5rKiAncOAB1rOx1x97VDoUa5uI/MKpyAAOcjp1rq/D0LefOIyECjarH09q5awjCSRbFLlmAGP72eg+nrXf2Eaw3BhAAOxdxHr3NVY58VPTlNO2hEibbnrzwDkUx4rbnMhV84Xr0qW3gTzVKl2bPB6ZrEs/HPhS9tp7iDUg8dvF5pLW0ql03+XuQFcyDf8uUzz9RWkYN7Hlymos6SOEiOMtt+9xn+GrDDKvjAx19+Otc5/wmOgTT2lrHq0Ej3kC3MCxxO29CGZeQMBiEbCn5jtOAcUab4s0O/0fVNRtNScafpuftby20sRhwu4gq6hvukHAFbKLXQyck9WzoFAZFLYGQcnv1p4hTYQp/EHmsTUPFOiact415qMcYsVha4HlsdnnZ8vAAyS2DwM9KjvPGWhWslhGb6WaW+thd2y21rLcGSHIHmYjU4X5hyfWnbyJcvM25JIbZGeXEagY3HjP418/wD7Ydx9o+GGmsgAi/tmLaR3/cz17dqvh2PV49moXEksLHJiyQpH0rw/9sZIbX4caVaI8YYapCUiBwQohmGQPTkChJpmj5eV2d2fPOn2F3e/DX7TZ2cjwWN2TcyoflG7hSw/TNc0RXT/AAu8Vt4W1ESTwi7025Robq0kPySKeMkd8dal8b2Gjtq01z4Xu2udOOC5kTYY2Pp6rnoa5IVJ068qU4+69U+nmn2f5m84KrTU4vVJJr9TkyDViytzc3UcCsiGQ7QznAH1qHBz0p+4cGMFTjnnv7V2PbQ5YpX1Gyo0c7xMQSrFcjocHrUbYHelYnJzzTTVIlsWmk88UDrgGhqYi9qep3WqTpPf3EtxOqLH5jnJ2qMAfgK1NDn0O2uYpNRtZb1g3+pmOImXBzkr82c4AH51zq8DvmtaPTEurUXNld2xcH57WRtkoxjJAPDDr0OfasKkYKPK3ZeWn/DHRSlNy5kk35/1qS22valaXkE+kf6BNbgpFLbjY4UkkhmH3uuM1X1G7k1O7SVolEm0BtvQnJP+c5NWNZs7vSUtYHlieJ4tyvCxw4JzyDyCOOPpWfbqzEbF3E9qUIw+OKXqVUc78k2zXQWd3oFy886pqcMqbIimfOjwchT2Knkg8YqK8u5pdFs7SVml8jdtVQNqAnJBI6knBz+FU5oCAMkLQt5cx2n2ZCViJywH8VJQ6rXUt1HrzaaWIbeJJScvtbr9aiODnjkVGWwaTv8AWt0jl5ltYec0nelJA70wv6UyWOZ8AgVGzE9TTTSCmkK4tJS0UxBRRScUALRXZ+BPDmj61ZXMurPq5nWVlij09I2+RI97s28gcDsK7Cb4d+CoQ7y6x4hW2Fj/AGilwbZAksWFPydyfnUcgDJxnilcdiv8PPFmm6D4Kgt7zXWuZnvo2k0R7eR1SBZ0dvLAGxpXKg7mPCjA5NaT/Y/FnxV8K285udatIbaaC7v7u0kVZiTPIuQ43HYGQc/3cDjFVh8OfDKxWU8E3iuQT3X2PMUEOYLjdt8tvm+93+XPHOa2dW+Gen6drtjpLan4xuZr4lYJYDGY3KjLclgflHJ4/Oi47Gbban4K0WxtI/sNpdAQRw3FzPpT4kYWjgkbwCMz+WSeD+Ga808cXmn6h4g+16RHDHBLa25lWCLykE/lL521ew37unFeiv4P8LzaXPd3ur+LUsxDLcwG4SNluliba/l8nLD0OOOaWb4eeDoNJvb281XX7ZrO5S0ltZIojL5jqGUDaSCNrA5zwOtK4WPG/rVG5/17fh/Kva/E/wANvD+mWPiVLO91s6jo9r9q23MCLFMu7blSOcZ9hnqMivE7n/XN+H8qaJZ6r+zUwXx3fZ6HTpB/5Fir6RKF3DwzSQxrxtCgg+5r4s8MeI9V8L373uh3X2W5eMws/lJJlSQSMMCOqj8q6g/GHx0WJ/t3k8H/AESD/wCIrGpTlKV0d2HxUKcOWSZ9TQpLHZmO8k3+RghlXG/3+tSokDENFKu/GT6ge9fKR+L3jjaF/tzjOf8Aj0g/+IqlJ8SvFsl4t02rnzx0YW8Q/QLip9g3ubrH010Z9bqztcOBIDEE+XIyS2f04qm9i009w95teBVIVNvc/eJPoRjivlz/AIWt403lxrRDHqfs0P8A8RTj8WvGzDB1rP8A26Qf/EUKjLoxvH0+z/r5n0R4QvLGxluND0SBhb2jF5pi5OJmP3RnsBXVxmY3IcwwtJjZuYlcj09v5V8h2nxK8WWZJttUWMl2c4tIeWY5JPyVZ/4W142Ax/bZxjH/AB6wf/EU50nJ3RksZTStZ/18z6s/t60g1ZtLkLQXe3eiSDG8f7J/ix6VNfFLm1DBS6g5ww5BHfFfI958T/F97CI7vVlmVTuXfaQEofVTsyp9xipY/iv41jj8tdbbb720JJ+pKZNS8O+gLGw7M+rTazmEPbSgfKdkcrZBPv6Cl06/EigXVtJbXO0K8ZOSp9mHUehr5W/4W/45z/yHP/JSD/4ioj8V/GhlMp1kbyME/ZIOn/fFHsJdRvGU30Z9bTabHfwPA4SSFwQwcdc9eDXCTaBEnjyIXcRtdK0yNVtIWYCKU4yWx65614OPi7444xrh46f6LB/8RUd78VvGd9j7Xq0c2B/FZW5/9kpxpTj1F9cg3qmfQmuXupw6gLmS8t7ew3bgipudo+5B9zUy+IBcnZ9tMjsm5VjY5QCvm6b4leLZiC+qg4AUYtoQAB0HCVVbx34kaTe2pfP/AHvIjB/9BqvZO2o/rlLfX+vmfUs13i3AtruRZxli4J4X3PesmDUb69bzJrkz2yNlAyg8+vsa+eofiZ4uhXbHq2FxjBtoSMfilQQ/EHxPDAIotTKxjoBBF/8AE0eyZcMdSW6Z9QwX7cxlijsuSTyXHof/AK9LGzPIZEJEkZAUhiMH1x6Yr5fX4ieKV3bdUxu64t4uf/Hal/4WV4t8tk/tc7WBBxbxA/ntzU+xkX/aFFdH+H+Z9haffteQSQyiJ2AwyN3HqK5rxL4IubzUIp9K1y90q3b/AI+IomJDJ6J/dJr5htPiV4ttFjEGsOPL+6TDEx/Mrk/jV2f4v+OZgvma6Tt5GLWAY/JKFSlF3TMXjKfRP+vmfXPhGwvH8SXN7OBDoFjbpDbxk73nmOC0jem0fLjuSTXe2cZ2NM8eC56Mf6fSvhSD43fEKBEWLxBtVM4H2K37/wDbPmp/+F9fEnIP/CSHIHH+g23/AMbo9jJnPUxCk7n3ctwVlCrEwxgdO1cb4a+Hq+HPDfk6ZeQyeIPIaD7ZdiSaLyzIXaJYy/7tGzghCPXtXyL/AML9+JZ/5mXoMf8AHhbf/G6P+F+fEvGP+ElOP+vG2/8AjdaRhKJhKUZH1fZfDM22p+Grm51KCSLSI4jMyxvHJNJCX8sYDbNiiTaNylgFxnk1rr4fB+G2paDcanFJf6jBcLPe7Dh5ptxL46kDdgDPQAV8bN8ePiSww3iQkf8AXjbf/G6Z/wALz+Iu0D/hIsgdP9CtuP8AyHVWkC5Otz6i1P4YWostZtdM1S3hstRNoXtbjzZEk8lHUh237sEsrjBGCg6inz+ANVuZdFuptfsNXu9Ns5rOSa6Sa38wNKHVsQuuNoAXBJHHSvlVvjZ8QnYlvEJJPH/Hnb//ABupV+OfxFVdq+IsDOf+PG2/+N0e8U/ZW0v+B9+RXsDEp56NIgG/b0GRXzt+2MltN4Dsr6ExSPJqsEYkCjIUQz5XPpk5rw1Pjp8RkjMaeIQEOcgWNtznr/yzrD8XfEjxX4v0mHTPEOqC7sYZRPHELaGLa4VlByiA9Gbv3p6k3gk7XMqytz/Zsc2RjJzzz1NPCHYWP54rEE0ioEEjhB/CGOKcbmcqFM0pHpvNLlY+ePRGsVJOTk570xzg4rK82T/no/8A30aTzZP77fnVWI5jUGM05uR6Vk+ZJ/fb86PNk/vt+dFg5jTAxSEfKazfNk/vt+dHmP8A32/OgVzZsIHu7uG2hKebKwRPMYKuT6k8D6mrGqafJp8iQzKnnYJYxyrIp56gr2rnvMcjBdsfWnJNLGSY5HU4I+ViOPSpale6ehalHlaa1Oz1Dw1qNhYWlzdbHjuELqFfcVGO9ZkIPlxmN9sgJ3VjPqV88YR725ZANu0ysRj0xmoBPKOksg+jGs4QqctptN+RtUq0ua9NNLzZ1F1MHVflGeu4DrVdflPBANc/9om/56yf99GgTzA8Syf99GrVO2iIlWu7mtc48w44PfFRjFZZlkPWRz+NHmP/AH2/OrSMnK7NFvSmGqPmP/fb86TzH/vt+dOwrl/rS4qh5j/32/OjzH/vt+dAXNCkqh5j/wB9vzo8x/77fnSsBoYpCKoeY/8Afb86PMf++350xHqHwv1rwnpMcjeL4Z7ny7gywW4thNFJuj2kvk8EYGK7/UPiP4Kv9VlvZtS1/wAryJIIbUWUeyAOgRtp6lcDIQ5UHmvnDzH/AL7fnR5j/wB9vzpWHc+jPD/j/wAB6MdK+zXOsSCwluJ9psURZZpVClyqnC7QMAD1NbF58XvBd1rWj6k8urLJprStGgtBtk8xNp3fN29q+W/Nk/vt+dHmyf33/Oiw+Y95HivwO+kSadeaz4hurZbee3tQ2nxp9mEzZcjB+c9ue1Xtd8afDLVdJSwhi1fTI41ZUNjbeWBuKliVDAMTtHWvnjzZP77fnR5j/wB9vzosK57x4s8eeFdR0zXmtdS1y7vryye0tYrq3VUhVmViC4O5x8vBbO3nHWvCbn/Xt+H8qb5j/wB9vzppJJyTk0JA2f/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    TDP-43 sarcoplasmic accumulations shown with paired H&amp;E secretions to demonstrate these are occuring in non-necrotic myofibers.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Salajegheh, M, Pinkus, JL, Taylor, JP, et al. Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis. Muscle &amp; Nerve 2009; 40:19. Copyright &copy; 2009. This material was reproduced with permission of John Wiley &amp; Sons.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_28_1481=[""].join("\n");
var outline_f1_28_1481=null;
var title_f1_28_1482="Cardiovascular risk of smoking and benefits of smoking cessation";
var content_f1_28_1482=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cardiovascular risk of smoking and benefits of smoking cessation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/28/1482/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/28/1482/contributors\">",
"     Melvyn Rubenfire, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/28/1482/contributors\">",
"     Elizabeth Jackson, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/28/1482/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/28/1482/contributors\">",
"     Christopher P Cannon, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/28/1482/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/28/1482/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/28/1482/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 21, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The facts regarding the risk of cigarette smoking and cardiovascular disease are well known to both the medical profession and the public [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/1-5\">",
"     1-5",
"    </a>",
"    ]. Currently, an estimated 21 percent of men and 17 percent of women in the United States smoke [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/6\">",
"     6",
"    </a>",
"    ]. Smoking rates are higher among men and women with lower educational and income levels. The majority of smokers start smoking before the age of 18, with the most common age being 14 to 15 years. Adolescents from Mexican subgroups have the highest rates of smoking followed by non-Hispanic blacks and non-Hispanic whites [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Trends towards increasing tobacco consumption among the young have also been observed in other countries besides the US [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/6,8\">",
"     6,8",
"    </a>",
"    ]. Globally, an estimated 1.3 billion people smoke, the majority of whom reside in developing countries, where estimates are as high as 50 percent or greater for male smokers.",
"   </p>",
"   <p>",
"    Many smokers do not believe that smoking is harmful for them. In one study, for example, over 60 percent of 737 current smokers, even those who smoked more than 40 cigarettes per day, did not believe that they were at an increased risk for a myocardial infarction (MI) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/59/39866?source=see_link\">",
"     \"Overview of the risk equivalents and established risk factors for cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The relationship between smoking and coronary heart disease, the effects of smoking on the atherosclerosis process, and the beneficial effects of smoking cessation will be reviewed here [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/2\">",
"     2",
"    </a>",
"    ]. The importance of smoking cessation in diabetic patients is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/4/5189?source=see_link\">",
"     \"Smoking and cardiovascular risk in diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SMOKING AND CARDIOVASCULAR DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;With respect to coronary heart disease (CHD), the following observations have been made regarding a major role for smoking:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Smoking is an independent major risk factor for CHD, cerebrovascular disease, and total atherosclerotic cardiovascular disease [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The incidence of a MI is increased sixfold in women and threefold in men who smoke at least 20 cigarettes per day compared to subjects who never smoked [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/11,12\">",
"       11,12",
"      </a>",
"      ]. In the worldwide INTERHEART study of patients from 52 countries, smoking accounted for 36 percent of the population-attributable risk of a first MI [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a systematic review and meta-analysis of 75 cohorts that evaluated the risks of smoking on CHD and adjusted for the effects of other known CHD risk factors (over 2.4 million persons with over 44,000 CHD events), female smokers were 25 percent more likely than male smokers to develop CHD (relative risk ratio 1.25, 95% CI 1.12-1.39) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Cigarette smoking increases all-cause and cardiovascular mortality [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/15,16\">",
"       15,16",
"      </a>",
"      ]. In one study, the adjusted hazard ratio for 35 year all-cause and cardiovascular mortality was 1.62 and 1.63, respectively, for current smokers compared to nonsmokers [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/15\">",
"       15",
"      </a>",
"      ]. Those who persisted in smoking cessation had no increased risk of death compared with nonsmokers.",
"     </li>",
"     <li>",
"      Patients who continue to smoke in the presence of established CHD have an increased risk of reinfarction and an increased risk of death, including sudden cardiac death [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/17,18\">",
"       17,18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Smoking status before coronary artery bypass graft (CABG) surgery does not affect survival after surgery, but persistent smokers after CABG have a greater relative risk of all-cause mortality (relative risk 1.68), cardiac death (relative risk 1.75), and need for repeat revascularization (relative risk 1.41) compared to those who stopped smoking for at least one year [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/19\">",
"       19",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/2/37930?source=see_link\">",
"       \"Long-term outcome after coronary artery bypass graft surgery\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      After percutaneous coronary intervention, persistent smokers have a greater relative risk of death (1.76) and Q wave myocardial infarction (2.08) compared to nonsmokers, and a higher relative risk of total and cardiac mortality (relative risk 1.44 and 1.49, respectively) when compared to those who quit smoking [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Among patients with left ventricular dysfunction (left ventricular ejection fraction &le;35 percent) in the SOLVD trial, smoking significantly increased all-cause mortality (relative risk 1.41 compared to ex-smokers or never smokers) and the incidence of death, recurrent heart failure requiring hospitalization, or myocardial infarction (relative risk 1.39) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Secondhand smoke",
"    </span>",
"    &nbsp;&mdash;&nbsp;The impact of secondhand smoke on the cardiovascular system is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/62/22505?source=see_link&amp;anchor=H8#H8\">",
"     \"Secondhand smoke exposure: Effects in adults\", section on 'Cardiovascular disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Cigar smoking",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there is an established association between cigar smoking and cancer of the upper respiratory, lungs, and gastrointestinal tract and the risk of chronic obstructive lung disease, cigars are generally perceived as being safer than cigarettes. Moreover, data about the role of cigar smoking and the risk of cardiovascular disease are limited. Cigar smoke contains the same toxic and carcinogenic compounds that are found in cigarette smoke, and subjects who smoke four or more cigars per day are exposed to an amount of smoke equivalent to 10 cigarettes; even those who do not inhale are exposed to their own environmental smoke. Cigar smoking may result in endothelial dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/22\">",
"     22",
"    </a>",
"    ]. One cohort study of 17,774 men followed for 14 years found that, compared to nonsmokers, those who smoked cigars were at a greater risk for developing coronary heart disease (relative risk 1.27); there was a dose-response relationship and the relative risk for those who smoke less than or greater than 5 cigars per day were 1.2 and 1.56, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An American Cancer Society study of 121,278 men &ge;30 years of age found that current cigar smokers &le;75 years of age had an increased risk of death from coronary heart disease (adjusted rate ratio 1.3); there was no increased risk in those &gt;75 years of age or former cigar smokers of any age [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Smokeless tobacco",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of snuff and other types of smokeless tobacco is increasing, particularly among adolescents and young adults; however, the cardiovascular health hazards of smokeless tobacco are not well established [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/25\">",
"     25",
"    </a>",
"    ]. One population based study of 687 men, aged 24 to 64, with a first-time MI and 687 matched controls found no difference in the incidence of MI between nonsmoking regular snuff users compared to those who never used any tobacco products (adjusted odds ratio 0.96) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, a much larger study of over 135,000 male construction industry employees from Sweden, including over 6000 smokeless tobacco users, found that the age-adjusted relative risk of cardiovascular mortality was 1.4 for smokeless tobacco users [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/27\">",
"     27",
"    </a>",
"    ]. For men aged 35 through 54 at the start of follow-up, the relative risk was 2.1.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     SMOKING AND ATHEROSCLEROSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The direct effect of smoking on the development of atherosclerosis was assessed in the ARIC (Atherosclerosis Risk in Communities) study [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/28\">",
"     28",
"    </a>",
"    ]. This study consisted of 10,914 patients in whom intima-medial thickness of the carotid artery was measured by ultrasound over a three-year period. Current smoking was associated with a 50 percent increase in the progression of atherosclerosis versus nonsmokers during the study period, and patients with environmental tobacco smoke exposure had a 20 percent greater rate of atherosclerosis progression compared to patients without environmental tobacco smoke exposure.",
"   </p>",
"   <p>",
"    Although more pack-years of exposure was independently associated with faster progression, the progression rates of current and previous smokers did not differ, suggesting that some of the adverse effects of cigarette smoking may be cumulative and irreversible. Another study of patients with preexisting coronary disease found that smoking accelerates the progression of lesion size and new lesion formation as assessed by serial coronary angiography [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Smoking has also been correlated with increases in atherosclerotic disease of the thoracic aorta and the carotid arteries [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/30,31\">",
"     30,31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the relationship between CHD and smoking, even when passive, appears clear, the mechanism by which it occurs is incompletely understood. Multiple factors are likely involved since smoking has a variety of effects that may contribute to atherogenesis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/2,32\">",
"     2,32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Smoking is associated with an adverse effect on serum lipids (elevated low-density lipoproteins and triglycerides and reduced high-density lipoproteins) and with insulin resistance [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/33-35\">",
"       33-35",
"      </a>",
"      ]. In addition, free radicals in cigarette smoke damage lipids, resulting in the formation of proatherogenic oxidized particles, specifically oxidized low-density lipoprotein cholesterol [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/36-38\">",
"       36-38",
"      </a>",
"      ]. A similar effect is seen with acute secondhand smoke exposure [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/39\">",
"       39",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/45/18138?source=see_link&amp;anchor=H15#H15\">",
"       \"Lipoprotein classification; metabolism; and role in atherosclerosis\", section on 'Lipoproteins and atherosclerosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cigarette smoking activates the sympathetic nervous system, producing an increase in heart rate and blood pressure, and cutaneous and perhaps coronary vasoconstriction [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/40-42\">",
"       40-42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Smoking enhances the prothrombotic state via inhibition of tissue plasminogen activator release from the endothelium, elevation in the blood fibrinogen concentration, increased platelet activity (possibly due to enhanced sympathetic activity), increased expression of tissue factor, and, in patients with advanced lung disease, elevated whole blood viscosity due to secondary polycythemia [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/43-46\">",
"       43-46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Smoking can damage the vascular wall, possibly leading to impaired prostacyclin production and enhanced platelet-vessel wall interactions [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/47\">",
"       47",
"      </a>",
"      ]. This can reduce the elastic properties of the aorta, resulting in stiffening of and trauma to the wall [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/48\">",
"       48",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Smoking, as well as passive exposure to smoke, impairs endothelium-dependent vasodilation of normal coronary arteries and reduces coronary flow reserve [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/49-54\">",
"       49-54",
"      </a>",
"      ]. Smoking can also potentiate the endothelial dysfunction induced by hypercholesterolemia [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/37,51\">",
"       37,51",
"      </a>",
"      ]. The effect on endothelial function results from oxidative stress with enhanced oxidation of LDL and from reduced generation of nitric oxide [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/50,53,55-57\">",
"       50,53,55-57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Smoking, in addition to narrowing the lumen of epicardial coronary arteries and larger arterioles, causes microvascular constriction through a variety of biochemical, physiological, and metabolic factors [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/58\">",
"       58",
"      </a>",
"      ]. Changes in endothelial and platelet function, and the adrenergic nervous system, in addition to changes in metabolic vasoregulation, may contribute to smoking-induced alterations in the coronary microcirculation and result in angina",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      cardiac dysfunction. The exact components of cigarette smoke that produce coronary artery and specifically microvascular disfunction have not been established, but nicotine and carbon monoxide are probably candidates in addition to many others [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Smoking has been correlated with elevated levels of C-reactive protein and fibrinogen [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/59,60\">",
"       59,60",
"      </a>",
"      ]. In addition, concentrations of soluble adhesion molecules are higher in smokers than nonsmokers [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/57,60\">",
"       57,60",
"      </a>",
"      ]. These findings suggest that smoking contributes to the inflammatory response that is a factor in the pathogenesis of atherosclerosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/0/27658?source=see_link&amp;anchor=H2#H2\">",
"       \"C-reactive protein in cardiovascular disease\", section on 'Possible pathogenic role of CRP'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Smoking has been correlated with elevations in serum homocysteine, which is thought to induce vascular injury by multiple mechanisms [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/59\">",
"       59",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/37/19034?source=see_link\">",
"       \"Overview of homocysteine\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Role of carbon monoxide",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carbon monoxide is inhaled in cigarette smoke. It binds more avidly than oxygen to hemoglobin, reducing the amount of hemoglobin available to carry oxygen and impeding oxygen release by hemoglobin that is not directly bound to carbon monoxide. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/16/22790?source=see_link\">",
"     \"Smoke inhalation\"",
"    </a>",
"    .) This effect can be detected clinically by measuring carboxyhemoglobin levels which average 5 to 10 percent higher in smokers than nonsmokers, in whom levels are less than 1 percent.",
"   </p>",
"   <p>",
"    In healthy subjects, carbon monoxide administration, under conditions similar to cigarette smoking, does not affect blood pressure, plasma catecholamines, platelet aggregation, or serum C-reactive protein [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/61\">",
"     61",
"    </a>",
"    ]. Since these parameters are changed with smoking, the observations suggest that some factor other than carbon monoxide is responsible.",
"   </p>",
"   <p>",
"    In comparison, carbon monoxide exposure in patients with CHD results in severe adverse effects. These include exercise-induced ischemia at a lower level of work, ventricular dysfunction, and increased number and complexity of ventricular arrhythmias [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/62,63\">",
"     62,63",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Role of nicotine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nicotine in cigarette smoke plays a major role in the transient smoking-related increases in cardiac output, heart rate, and blood pressure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/23/30073?source=see_link\">",
"     \"Cardiovascular effects of nicotine\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is not clear if nicotine plays a direct role in the development of atherosclerosis. Nicotine has been reported to have variable effects on nitric oxide, but does not appear to increase lipid deposition in the vascular wall [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/64-66\">",
"     64-66",
"    </a>",
"    ]. Nicotine may contribute to acute endothelial dysfunction in smokers [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Role of oxidative stress",
"    </span>",
"    &nbsp;&mdash;&nbsp;Free radical-mediated oxidative stress may play a pivotal role in the development of atherosclerosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/53/26456?source=see_link&amp;anchor=H2#H2\">",
"     \"Nutritional antioxidants in coronary heart disease\", section on 'Pathophysiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Free radicals are present in both the gas and \"tar\" phases of cigarette smoke and may also be generated from endogenous sources in response to smoking [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/68,69\">",
"     68,69",
"    </a>",
"    ]. A study in human coronary artery endothelial cells found significantly lower nitric-oxide production with exposure to smokers' serum than nonsmokers' serum, an effect that was mitigated by the addition of antioxidants [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/70\">",
"     70",
"    </a>",
"    ]. In humans, antioxidant therapy improves endothelial dysfunction in smokers [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/71\">",
"     71",
"    </a>",
"    ]. However, chronic administration of antioxidants such as vitamin C, vitamin E, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/50/21283?source=see_link\">",
"     beta-carotene",
"    </a>",
"    does not appear to improve long-term outcomes with the possible exception of specific patient subsets. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/53/26456?source=see_link\">",
"     \"Nutritional antioxidants in coronary heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SMOKING AND OUTCOME AFTER REPERFUSION THERAPIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The relative outcomes of smokers compared to nonsmokers after reperfusion therapies have been evaluated across the spectrum of coronary artery disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Myocardial infarction",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     After fibrinolytic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite the important role of cigarette smoking in the development of atherosclerosis, several studies have reported that smokers who receive a fibrinolytic agent for an acute MI have a",
"    <strong>",
"     better",
"    </strong>",
"    outcome than nonsmokers [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/72-79\">",
"     72-79",
"    </a>",
"    ]. This phenomenon is called the \"smoker's paradox.\" (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/43/1721?source=see_link\">",
"     \"Fibrinolytic therapy in acute ST elevation myocardial infarction: Initiation of therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As an example, the International Tissue Plasminogen",
"    <span class=\"nowrap\">",
"     Activator/Streptokinase",
"    </span>",
"    Mortality trial, which involved 2366 nonsmokers, 2244 ex-smokers, and 3649 active smokers, found that nonsmokers, compared to the other two groups, had a higher incidence of in-hospital complications including shock, stroke, and bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/72\">",
"     72",
"    </a>",
"    ]. Nonsmokers also had a higher in-hospital and six-month mortality than ex-smokers or active smokers.",
"   </p>",
"   <p>",
"    Similar findings were noted in TIMI II and GUSTO I [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/73,74\">",
"     73,74",
"    </a>",
"    ]. GUSTO I was largest trial to evaluate the impact of cigarette smoking on outcome as it included 11,975 nonsmokers, 11,117 ex-smokers, and 17,507 current smokers [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/74\">",
"     74",
"    </a>",
"    ]. Nonsmokers had a significantly higher rate of in-hospital complications and a higher in-hospital (9.9 versus 3.7) and 30 day mortality (10.3 versus 4.0 percent).",
"   </p>",
"   <p>",
"    The reason for the surprisingly better outcomes after fibrinolysis in smokers may be related to the following factors:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Smokers have a higher hematocrit and baseline level of fibrinogen, suggesting a hypercoagulable state [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/75,76\">",
"       75,76",
"      </a>",
"      ]. This could explain the angiographic finding that the mechanism of infarction in smokers is more often thrombosis of a less critical atherosclerotic lesion than in nonsmokers [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/75\">",
"       75",
"      </a>",
"      ]. More active thrombogenic mechanisms may lead to a larger thrombus component that is more susceptible to fibrinolytic therapy, resulting in smokers having a higher patency rate and being more likely to have TIMI-3 flow in the infarct artery after fibrinolysis [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/75,76,80\">",
"       75,76,80",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Smokers have an otherwise better risk profile than nonsmokers; they tend to be significantly younger (mean 11 years in GUSTO I) and have a lower incidence of diabetes, hypertension, previous infarction, and severe coronary disease than nonsmokers [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/72-79\">",
"       72-79",
"      </a>",
"      ]. Also, for unclear reasons, smokers are more likely to have an inferior rather than anterior wall infarction [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/75,76,79\">",
"       75,76,79",
"      </a>",
"      ]. After adjustment for these clinical factors, some [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/74,75,77\">",
"       74,75,77",
"      </a>",
"      ] but not all [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/79\">",
"       79",
"      </a>",
"      ] studies reported that smoking history was of not an independent prognostic factor (",
"      <a class=\"graphic graphic_figure graphicRef60195 \" href=\"UTD.htm?37/40/38541\">",
"       figure 1",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     After primary percutaneous coronary intervention",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a post hoc analysis of patients with ST-elevation MI in the CADILLAC trial, there was no significant difference in survival at one year after correction for baseline differences such as age and other cardiovascular risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/81\">",
"     81",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/31/19961?source=see_link&amp;anchor=H4#H4\">",
"     \"Early trials of platelet glycoprotein IIb/IIIa receptor inhibitors in coronary heart disease\", section on 'Abciximab'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Unstable angina",
"    </span>",
"    &nbsp;&mdash;&nbsp;The smoker's paradox appears not to apply to patients presenting with unstable angina. In a multicenter registry that included almost 8000 patients with unstable angina, intensive care unit mortality was lower for smokers than for ex-smokers or nonsmokers (0.7 versus 1.0 and 1.5 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/79\">",
"     79",
"    </a>",
"    ]. However, when corrected for age and other cardiovascular risk factors, smoking history was not an independent predictor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Stable coronary artery disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients with stable coronary artery disease, smokers who undergo percutaneous coronary intervention may also have better short-term outcomes than nonsmokers. In an observational study evaluating 5682 patients treated with PCI in 9 clinical trials, target lesion revascularization was significantly lower in smokers, with an adjusted relative risk of 0.69 (95% CI 0.54-0.88) after adjustment for baseline clinical and angiographic differences [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     CARDIOVASCULAR BENEFITS OF SMOKING CESSATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The benefits of quitting cigarette smoking are also firmly established but perhaps less well known and accepted. Among subjects without known CHD, the reduction in cardiac event rate associated with smoking cessation ranges from 7 to 47 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/83-86\">",
"     83-86",
"    </a>",
"    ]. The cardiac risks associated with cigarette smoking diminish relatively soon after smoking cessation and continue to fall with increasing length of time since quitting [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/87\">",
"     87",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Acute coronary syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Smoking cessation improves outcomes in patients who have had an acute coronary syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/18,88-92\">",
"     18,88-92",
"    </a>",
"    ]. The range of benefits can be illustrated by the following findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The mortality benefit of smoking cessation was assessed in a meta-analysis of 20 prospective cohort studies with at least two years follow-up including 12,603 smokers, of whom 5659 ceased smoking and 6944 continued to smoke [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/88\">",
"       88",
"      </a>",
"      ]. All patients had had an MI, CABG, angioplasty, or known CHD. The relative risk of mortality for smokers who quit compared with those who continued to smoke was 0.64 (95% CI 0.58-0.71). The benefit was not affected by age, sex, index cardiac event, country, or the year in which the study began.",
"     </li>",
"     <li>",
"      The effect of smoking cessation on recurrent coronary events was evaluated in a retrospective, population-based cohort study of 2619 patients who survived to hospital discharge after a first myocardial infarction [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/92\">",
"       92",
"      </a>",
"      ]. At the time of the infarction, roughly equal percentages were nonsmokers, former smokers, and current smokers (56 percent of whom quit smoking). Using the nonsmokers as the reference group, the multivariable risk ratio (RR) for recurrent coronary events was nonsignificantly increased in former smokers (RR 1.17) and significantly increased for active smokers (RR 1.51). Among those who permanently quit smoking, the risk ratio progressively and significantly decreased with longer duration of cessation (RR 1.62 at 0 to &lt;6 months, 1.60 from 6 to &lt;18 months, 1.48 for 18 to &lt;36 months, and 1.02 for &ge;36 months).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The efficacy and cardiovascular benefits of smoking cessation vary importantly with the method used to attain smoking cessation. This was illustrated in a randomized trial in which 209 hospitalized patients, 90 percent of whom had an acute coronary syndrome, were randomly assigned to 12 weeks of behavior modification counseling and individualized pharmacotherapy (nicotine replacement therapy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/29/26073?source=see_link\">",
"     bupropion",
"    </a>",
"    ) at no cost or to usual care (in-hospital counseling and printed educational material) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/89\">",
"     89",
"    </a>",
"    ]. After 24 months, patients in the intensive smoking cessation group had significantly lower rates of all-cause mortality (2.8 versus 12.0 percent, relative risk reduction 0.77, 95% CI 0.27-0.93) and hospitalization (23 versus 41 percent, relative risk reduction 0.44, 95% CI 0.16-0.63). These improved outcomes were associated with a significantly higher rate of continuous abstinence from smoking (33 versus 9 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5055694\">",
"    <span class=\"h2\">",
"     Sudden cardiac death",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many states and municipalities have implemented laws restricting the ability to smoke in workplaces or public buildings, which may aid in the process of smoking cessation while simultaneously reducing the exposure of non-smokers to second-hand smoke. The impact of such laws on cardiac morbidity and mortality was assessed in Olmsted County, Minnesota, where the incidence of myocardial infarction declined by 33 percent and the incidence of sudden cardiac death declined by 17 percent (109.1 to 92.0 per 100,000 population) in the 18 months following implementation of the smoke-free workplace law compared to the 18 months before the law [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/86\">",
"     86",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/62/22505?source=see_link\">",
"     \"Secondhand smoke exposure: Effects in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/58/41895?source=see_link&amp;anchor=H10#H10\">",
"     \"Control of secondhand smoke exposure\", section on 'Workplaces'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Stroke",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of ischemic stroke also decreases over time after smoking cessation. In one series of middle-aged women, for example, the excess risk among former smokers largely disappeared two to four years after cessation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/93\">",
"     93",
"    </a>",
"    ]. The continued decline in risk over time after smoking cessation suggests that more than one mechanism may be involved. The early benefit may result from improved coagulation parameters or reversal of endothelial dysfunction, while the late benefit may reflect slowing or even reversal of the atherosclerosis process.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Effect of age",
"    </span>",
"    &nbsp;&mdash;&nbsp;The relative benefits of smoking cessation are equivalent in young and old patients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/88,90\">",
"     88,90",
"    </a>",
"    ]. In one study of 1893 patients with CHD who were older than 55 years, the mortality after six-year follow-up was significantly higher among patients who continued to smoke compared to those who stopped (relative risk 1.7) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/90\">",
"     90",
"    </a>",
"    ]. The benefits were equivalent in those aged 55 to 64 and over age 65 and were the same as observed among comparable patients aged 34 to 54.",
"   </p>",
"   <p>",
"    Despite these facts, approximately 25 percent of the adult United States population continues to smoke and there has been little change in the prevalence of smoking since 1990 (",
"    <a class=\"graphic graphic_figure graphicRef59771 \" href=\"UTD.htm?28/21/29022\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/94\">",
"     94",
"    </a>",
"    ]. Nearly equal numbers of men and women smoke; in both sexes smoking rates are higher in less educated and poorer segments of the population. Approximately 70 percent of cigarette smokers state that they would like to quit smoking.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84151498\">",
"    <span class=\"h2\">",
"     Improvement in endothelial function",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned above, smoking impairs endothelium-dependent vasodilation of normal coronary arteries and reduces coronary flow reserve [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/49,52\">",
"     49,52",
"    </a>",
"    ]. The impact of smoking cessation on endothelial function was studied prospectively in over 1500 smokers; after one year, 36 percent had successfully quit smoking [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/54\">",
"     54",
"    </a>",
"    ]. Despite gaining an average of 5 kg, smokers who quit had significantly improved endothelial function compared to baseline, while endothelial function did not improve from baseline in those who continued to smoke. This improvement in endothelial function likely contributes to the reduction in mortality and other benefits associated with smoking cessation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Possible deleterious effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no convincing reasons not to quit smoking although several issues have been raised:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nicotine withdrawal and depression can occur as a result of quitting. While the depression associated with cessation is usually mild, it may be sufficiently severe to require counseling, antidepressant therapy, or a return to smoking.",
"     </li>",
"     <li>",
"      Many smokers, especially women, cite weight gain as a reason not to quit smoking. This issue was studied in the third National Health and Nutrition Survey conducted from 1988 through 1991 [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/95\">",
"       95",
"      </a>",
"      ]. The long-term weight gain for smokers who quit compared to smokers who continued to smoke was 4.4 kg for men and 5.0 kg for women. Smokers who quit were significantly more likely to gain weight than life-long nonsmokers. Despite this weight gain, however, an independent and significant improvement in endothelial function has been prospectively observed which may offset any deleterious effects of modest weight gain [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/54\">",
"       54",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H84151498\">",
"       'Improvement in endothelial function'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cessation has been associated with exacerbations of ulcerative colitis [",
"      <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/96\">",
"       96",
"      </a>",
"      ], and nicotine is now being evaluated as a therapeutic agent in this condition.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An analysis of the health care costs of smoking cessation revealed short-term savings, but increased health care costs in the long run since former smokers lived longer and used greater amounts of terminal health care [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/97\">",
"     97",
"    </a>",
"    ]. This observation has no relevance to the individual who, by quitting smoking, can markedly improve his or her health. From a public health standpoint it can be argued that any other effective measure for prevention of cigarette use may also increase health care costs in the long run, but the promotion of healthy, long lives should be the goal of modern society.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Methods of smoking cessation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians often fail to intervene against smoking [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/98\">",
"     98",
"    </a>",
"    ]. The lack of economic incentives for clinicians to promote smoking cessation and pessimism among clinicians regarding the effects of these interventions may explain these findings [",
"    <a class=\"abstract\" href=\"UTD.htm?1/28/1482/abstract/94\">",
"     94",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are a number of ways that clinicians can and should actively intervene against smoking in virtually all smokers (",
"    <a class=\"graphic graphic_table graphicRef62871 \" href=\"UTD.htm?4/51/4924\">",
"     table 1",
"    </a>",
"    ). Behavioral therapy, nicotine replacement therapy, and the use of certain medications may each improve the quit rate. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/3/23609?source=see_link\">",
"     \"Overview of smoking cessation management in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?17/46/18146?source=see_link\">",
"       \"Patient information: Quitting smoking (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?37/6/37987?source=see_link\">",
"       \"Patient information: Heart attack recovery (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?20/42/21156?source=see_link\">",
"       \"Patient information: Recovery after coronary artery bypass graft surgery (CABG) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?19/13/19670?source=see_link\">",
"       \"Patient information: Quitting smoking (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?11/52/12100?source=see_link\">",
"       \"Patient information: Heart attack recovery (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?23/16/23813?source=see_link\">",
"       \"Patient information: Recovery after coronary artery bypass graft surgery (CABG) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Smoking is a leading preventable risk factor for cardiovascular disease. Given the high number of smokers who first start smoking during adolescence, assessment and education regarding smoking is recommended for all adolescents in addition to adults. Similarly, among those patients with established cardiovascular disease, the risk of a recurrent event is increased among those who continue to smoke, compared to those who do not. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Smoking and cardiovascular disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Available evidence suggests that cigar smoking increases the risk of the development of cardiovascular disease. However, the cardiovascular health hazards of smokeless tobacco are not well established. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Cigar smoking'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Smokeless tobacco'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The benefits of smoking cessation have been demonstrated in a broad range of patients with cardiovascular disease. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Smoking and outcome after reperfusion therapies'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17\">",
"       'Cardiovascular benefits of smoking cessation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Many providers fail to counsel patients regarding smoking cession. However, patients are more likely to attempt to quit if advised to do so by healthcare providers. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/3/23609?source=see_link\">",
"       \"Overview of smoking cessation management in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/1\">",
"      Ockene IS, Miller NH. Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. Circulation 1997; 96:3243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/2\">",
"      Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 2004; 43:1731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/3\">",
"      AHA, ACC, National Heart, Lung, and Blood Institute, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol 2006; 47:2130.",
"     </a>",
"    </li>",
"    <li>",
"     AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update A Guideline From the American Heart Association and American College of Cardiology Foundation file://circ.ahajournals.",
"    </li>",
"    <li>",
"     Value of Primordial and Primary Prevention for Cardiovascular Disease. A Policy Statement From the American Heart Association file://circ.ahajournals.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/6\">",
"      Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation 2013; 127:e6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/7\">",
"      Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119:e182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/8\">",
"      Jha P, Jacob B, Gajalakshmi V, et al. A nationally representative case-control study of smoking and death in India. N Engl J Med 2008; 358:1137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/9\">",
"      Ayanian JZ, Cleary PD. Perceived risks of heart disease and cancer among cigarette smokers. JAMA 1999; 281:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/10\">",
"      Jee SH, Suh I, Kim IS, Appel LJ. Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance Corporation Study. JAMA 1999; 282:2149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/11\">",
"      Nj&oslash;lstad I, Arnesen E, Lund-Larsen PG. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. Circulation 1996; 93:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/12\">",
"      Prescott E, Hippe M, Schnohr P, et al. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 1998; 316:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/13\">",
"      Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/14\">",
"      Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 2011; 378:1297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/15\">",
"      Qiao Q, Tervahauta M, Nissinen A, Tuomilehto J. Mortality from all causes and from coronary heart disease related to smoking and changes in smoking during a 35-year follow-up of middle-aged Finnish men. Eur Heart J 2000; 21:1621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/16\">",
"      Foody JM, Cole CR, Blackstone EH, Lauer MS. A propensity analysis of cigarette smoking and mortality with consideration of the effects of alcohol. Am J Cardiol 2001; 87:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/17\">",
"      Tofler GH, Muller JE, Stone PH, et al. Comparison of long-term outcome after acute myocardial infarction in patients never graduated from high school with that in more educated patients. Multicenter Investigation of the Limitation of Infarct Size (MILIS). Am J Cardiol 1993; 71:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/18\">",
"      Goldenberg I, Jonas M, Tenenbaum A, et al. Current smoking, smoking cessation, and the risk of sudden cardiac death in patients with coronary artery disease. Arch Intern Med 2003; 163:2301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/19\">",
"      van Domburg RT, Meeter K, van Berkel DF, et al. Smoking cessation reduces mortality after coronary artery bypass surgery: a 20-year follow-up study. J Am Coll Cardiol 2000; 36:878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/20\">",
"      Hasdai D, Garratt KN, Grill DE, et al. Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N Engl J Med 1997; 336:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/21\">",
"      Suskin N, Sheth T, Negassa A, Yusuf S. Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction. J Am Coll Cardiol 2001; 37:1677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/22\">",
"      Santo-Tomas M, Lopez-Jimenez F, Machado H, et al. Effect of cigar smoking on endothelium-dependent brachial artery dilation in healthy young adults. Am Heart J 2002; 143:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/23\">",
"      Iribarren C, Tekawa IS, Sidney S, Friedman GD. Effect of cigar smoking on the risk of cardiovascular disease, chronic obstructive pulmonary disease, and cancer in men. N Engl J Med 1999; 340:1773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/24\">",
"      Jacobs EJ, Thun MJ, Apicella LF. Cigar smoking and death from coronary heart disease in a prospective study of US men. Arch Intern Med 1999; 159:2413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/25\">",
"      Gupta R, Gurm H, Bartholomew JR. Smokeless tobacco and cardiovascular risk. Arch Intern Med 2004; 164:1845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/26\">",
"      Huhtasaari F, Lundberg V, Eliasson M, et al. Smokeless tobacco as a possible risk factor for myocardial infarction: a population-based study in middle-aged men. J Am Coll Cardiol 1999; 34:1784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/27\">",
"      Bolinder G, Alfredsson L, Englund A, de Faire U. Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health 1994; 84:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/28\">",
"      Howard G, Wagenknecht LE, Burke GL, et al. Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. JAMA 1998; 279:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/29\">",
"      Waters D, Lesp&eacute;rance J, Gladstone P, et al. Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy. CCAIT Study Group. Circulation 1996; 94:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/30\">",
"      Inoue T, Oku K, Kimoto K, et al. Relationship of cigarette smoking to the severity of coronary and thoracic aortic atherosclerosis. Cardiology 1995; 86:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/31\">",
"      Howard G, Burke GL, Szklo M, et al. Active and passive smoking are associated with increased carotid wall thickness. The Atherosclerosis Risk in Communities Study. Arch Intern Med 1994; 154:1277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/32\">",
"      Leone A, Landini L. Vascular Pathology from Smoking: Look at the Microcirculation! Curr Vasc Pharmacol 2011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/33\">",
"      Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 1989; 298:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/34\">",
"      Facchini FS, Hollenbeck CB, Jeppesen J, et al. Insulin resistance and cigarette smoking. Lancet 1992; 339:1128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/35\">",
"      Reaven G, Tsao PS. Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease? J Am Coll Cardiol 2003; 41:1044.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/36\">",
"      Miller ER 3rd, Appel LJ, Jiang L, Risby TH. Association between cigarette smoking and lipid peroxidation in a controlled feeding study. Circulation 1997; 96:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/37\">",
"      Heitzer T, Yl&auml;-Herttuala S, Luoma J, et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 1996; 93:1346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/38\">",
"      Pech-Amsellem MA, Myara I, Storogenko M, et al. Enhanced modifications of low-density lipoproteins (LDL) by endothelial cells from smokers: a possible mechanism of smoking-related atherosclerosis. Cardiovasc Res 1996; 31:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/39\">",
"      Valkonen M, Kuusi T. Passive smoking induces atherogenic changes in low-density lipoprotein. Circulation 1998; 97:2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/40\">",
"      Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976; 295:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/41\">",
"      Winniford MD, Wheelan KR, Kremers MS, et al. Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: evidence for adrenergically mediated alterations in coronary artery tone. Circulation 1986; 73:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/42\">",
"      Narkiewicz K, van de Borne PJ, Hausberg M, et al. Cigarette smoking increases sympathetic outflow in humans. Circulation 1998; 98:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/43\">",
"      Newby DE, Wright RA, Labinjoh C, et al. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. Circulation 1999; 99:1411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/44\">",
"      Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. Am Heart J 1987; 113:1006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/45\">",
"      Fusegawa Y, Goto S, Handa S, et al. Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers. Thromb Res 1999; 93:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/46\">",
"      Matetzky S, Tani S, Kangavari S, et al. Smoking increases tissue factor expression in atherosclerotic plaques: implications for plaque thrombogenicity. Circulation 2000; 102:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/47\">",
"      Nowak J, Murray JJ, Oates JA, FitzGerald GA. Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation 1987; 76:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/48\">",
"      Stefanadis C, Tsiamis E, Vlachopoulos C, et al. Unfavorable effect of smoking on the elastic properties of the human aorta. Circulation 1997; 95:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/49\">",
"      Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88:2149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/50\">",
"      Barua RS, Ambrose JA, Eales-Reynolds LJ, et al. Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation. Circulation 2001; 104:1905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/51\">",
"      Sumida H, Watanabe H, Kugiyama K, et al. Does passive smoking impair endothelium-dependent coronary artery dilation in women? J Am Coll Cardiol 1998; 31:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/52\">",
"      Celermajer DS, Adams MR, Clarkson P, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996; 334:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/53\">",
"      Kaufmann PA, Gnecchi-Ruscone T, di Terlizzi M, et al. Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation 2000; 102:1233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/54\">",
"      Johnson HM, Gossett LK, Piper ME, et al. Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. J Am Coll Cardiol 2010; 55:1988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/55\">",
"      Kugiyama K, Yasue H, Ohgushi M, et al. Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers. J Am Coll Cardiol 1996; 28:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/56\">",
"      Ichiki K, Ikeda H, Haramaki N, et al. Long-term smoking impairs platelet-derived nitric oxide release. Circulation 1996; 94:3109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/57\">",
"      Mazzone A, Cusa C, Mazzucchelli I, et al. Cigarette smoking and hypertension influence nitric oxide release and plasma levels of adhesion molecules. Clin Chem Lab Med 2001; 39:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/58\">",
"      Rooks C, Faber T, Votaw J, et al. Effects of smoking on coronary microcirculatory function: a twin study. Atherosclerosis 2011; 215:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/59\">",
"      Bazzano LA, He J, Muntner P, et al. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med 2003; 138:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/60\">",
"      Bermudez EA, Rifai N, Buring JE, et al. Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol 2002; 89:1117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/61\">",
"      Zevin S, Saunders S, Gourlay SG, et al. Cardiovascular effects of carbon monoxide and cigarette smoking. J Am Coll Cardiol 2001; 38:1633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/62\">",
"      Allred EN, Bleecker ER, Chaitman BR, et al. Short-term effects of carbon monoxide exposure on the exercise performance of subjects with coronary artery disease. N Engl J Med 1989; 321:1426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/63\">",
"      Aronow WS, Cassidy J, Vangrow JS, et al. Effect of cigarette smoking and breathing carbon monoxide on cardiovascular hemodynamics in anginal patients. Circulation 1974; 50:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/64\">",
"      Mayhan WG, Sharpe GM. Chronic exposure to nicotine alters endothelium-dependent arteriolar dilatation: effect of superoxide dismutase. J Appl Physiol 1999; 86:1126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/65\">",
"      Li Z, Barrios V, Buchholz JN, et al. Chronic nicotine administration does not affect peripheral vascular reactivity in the rat. J Pharmacol Exp Ther 1994; 271:1135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/66\">",
"      Sun YP, Zhu BQ, Browne AE, et al. Nicotine does not influence arterial lipid deposits in rabbits exposed to second-hand smoke. Circulation 2001; 104:810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/67\">",
"      Neunteufl T, Heher S, Kostner K, et al. Contribution of nicotine to acute endothelial dysfunction in long-term smokers. J Am Coll Cardiol 2002; 39:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/68\">",
"      Pryor WA, Stone K. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci 1993; 686:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/69\">",
"      Svrivastava SK, Barua RS, Saha DC, et al. Endogenous free radical generating sources are involved in smoking-mediated dysfunction of nitric oxide biosynthesis in human coronary artery endothelial cells: an in vitro demonstration. J Am Coll Cardiol 2003; 41 Suppl A:306A.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/70\">",
"      Barua RS, Ambrose JA, Srivastava S, et al. Reactive oxygen species are involved in smoking-induced dysfunction of nitric oxide biosynthesis and upregulation of endothelial nitric oxide synthase: an in vitro demonstration in human coronary artery endothelial cells. Circulation 2003; 107:2342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/71\">",
"      Heitzer T, Just H, M&uuml;nzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 1996; 94:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/72\">",
"      Barbash GI, White HD, Modan M, et al. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation 1993; 87:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/73\">",
"      Mueller HS, Cohen LS, Braunwald E, et al. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II. Circulation 1992; 85:1254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/74\">",
"      Barbash GI, Reiner J, White HD, et al. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the \"smoker's paradox\" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1995; 26:1222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/75\">",
"      Burke AP, Farb A, Malcom GT, et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997; 336:1276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/76\">",
"      Gomez MA, Karagounis LA, Allen A, Anderson JL. Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction. TEAM-2 Investigators. Second Multicenter Thrombolytic Trials of Eminase in Acute Myocardial Infarction. Am J Cardiol 1993; 72:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/77\">",
"      Gottlieb S, Boyko V, Zahger D, et al. Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey). J Am Coll Cardiol 1996; 28:1506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/78\">",
"      Ishihara M, Sato H, Tateishi H, et al. Clinical implications of cigarette smoking in acute myocardial infarction: acute angiographic findings and long-term prognosis. Am Heart J 1997; 134:955.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/79\">",
"      Ruiz-Bail&eacute;n M, de Hoyos EA, Reina-Toral A, et al. Paradoxical effect of smoking in the Spanish population with acute myocardial infarction or unstable angina: results of the ARIAM Register. Chest 2004; 125:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/80\">",
"      de Chillou C, Riff P, Sadoul N, et al. Influence of cigarette smoking on rate of reopening of the infarct-related coronary artery after myocardial infarction: a multivariate analysis. J Am Coll Cardiol 1996; 27:1662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/81\">",
"      Weisz G, Cox DA, Garcia E, et al. Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction--the smoker's paradox revisited. Am Heart J 2005; 150:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/82\">",
"      Cohen DJ, Doucet M, Cutlip DE, et al. Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: another smoker's paradox? Circulation 2001; 104:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/83\">",
"      Rose G, Hamilton PJ, Colwell L, Shipley MJ. A randomised controlled trial of anti-smoking advice: 10-year results. J Epidemiol Community Health 1982; 36:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/84\">",
"      Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group. JAMA 1982; 248:1465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/85\">",
"      Hjermann I, Velve Byre K, Holme I, Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men. Lancet 1981; 2:1303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/86\">",
"      Hurt RD, Weston SA, Ebbert JO, et al. Myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, before and after smoke-free workplace laws. Arch Intern Med 2012; 172:1635.",
"     </a>",
"    </li>",
"    <li>",
"     The health benefits of smoking cessation. A report of the Surgeon General. DHHS Publication (CDC) 90-8416; U.S. Department of Health and Human Services, Washington, DC, 1990.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/88\">",
"      Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 2003; 290:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/89\">",
"      Mohiuddin SM, Mooss AN, Hunter CB, et al. Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. Chest 2007; 131:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/90\">",
"      Hermanson B, Omenn GS, Kronmal RA, Gersh BJ. Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry. N Engl J Med 1988; 319:1365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/91\">",
"      Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch Intern Med 2000; 160:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/92\">",
"      Rea TD, Heckbert SR, Kaplan RC, et al. Smoking status and risk for recurrent coronary events after myocardial infarction. Ann Intern Med 2002; 137:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/93\">",
"      Kawachi I, Colditz GA, Stampfer MJ, et al. Smoking cessation and decreased risk of stroke in women. JAMA 1993; 269:232.",
"     </a>",
"    </li>",
"    <li>",
"     Behaviorial Risk Factor Surveillance System. Survey data, 2000. Centers for Disease Control and Prevention www.cdc.gov/brfss/ (Accessed on March 07, 2005).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/95\">",
"      Flegal KM, Troiano RP, Pamuk ER, et al. The influence of smoking cessation on the prevalence of overweight in the United States. N Engl J Med 1995; 333:1165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/96\">",
"      Motley RJ, Rhodes J, Ford GA, et al. Time relationships between cessation of smoking and onset of ulcerative colitis. Digestion 1987; 37:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/97\">",
"      Barendregt JJ, Bonneux L, van der Maas PJ. The health care costs of smoking. N Engl J Med 1997; 337:1052.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/28/1482/abstract/98\">",
"      Frank E, Winkleby MA, Altman DG, et al. Predictors of physician's smoking cessation advice. JAMA 1991; 266:3139.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1504 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-41.222.196.37-062E1C4994-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_28_1482=[""].join("\n");
var outline_f1_28_1482=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SMOKING AND CARDIOVASCULAR DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Secondhand smoke",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Cigar smoking",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Smokeless tobacco",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      SMOKING AND ATHEROSCLEROSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Role of carbon monoxide",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Role of nicotine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Role of oxidative stress",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SMOKING AND OUTCOME AFTER REPERFUSION THERAPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - After fibrinolytic therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - After primary percutaneous coronary intervention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Unstable angina",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Stable coronary artery disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      CARDIOVASCULAR BENEFITS OF SMOKING CESSATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Acute coronary syndromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5055694\">",
"      Sudden cardiac death",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Stroke",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Effect of age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H84151498\">",
"      Improvement in endothelial function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Possible deleterious effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Methods of smoking cessation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1504\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1504|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/40/38541\" title=\"figure 1\">",
"      Smoking outcome after MI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/21/29022\" title=\"figure 2\">",
"      US smoking prevalence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1504|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/51/4924\" title=\"table 1\">",
"      Strategy smoking cessation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/0/27658?source=related_link\">",
"      C-reactive protein in cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/23/30073?source=related_link\">",
"      Cardiovascular effects of nicotine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/58/41895?source=related_link\">",
"      Control of secondhand smoke exposure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/31/19961?source=related_link\">",
"      Early trials of platelet glycoprotein IIb/IIIa receptor inhibitors in coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/43/1721?source=related_link\">",
"      Fibrinolytic therapy in acute ST elevation myocardial infarction: Initiation of therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/45/18138?source=related_link\">",
"      Lipoprotein classification; metabolism; and role in atherosclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/2/37930?source=related_link\">",
"      Long-term outcome after coronary artery bypass graft surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/53/26456?source=related_link\">",
"      Nutritional antioxidants in coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/37/19034?source=related_link\">",
"      Overview of homocysteine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/3/23609?source=related_link\">",
"      Overview of smoking cessation management in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/59/39866?source=related_link\">",
"      Overview of the risk equivalents and established risk factors for cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?11/52/12100?source=related_link\">",
"      Patient information: Heart attack recovery (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/6/37987?source=related_link\">",
"      Patient information: Heart attack recovery (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/13/19670?source=related_link\">",
"      Patient information: Quitting smoking (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?17/46/18146?source=related_link\">",
"      Patient information: Quitting smoking (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?23/16/23813?source=related_link\">",
"      Patient information: Recovery after coronary artery bypass graft surgery (CABG) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/42/21156?source=related_link\">",
"      Patient information: Recovery after coronary artery bypass graft surgery (CABG) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/62/22505?source=related_link\">",
"      Secondhand smoke exposure: Effects in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/16/22790?source=related_link\">",
"      Smoke inhalation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/4/5189?source=related_link\">",
"      Smoking and cardiovascular risk in diabetes mellitus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_28_1483="Distribution of somatostatin receptor subtypes";
var content_f1_28_1483=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F75201&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F75201&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Distribution of somatostatin receptor subtypes",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Subtype 1",
"       </td>",
"       <td>",
"        Brain, pancreas, liver, GI tract, lung",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Subtype 2",
"       </td>",
"       <td>",
"        Brain, kidney",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Subtype 3",
"       </td>",
"       <td>",
"        Brain, pancreas",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Subtype 4",
"       </td>",
"       <td>",
"        Brain, lung",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Subtype 5",
"       </td>",
"       <td>",
"        Brain, heart, adrenal, pituitary, GI tract, skeletal muscle",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Lamberts SW, van der Lely AJ, de Herder WW, Hofland LJ. N Engl J Med 1996; 334:246.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_28_1483=[""].join("\n");
var outline_f1_28_1483=null;
var title_f1_28_1484="Metered dose inhaler technique";
var content_f1_28_1484=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F72362&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F72362&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Technique for use of a metered dose inhaler (MDI)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Warm MDI canister to body temperature.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Shake MDI canister vigorously for 5 seconds.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Uncap mouthpiece and check for loose objects in the device.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Insert MDI into spacer in a vertical position. Hold the MDI upright with the index finger on the top of the medication canister and the thumb supporting the bottom of the inhaler. You may need to use the other hand to hold the spacer.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Breathe out normally.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Close lips around spacer. For spacers that have a mask, place mask completely over nose and mouth and&nbsp;hold the mask snugly to the face. If no spacer is available, close lips around mouthpiece or position it about 4 cm from the mouth.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Keep tongue away from the spacer opening or mouthpiece.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Press down the top of the medication canister with the index finger to release the medication.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        At the same time as the canister is pressed, inhale deeply and slowly through the mouth until the lungs are completely filled; this should take four to six seconds.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hold the medication in the lungs as long as possible (4 to 10) seconds before exhaling. If using a spacer, you may inhale a second time and hold the breath if needed.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If a second puff is needed, wait approximately 15 to 30 seconds between puffs, or long enough to perform the next inhalation properly. Shake canister again before use.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Recap mouthpiece.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rinse your mouth with water after using an inhaled glucocorticoid, and spit the water out rather than swallowing it.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    These instructions do NOT apply to dry powder inhalers. Cleaning instructions are provided separately.",
"    <div class=\"footnotes\">",
"     More detailed information about individual medication formulations can be found at file://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_28_1484=[""].join("\n");
var outline_f1_28_1484=null;
var title_f1_28_1485="Dose ranges adj analgesics";
var content_f1_28_1485=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F82318&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F82318&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Therapeutic dose ranges for commonly used adjuvant analgesics",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Category based on conventional use",
"      </td>",
"      <td class=\"subtitle1\">",
"       Class",
"      </td>",
"      <td class=\"subtitle1\">",
"       Drugs",
"      </td>",
"      <td class=\"subtitle1\">",
"       Usual starting dose",
"      </td>",
"      <td class=\"subtitle1\">",
"       Usual effective dose range*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"8\">",
"       Multipurpose analgesics",
"      </td>",
"      <td rowspan=\"2\">",
"       Corticosteroids",
"      </td>",
"      <td>",
"       Dexamethasone",
"      </td>",
"      <td>",
"       Varies",
"      </td>",
"      <td>",
"       1-2 mg twice daily, orally or IV",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Prednisone",
"      </td>",
"      <td>",
"       Varies",
"      </td>",
"      <td>",
"       5-10 mg twice daily",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"5\">",
"       Antidepressants",
"      </td>",
"      <td>",
"       Desipramine",
"      </td>",
"      <td>",
"       10-25 mg at bedtime",
"      </td>",
"      <td>",
"       50-150 mg at bedtime",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Duloxetine",
"      </td>",
"      <td>",
"       20-30 mg daily",
"      </td>",
"      <td>",
"       60-120 mg daily&bull;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Bupropion",
"      </td>",
"      <td>",
"       75 mg twice daily",
"      </td>",
"      <td>",
"       300-450 mg daily&Delta;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Venlafaxine, sustained release",
"      </td>",
"      <td>",
"       75 mg once daily",
"      </td>",
"      <td>",
"       150-225 mg daily",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Nortriptyline",
"      </td>",
"      <td>",
"       10 to 25 mg at bedtime",
"      </td>",
"      <td>",
"       50 to 150 mg at bedtime",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Alpha-2 adrenergic agonists",
"      </td>",
"      <td>",
"       Tizanidine",
"      </td>",
"      <td>",
"       1-2 mg at bedtime",
"      </td>",
"      <td>",
"       2-8 mg twice daily",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"3\">",
"       Used for neuropathic pain",
"      </td>",
"      <td rowspan=\"2\">",
"       Anticonvulsants",
"      </td>",
"      <td>",
"       Gabapentin",
"      </td>",
"      <td>",
"       100-300 mg twice daily",
"      </td>",
"      <td>",
"       300-1200 mg three times daily",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pregabalin",
"      </td>",
"      <td>",
"       25-75 mg twice daily",
"      </td>",
"      <td>",
"       150-300 mg twice daily",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       GABA agonists",
"      </td>",
"      <td>",
"       Clonazepam",
"      </td>",
"      <td>",
"       0.5 mg at bedtime",
"      </td>",
"      <td>",
"       0.5-3 mg daily",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Used for bone pain",
"      </td>",
"      <td rowspan=\"2\">",
"       Osteoclast inhibitors",
"      </td>",
"      <td>",
"       Pamidronate",
"      </td>",
"      <td>",
"       -",
"      </td>",
"      <td>",
"       60-90 mg monthly, IV",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Zoledronic acid",
"      </td>",
"      <td>",
"       -",
"      </td>",
"      <td>",
"       4 mg monthly, IV",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Used for bowel obstruction",
"      </td>",
"      <td>",
"       Anticholinergic drugs",
"      </td>",
"      <td>",
"       Glycopyrrolate",
"      </td>",
"      <td>",
"       0.1 mg daily",
"      </td>",
"      <td>",
"       0.1-0.2 mg three times daily, subcutaneously",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Somatostatin analogue",
"      </td>",
"      <td>",
"       Octreotide",
"      </td>",
"      <td>",
"       Varies",
"      </td>",
"      <td>",
"       0.1-0.3 mg twice daily, subcutaneously",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     GABA: gamma amino butyric acid.",
"     <br>",
"      * All dosages shown are for adult patients, oral administration, unless otherwise noted.",
"      <br>",
"       &bull; Randomized trials conducted in patients with diabetic peripheral neuropathy suggest no additional efficacy from 120 mg daily versus 60 mg daily.",
"       <br>",
"        &Delta; Bupropion doses &ge;150 mg should be sustained release.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_28_1485=[""].join("\n");
var outline_f1_28_1485=null;
var title_f1_28_1486="Contents: Hospital medicine womens health, obstetrics and gynecology";
var content_f1_28_1486=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?2/63/3070\">",
"       Hospital Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Hospital medicine womens health, obstetrics and gynecology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Hospital medicine womens health, obstetrics and gynecology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/34/42536\">",
"           Acute appendicitis in pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/44/36554\">",
"           Approach to abdominal pain and the acute abdomen in pregnant and postpartum women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/9/1178\">",
"           Clinical manifestations, diagnosis, and management of ectopic pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/55/39801\">",
"           Eclampsia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/44/17095\">",
"           Evaluation of acute pelvic pain in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/30/17897\">",
"           HELLP syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/57/31639\">",
"           Intrapartum fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/58/934\">",
"           Long-term complications of pelvic inflammatory disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/18/43305\">",
"           Management of hemorrhage in gynecologic surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/7/13434\">",
"           Management of hypertension in pregnant and postpartum women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/44/27336\">",
"           Management of postpartum hemorrhage at cesarean delivery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/60/41929\">",
"           Management of postpartum hemorrhage at vaginal delivery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/7/15482\">",
"           Management of pregnant women undergoing nonobstetric surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/38/42600\">",
"           Overview of postpartum hemorrhage",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/55/39800\">",
"           Overview of preoperative evaluation and preparation for gynecologic surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/1/5141\">",
"           Precipitous birth not occurring on a labor and delivery unit",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/23/21882\">",
"           Preeclampsia: Management and prognosis",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-0BDCA19A0E-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f1_28_1486=[""].join("\n");
var outline_f1_28_1486=null;
var title_f1_28_1487="Contents: Pediatric procedures";
var content_f1_28_1487=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?17/55/18302\">",
"       Pediatrics",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Pediatric procedures",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Pediatric procedures",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Airway",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/22/29030\">",
"           Basic airway management in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/26/39337\">",
"           Devices for difficult endotracheal intubation in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/61/17367\">",
"           Emergency airway management in children: Unique pediatric considerations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/45/37593\">",
"           Emergency rescue devices for difficult pediatric airway management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/48/29450\">",
"           Emergent endotracheal intubation in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/3/16441\">",
"           Needle cricothyroidotomy with percutaneous transtracheal ventilation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/29/24026\">",
"           Rapid sequence intubation (RSI) in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Anesthesia and sedation",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/9/23703\">",
"           Digital nerve block",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/57/33689\">",
"           Infiltration of local anesthetics",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/29/31194\">",
"           Pharmacologic agents for pediatric procedural sedation outside of the operating room",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/47/29432\">",
"           Preparation for pediatric procedural sedation outside of the operating room",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/23/43384\">",
"           Procedural sedation in children outside of the operating room",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/3/25658\">",
"           Selection of medications for pediatric procedural sedation outside of the operating room",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/50/43817\">",
"           Topical anesthetics in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cardiopulmonary life support",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/17/28948\">",
"           Assessment of perfusion in pediatric resuscitation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/43/7864\">",
"           Basic life support in infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/49/21272\">",
"           Defibrillation and cardioversion in children (including automated external defibrillation)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/51/40761\">",
"           Intraosseous infusion",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/55/8057\">",
"           Vascular (venous) access for pediatric resuscitation and other pediatric emergencies",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cardiovascular",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/61/2009\">",
"           Arterial puncture and cannulation in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/47/3833\">",
"           Principles of ultrasound-guided venous access",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/55/8057\">",
"           Vascular (venous) access for pediatric resuscitation and other pediatric emergencies",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Ear nose and throat",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/53/28504\">",
"           Diagnosis and management of foreign bodies of the outer ear",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/21/17752\">",
"           Diagnosis and management of intranasal foreign bodies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/58/26536\">",
"           Management of epistaxis in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gastroenterology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/3/21561\">",
"           Overview of inguinal hernia in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Genitourinary",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/25/30100\">",
"           Management of zipper injuries",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/48/33543\">",
"           Paraphimosis reduction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/56/42886\">",
"           Urine collection techniques in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Minor emergency procedures",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/63/6137\">",
"           Assessment and management of auricle (ear) lacerations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/53/12122\">",
"           Assessment and management of facial lacerations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/51/18232\">",
"           Assessment and management of intra-oral lacerations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/29/23000\">",
"           Assessment and management of lip lacerations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/9/30872\">",
"           Assessment and management of scalp lacerations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/22/33124\">",
"           Closure of minor skin wounds with staples",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/7/18553\">",
"           Closure of skin wounds with sutures",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/53/16216\">",
"           Digit dislocation reduction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/47/24309\">",
"           Evaluation and repair of tongue lacerations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/42/38564\">",
"           Fish-hook removal techniques",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/47/13044\">",
"           Hair entrapment removal techniques",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/23/4472\">",
"           Management of fingertip injuries",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/25/30100\">",
"           Management of zipper injuries",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/51/32567\">",
"           Minor wound preparation and irrigation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/40/38532\">",
"           Radial head subluxation (nursemaid's elbow)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/46/26340\">",
"           Reduction of temporomandibular joint (TMJ) dislocation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/49/8981\">",
"           Ring removal techniques",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/8/9351\">",
"           Subungual hematoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/32/41478\">",
"           Superficial wound repair with tissue adhesives",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/46/5865\">",
"           Technique of incision and drainage for skin abscess",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Musculoskeletal",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/40/31368\">",
"           Closed reduction and casting of distal forearm fractures in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/9/38038\">",
"           Knee (tibiofemoral) dislocation and reduction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/0/24581\">",
"           Patellar dislocations in children and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/44/6854\">",
"           Pediatric cervical spine immobilization",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/40/38532\">",
"           Radial head subluxation (nursemaid's elbow)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/46/26340\">",
"           Reduction of temporomandibular joint (TMJ) dislocation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/54/15208\">",
"           Splinting of musculoskeletal injuries",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/8/9351\">",
"           Subungual hematoma",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neurology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/1/25625\">",
"           Lumbar puncture: Indications, contraindications, technique, and complications in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/44/6854\">",
"           Pediatric cervical spine immobilization",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Ophthalmology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/28/44486\">",
"           Slit lamp examination",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pulmonary",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/61/2009\">",
"           Arterial puncture and cannulation in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/12/1226\">",
"           Placement and management of thoracostomy tubes",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Trauma life support",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/44/6854\">",
"           Pediatric cervical spine immobilization",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/12/1226\">",
"           Placement and management of thoracostomy tubes",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-3C0B11926B-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f1_28_1487=[""].join("\n");
var outline_f1_28_1487=null;
